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Abstract 
 
Applications of Enantioselective Halolactonization Reactions, Synthesis 
of Photocaged Compounds for Identifying Neurons Based on Function, 
and Progress Towards the Total Synthesis of Alstoscholarisine E 
 
Daniel William Klosowski, Ph.D. 
The University of Texas at Austin, 2018 
 
Supervisor: Stephen F. Martin 
 
Recently the Martin group developed a bifunctional organic catalyst that promotes 
highly efficient enantioselective halolactonization reactions for olefinic acids. Using the 
BINOL-amidine catalyst we invented, our group was able to perform halolactonization 
reactions on a broad array of substrates. Herein we describe the synthetic utility of this 
method through a concise synthesis of (+)-disparlure, along with the preparation of F ring 
synthons for the natural product kibdelone C.  
As part of a separate project, in collaboration with the Zemelman research group, 
we are working to design a system for identifying behaviorally relevant assemblies of 
neurons in awake animals. This novel technique identifies active neurons and tags them 
using fluorescent proteins that are expressed upon irradiation of the neuron with visible 
light. This system hinges on the preparation on light sensitive derivatives of a variety of 
repressor protein ligands using “cages” or “photocages.” Toward this end, we prepared 
photocaged derivatives of anhydrotetracycline and vanillic acid.  
 viii 
Finally, we disclose our progress towards the total synthesis of alstoscholarisine E, 
a natural product isolated in 2014 that was found to be a strong promoter of adult neuronal 
stem cell proliferation. We envisioned a convergent synthesis where skatole and a hetero-
Diels-Alder product could be joined through a metal catalyzed coupling to form the 
tetracyclic core of the molecule, which could then be easily transformed to 
alstoscholarisine E through an olefin reduction followed by a reductive cyclization. 
Accessing our desired hetero-Diels-Alder product quickly was paramount to the 
effectiveness of this route, and thus, we developed a method to access hetero-Diels-Alder 
precursors in one step starting from readily available hexahydrotriazines. 
 ix 
Table of Contents 
List of Tables .....................................................................................................................xv 
List of Figures .................................................................................................................. xvi 
List of Schemes ............................................................................................................... xvii 
APPLICATIONS OF ENANTIOSELECTIVE HALOLACTONIZATION REACTIONS ...................1 
Chapter 1: Catalytic Enantioselective Halolactonization Reactions ....................................1 
1.1 Introduction ...........................................................................................................1 
1.2 Developments in Catalytic Enantioselective Halolactonizations .........................4 
1.2.1 Overview of Reported Catalysts ............................................................4 
1.2.2 Yeung ...................................................................................................11 
1.2.3 Summary ..............................................................................................15 
1.3 Martin Group Halolactonization Methodology ..................................................16 
1.3.1 Catalyst Development ..........................................................................16 
1.3.2 Effects of Catalyst Modification ..........................................................20 
1.3.3 Halolactonization Reactions ................................................................23 
1.3.4 Mechanistic Aspects ............................................................................32 
1.3.5 Applications to Methodological Problems ..........................................34 
1.4 Desymmetrization via Asymmetric Halolactonization Reactions ......................36 
1.4.1 Introduction ..........................................................................................36 
1.4.2 Hennecke .............................................................................................37 
1.4.3 Desymmetrization of 1,4-Cyclohexadienoic Acids .............................38 
1.4.4 Johnston ...............................................................................................41 
1.4.5 Summary ..............................................................................................42 
 x 
1.5 Asymmetric Epoxidation of Unactivated Z-Disubstituted Olefins .....................43 
1.6 Summary and Conclusions .................................................................................48 
Chapter 2: Applications of Enantioselective Halolactonization Reactions .......................50 
2.1 Kibdelone C – Introduction and Isolation...........................................................50 
2.2 Previous Syntheses of F-Ring Subunits of Kibdelone C ....................................52 
2.2.1 Porco’s F-Ring for (+)-Kibdelone C ....................................................52 
2.2.2 Hudlicky’s Synthesis of Porco’s F-Ring .............................................59 
2.2.3 Ready’s F-Ring for (–)-Kibdelone C ...................................................60 
2.3 Martin Group Strategy ........................................................................................65 
2.3.1 Introduction and Synthetic Approach ..................................................65 
2.3.2 Strategies for Halogen Atom Installation on Kibdelone F-ring 
Subunits ..................................................................................................67 
2.3.2.1 β-Halogenation .........................................................................67 
2.3.2.2 Hunsdiecker Halodecarboxylation ...........................................69 
2.4 Martin Group Synthesis of F-Ring Subunits ......................................................74 
2.5 Summary of Martin Group F-ring syntheses ......................................................94 
2.6 (+)–Disparlure – Introduction .............................................................................96 
2.7 Select Previous Syntheses of Disparlure ............................................................98 
2.7.1 Iwaki’s Synthesis of (+)–Disparlure – Chiral Pool Starting 
Materials .................................................................................................98 
2.7.2 Sharpless’ Syntheses of (+)-Disparlure – Asymmetric Epoxidation 
and Dihydroxylation .............................................................................100 
2.7.3 Tsuboi’s Synthesis of (–)-Disparlure – Enzymatic Resolution .........103 
2.7.4 Kim’s Synthesis of (+)-Disparlure – Proline Organic Catalysis .......106 
2.7.5 Satoh’s Synthesis of (+)-Disparlure – Chiral Sulfoxide Auxiliary ....107 
 xi 
2.7.6 Summary of Previous Syntheses........................................................109 
2.8 Enantioselective Synthesis of (+)-Disparlure Via Asymmetric 
Iodolactonization ..............................................................................................109 
2.8.1 Synthetic Approach............................................................................109 
2.8.2 First Generation Synthesis .................................................................111 
2.8.3 Carbocupration of Acetylene .............................................................115 
2.8.4 Second Generation Synthesis.............................................................120 
2.8.5 Summary ............................................................................................128 
2.9 Summary and Conclusions ...............................................................................129 
SYNTHESIS OF PHOTOCAGED COMPOUNDS FOR LABELING NEURONS BASED ON 
FUNCTION ..................................................................................................................131 
Chapter 3: Photolabile Protecting Groups ..............................................................131 
3.1 Introduction .......................................................................................................131 
3.2 o-Nitrophenyl Photolabile Protecting Groups ..................................................133 
3.2.1 o-Nitrobenzyl Photolabile Protecting Groups....................................133 
3.2.1.1 Mechanism of Deprotection ...................................................134 
3.2.1.2 o-Nitrobenzyl Photolabile Protecting Group Derivatives ......137 
3.2.2  2-(2-Nitrophenyl)ethyl Photolabile Protecting Groups .....................139 
3.2.3 o-Nitroanilide Photolabile Protecting Groups ...................................141 
3.3  Arylcarbonyl Photolabile Protecting Groups ...................................................143 
3.3.1 Phenacyl Photolabile Protecting Groups ...........................................143 
3.3.1.1 p-Hydroxyphenacy Photolabile Protecting Groupsl ..............143 
3.3.1.2 Benzoin Photolabile Protecting Groups .................................145 
3.3.2 Deprotection Via Photoenolization ....................................................146 
 xii 
3.3.2.1 2-Methyl-Substituted Acetophenones ....................................147 
3.3.2.2 2-Ethylene-Subtituted Arylcarbonyl Photolabile Protecting 
Groups ..........................................................................................149 
3.3.2.3 Intramolecular Lactonization .................................................150 
3.4 Coumarin Based Photolabile Protecting Groups ..............................................151 
3.4.1 Mechanism of Deprotection...............................................................151 
3.4.2 Select Examples of Coumarin PPG Derivatives ................................153 
3.5 Bodipy Derived Photolabile Protecting Groups ...............................................155 
3.6 Biological Application of Photocages: Light Controlled Gene Expression .....156 
3.6.1 Overview of Small Molecule Regulated Gene Expression Systems .156 
3.6.2 Tetracycline Dependent Gene Expression .........................................159 
3.6.2.1 Tetracycline Resistance in Bacteria .......................................159 
3.6.2.2 TetON Gene Expression ..........................................................160 
3.6.2.3 Photocaged Doxycycline: Light Controlled TetON ................161 
3.6.3 Erythromycin Dependent Gene Expression ...................................................163 
3.6.3.1 Erythromycin Antibiotic Resistance ......................................163 
3.6.3.2 Photocaged Erythromycin: Light Controlled EryON ..............164 
3.7 Summary of Photolabile Protecting Groups .....................................................166 
Chapter 4: Synthesis of Photocaged Ligands...................................................................170 
4.1 Introduction .......................................................................................................170 
4.2 Novel Method for Identifying Active Neurons .................................................170 
4.2.1 Overview of Proposed Method ..........................................................170 
4.2.2 Generic Genetic Components of Neuron Labeling System ...............171 
4.2.2.1 Transcription Factor and Promoter X ....................................173 
 xiii 
4.2.2.2 Prokaryotic Operator/Repressor Pairs....................................174 
4.2.3 Implementation of Proposed Method ................................................176 
4.3 Design of Photocaged Ligands .........................................................................178 
4.4 Synthesis of CANBP Photocages .....................................................................183 
4.5 Synthesis of Caged Vanilic Acid Derivatives...................................................185 
4.5.1 Caging Vanillic Acid – Ester Derivatization .....................................185 
4.5.2 Caging Vanillic Acid – Phenol Derivatization ..................................190 
4.5.3 Synthesis of Caged Vanillic Acid Derivatives Summary and 
Conclusions ...........................................................................................192 
4.6 Synthesis of Caged Tetracycline Derivatives ...................................................193 
4.7 Summary and Future Directions .......................................................................205 
PROGRESS TOWARDS THE TOTAL SYNTHESIS OF ALSTOSCHOLARISINE E ..................208 
Chapter 5: Alstoscholarisines A–E – Isolation and Previous Syntheses .........................208 
5.1 Isolation ............................................................................................................208 
5.2 Previous Syntheses of Alstoscholarisine A ......................................................209 
5.2.1 Bihelovic and Ferjancic’s Synthesis of (±)-Alstoscholarisine A .......209 
5.2.2 Yang’s Synthesis of (–)-Alstoscholarisine A.....................................215 
5.2.3 Weinreb’s Synthesis of (±)-Alstoscholarisines B and C ...................219 
5.3 Summary ...........................................................................................................225 
Chapter 6: Progress Towards the Total Synthesis of Alstoscholarisine E .......................227 
6.1 Synthetic Strategy .............................................................................................227 
6.1.2 Martin Group Previous Work: Intramolecular Hetero-Diels–Alder 
Reactions ...............................................................................................228 
6.2 One-Step Preparation of Hetero-Diels–Alder Precursor ..................................232 
 xiv 
6.3 Hetero-Diels-Alder Reaction ............................................................................236 
6.4 Halogenation of Hetero-Diels–Alder Product ..................................................237 
6.5 Skatole Cross Coupling Efforts ........................................................................239 
6.5.1 Direct C-2 Coupling to Skatole .........................................................239 
6.5.2 C-2 Lithiation of Skatole ...................................................................240 
6.6 Summary ...........................................................................................................249 
6.7 Future Directions ..............................................................................................251 
Chapter 7 Experimental Procedures .................................................................................255 
7.1 General Experimental .......................................................................................255 
7.2 Experimental Procedures ..................................................................................256 
References .......................................................................................................................290 
 xv 
List of Tables 
Table 1.1 Effects of catalyst modification on the conversion of 1.74 to 1.75a .................23 
Table 1.2 Halolactonization of 4-substituted-4-pentenoic acidsa ......................................26 
Table 1.3 Halolactonization of 5-aryl-4(E)-pentenoic acidsa ............................................27 
Table 1.4 Halolactonization of 5-substituted-5-hexenoic acidsa .......................................29 
Table 1.5 Halolactonization of 5-substituted-4(Z)-pentenoic Acidsa ................................31 
Table 1.6 Iodolactonization of 6-substituted-5(Z)-hexenoic acidsa ..................................32 
Table 1.7 Desymmetrization of 1.117a–d via bromolactonization with 1.19...................39 
Table 2.1 Evaluation of catalysts 2.93 and 2.94 for the desymmetrization of 2.58 ..........78 
Table 2.2 Dihydroxylation of 2.59 ....................................................................................81 
Table 2.3. Conditions screened to prepare 2.101 ..............................................................86 
Table 2.4. Optimization of the preparation of Grignard reagent 2.193 ...........................121 
Table 2.5 Optimization of the carbocupration of 2.200 and 2.201 model systems. ........124 
Table 6.1. Negishi coupling conditions screened to form 6.60 .......................................246 
Table 7.1 Comparison of 13C NMR peaks of disparlure with reported literature 
values. .........................................................................................................272 
 xvi 
List of Figures 
Figure 1.1 Select examples of halogenated natural products. .............................................2 
Figure 1.2 Exo-cyclization mode of 5-aryl-4(Z)-pentenoic acids .....................................33 
Figure 1.3 Substrate scope of desymmetrizations of cyclohexadienes with 1.19 .............40 
Figure 1.4. Asymmetric epoxidations of unfunctionalized olefins with 1.147. ................47 
Figure 2.1 Kibdelones A–C ..............................................................................................51 
Figure 2.2 Mechanistic rationale for the observed diastereomeric ratio of 2.16 and 
2.17................................................................................................................56 
Figure 2.3 Summary of modifications to the Hunsdiecker halodecarboxylation .............71 
Figure 2.4. The gypsy moth pheromone disparlure. .........................................................97 
Figure 3.1. Select examples of o-nitrobenzyl photolabile protecting groups. ................139 
Figure 3.2. Select derivatives of the 2-(2-Nitrophenyl)ethyl PPG class .........................141 
Figure 3.3 Generic examples of expression-ON and expression-OFF systems ..............158 
Figure 3.4 Select tetracycline derivatives. ......................................................................159 
Figure 3.5. Select examples from most common classes of PPGs .................................168 
Figure 4.1 Basic components of the proposed neuron labeling system and their 
functions. .....................................................................................................173 
Figure 4.2. Select small molecule/repressor protein pairs ..............................................176 
Figure 4.3. Summary of the proposed method in practice ..............................................178 
Figure 4.4. Possible photocages for preparation of caged ligands ..................................179 
Figure 4.5. Planned photocaged derivatives of ligands 4.1, 4.2, and 4.4. .......................182 
Figure 4.6 Carbamate linked caged ATc derivative. ......................................................206 
Figure 5.1. Alstoscholarisines A–E (5.1–5.5) .................................................................208 
 xvii 
List of Schemes 
Scheme 1.1 General mechanism for bromonium ion transfer between olefins ...................3 
Scheme 1.2 Halonium stability studies by Olah. .................................................................4 
Scheme 1.3 Preparation of catalyst 1.67 from R-BINOL (1.57) .......................................18 
Scheme 1.4 Two-step preparation of enantioenriched epoxides from 4(Z)-alkenoic 
acids. .......................................................................................................36 
Scheme 1.5. Asymmetric epoxidations of 1.141 and 1.143 with catalyst 1.145. ..............46 
Scheme 2.1 Porco’s synthetic strategy towards (+)-kibdelone C. .....................................53 
Scheme 2.2. Porco’s synthesis of F-ring fragment 2.16 ....................................................54 
Scheme 2.3 Connection of ABCD-rings 2.4 and F-ring 2.5 and E-ring formation ...........58 
Scheme 2.5 Ready’s synthetic strategy for (–)-kibdelone C. ............................................61 
Scheme 2.6. Ready’s synthesis of F-ring fragment 2.48 ...................................................63 
Scheme 2.7 Connection of 2.54 and 2.48 and conversion to 2.57 ....................................65 
Scheme 2.8 Martin group synthetic plan for preparing kibdelone F-ring fragments. .......66 
Scheme 2.9 Bartlett’s synthesis of β-chlorinated cyclohexenoate 2.75 ............................69 
Scheme 2.10. General Barton–Hunsdiecker reaction and mechanism of radical 
decarboxylation. ......................................................................................72 
Scheme 2.11. Conjugate addition of p-methoxythiophenolate to 2.99 and mechanistic 
rationale for stereochemical outcome. ....................................................87 
Scheme 2.12. Halodecarboxylation of 2.105 via formation of 2.108................................91 
Scheme 2.13. Synthesis of F-ring fragments for kibdelone C natural products. ...............95 
Scheme 2.14. Iwaki’s enantioselective synthesis of (+)-disparlure. .................................99 
Scheme 2.15 Synthesis of (+)-disparlure via Sharpless asymmetric epoxidation. ..........101 
Scheme 2.16. Synthesis of (+)-disparlure via Sharpless asymmetric dihydroxylation. ..103 
Scheme 2.17. Tsuboi’s synthesis of (–)-disparlure via enzymatic chiral resolution. ......105 
 xviii 
Scheme 2.18. Kim’s synthesis of (+)-disparlure via proline catalysis. ...........................106 
Scheme 2.19. Satoh’s synthesis of (+)-disparlure. ..........................................................108 
Scheme 2.20. Martin group synthetic approach to (+)-disparlure. ..................................110 
Scheme 2.21 First generation synthesis of (+)-disparlure ...............................................114 
Scheme 2.22. Synthetic strategy for the one-step preparation of 2.158 ..........................115 
Scheme 2.23. Regiochemical outcomes in the carbocupration of alkynes ......................116 
Scheme 2.24. Theoretical mechanism of carbocupration of acetylene for clustered 
cuprates (R2CuLi•LiX) as proposed by Nakamura and Morokuma. ....118 
Scheme 2.25 One-step method for the preparation of Z-alkenoic acids reported by 
Fujisawa. ...............................................................................................119 
Scheme 3.1. Photodeprotection mechanism of o-nitrobenzyl photolabile protecting 
groups ....................................................................................................135 
Scheme 3.2. Photodeprotection mechanism for the 2-(2-nitrophenyl)ethyl-based 
PPGs ......................................................................................................140 
Scheme 3.3. Photodeprotection mechanism for the o-nitroanilide class of PPG. ...........142 
Scheme 3.4.Photodeprotection mechanism of the p-hydroxyphenacyl PPG. .................144 
Scheme 3.5. Photodeprotection mechanism for the 3’,5’-dimethoxybenzoin class of 
PPG. ......................................................................................................145 
Scheme 3.6 Problematic side reactions when protecting alcohols and amines with 
DMB. ....................................................................................................146 
Scheme 3.7 Photodeprotection mechanism of the 2-methylacetophenone PPG. ............148 
Scheme 3.8. Photodeprotection mechanism for the ethylene-substituted arylcarbonyl 
PPG .......................................................................................................149 
Scheme 3.9. Photodeprotection mechanism of 3.63 via intramolecular lactonization ....150 
Scheme 3.10 Photodeprotection mechanism for the coumarin PPGs .............................152 
 xix 
Scheme 3.11. Preparation of photocaged erythromycin derivative 3.92. ........................165 
Scheme 4.1. Synthesis of CANBP photocage 4.21. ........................................................184 
Scheme 4.2. Synthesis of nor-methyl CANBP photocage 4.25. .....................................185 
Scheme 4.3. Preparation of MOM protected vanillic acid 4.29. .....................................186 
Scheme 4.4. Yamaguchi esterification of 4.29 to prepare 4.30. ......................................189 
Scheme 4.5. Preparation of 4.38 from 4.27. ....................................................................191 
Scheme 4.6. Acylation of 4.1 with CbzCl in the absence of NMI. .................................198 
Scheme 4.7. Epimerization of ATc during the preparation from 4.55 ............................201 
Scheme 4.8. Synthesis of caged ATc derivative 4.61. ....................................................204 
Scheme 4.9. Release of substrates from a photocage connected by an ethylene 
diamine carbamate linker. .....................................................................206 
Scheme 5.1. Synthesis of 5.14 .........................................................................................210 
Scheme 5.2. Attempted domino cyclization sequence using 5.15 ..................................211 
Scheme 5.3 Successful domino cyclization sequence using 5.14 and 5.18 ....................212 
Scheme 5.4. Equilibration between 5.22 and 5.20. .........................................................213 
Scheme 5.5. Elaboration of 5.14 to alstoscholarisine A (5.1) .........................................214 
Scheme 5.6. Preparation of enantioselective Friedel–Crafts alkylation starting 
material. ................................................................................................216 
Scheme 5.7. Elaboration of 5.33 to 5.38. ........................................................................217 
Scheme 5.8. Completion of (–)-5.1 from 5.38 ................................................................218 
Scheme 5.9. Preparation of the Michael acceptor 5.45 ...................................................219 
Scheme 5.10 Synthesis of the tetracyclic core 5.50 of 5.2 and 5.3 .................................221 
Scheme 5.11. Elaboration of 5.50 to (±)-alstoscholarisine C (5.3) .................................223 
Scheme 5.12. Elaboration of 5.53 to 5.2 .........................................................................224 
Scheme 6.1. Synthetic strategy for the preparation of alstoscholarisine E (6.1). ............228 
 xx 
Scheme 6.2. Previous Martin group synthesis of intramolecular HDA precursors. ........230 
Scheme 6.3. Possible transition states for intramolecular HDA cycloadditions for 
amide tethered trienes. ..........................................................................231 
Scheme 6.4 General reactivity of hexahydrotriazines with acyl chlorides and 
nucleophilic capture of intermediates 6.28 or 6.29. ..............................232 
Scheme 6.5 Proposed mechanism for the halogenation of vinyl ethers by N-
halosuccinimides and silver nitrate. ......................................................239 
Scheme 6.6. C-2 -lithiation of skatole derivatives and transmetallation of 6.48. ............241 
Scheme 6.7. Proposed one-pot sequence for Negishi coupling of 6.45 and 6.35 or 
6.36........................................................................................................242 
Scheme 6.8. C-2 lithiation of 6.52 and subsequent deuterium quenching. .....................243 
Scheme 6.9. Summary of progress towards the total synthesis of alstoscholarisine E. ..250 
Scheme 6.10. Alternative Suzuki coupling strategy for connecting 6.36 and 6.72. ........253 
Scheme 6.11. Stille coupling strategy to prepare 6.3. .....................................................254 
 
 
 1 
APPLICATIONS OF ENANTIOSELECTIVE 
HALOLACTONIZATION REACTIONS 
Chapter 1: Catalytic Enantioselective Halolactonization Reactions 
1.1 INTRODUCTION 
Nature provides a wealth of complex natural products to inspire synthetic chemists. 
To date, there have been nearly 5,000 halogenated natural products discovered, 
approximately half of which contain sp3 hybridized carbon-halogen bonds.1 Consequently, 
the introduction of  carbon-halogen chiral centers is a critical component for targeting an 
enormous number of natural products. Natural products such as bromophycolide A (1.1), 
β-snyderol (1.2), (–)-kumausallene (1.3), and laurencin (1.4) have driven an ever-growing 
field of enantioselective halocyclization reactions (Figure 1.1). To date, enantioselective 
halolactonizations (1.5, Y = O, Z = OH),2–33 haloetherifcations (1.5, Y = O, Z = H2),
34–43 
and haloaminocyclizations (1.5, Y = NHR, Z = H2)
44–52 have been extensively explored 
(Equation 1.1). Other less explored halocyclization modes include oxazoline formation, 
oxazolidinone formation, and cyclization of oximes Although, catalytic halo-polyene 
cyclizations have proven to be particularly challenging, there has been some progress in 
the area (Equation 1.2).53–55 
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Figure 1.1 Select examples of halogenated natural products. 
 
 
 
The development of enantioselective halocyclization reactions is inherently 
difficult due to the propensity of halonium ions to transfer between olefins 
intermolecularly.56 Using variable-temperature 1H NMR experiments and computational 
studies, Brown demonstrated that a rapid olefin-to-olefin transfer process occurs between 
2-(2-adamantylidene)adamantane and the isolable halonium ions derived from it (Scheme 
1.1).57,58 In the context of enantioselective halocyclization reactions, this olefin-to-olefin 
 3 
transfer must be suppressed because of its potential to racemize halonium ions that are 
generated stereoselectively. Importantly, this transfer process has been shown to be 
competitive with nucleophilic capture of the halonium ion, and in an achiral environment, 
the equilibration will result in racemic products, even if the halogen atom is initially 
delivered selectively.56 
 
 
Scheme 1.1 General mechanism for bromonium ion transfer between olefins 
Additional challenges arise in the development of chloro- and fluorocyclization 
reactions because of the instability of the halonium intermediates. Olah studied the stability 
of halonium ions using 1.14 with varying degrees of methyl substitution at the R groups 
and found that all iodonium and bromonium ions were cyclic on the 1H NMR time scale at 
low temperatures, where chloro- and fluoro-substituted substrates of 1.14 existed as the 
cationic species 1.15 (Scheme 1.2).59–61 This is potentially detrimental to selectivity in 
halocyclization reactions because cationic intermediates provide little steric differentiation 
between either face of the cation, whereas nucleophilic attack onto a fully formed halonium 
ion would proceed from its opposite face, leading to excellent diastereoselectivity. 
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Scheme 1.2 Halonium stability studies by Olah. 
Despite these difficulties, considerable progress has been made in the area of 
catalytic enantioselective halocyclization reactions in the last 10 years. The majority of the 
work in this area has focused on enantioselective halolactonization reactions, and there has 
been a number of recent reviews that extensively cover the evolution of this field of 
research.56,62–67 The field of asymmetric halolactonization saw rapid development of 
organocatalysts between 2010–2016, but few new catalysts have been reported since. 
Herein we will discuss some of the major developments of organocatalytic enantioselective 
methods that have emerged in recent years. 
1.2 DEVELOPMENTS IN CATALYTIC ENANTIOSELECTIVE HALOLACTONIZATIONS 
1.2.1 Overview of Reported Catalysts 
Gao disclosed the first catalytic method for an enantioselective halolactonization 
reaction that provided the halolactones in good yield and with good enantioselectivities.68 
After Gao’s seminal reports, other groups quickly joined the effort. Borhan described the 
first highly enantioselective (up to 95:5 er) chlorolactonizations of a series of 4-aryl-
substituted-4-pentenoic acids 1.17 using the commercially available (DHQD)2PHAL 
(1.19) as the catalyst (Equation 1.3). Chlorolactonization has remained a particularly 
challenging area of research, in part due to the instability of the chloronium ion as 
previously mentioned. There have been only two other reported catalysts capable of 
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promoting enantioselective chlorolactonization reactions, and the substrate scope for these 
catalysts is limited. Tang reported the modified cinchona catalyst 1.21 which promotes 
chlorolactonizations of 4-aryl-substituted-4-pentenoic acids 1.17 with similar selectivities 
as 1.19 (Equation 1.4).12 Zhou reported the cinchonine-squaramide catalyst 1.25, which 
promotes the chlorolactonization of vinylbenzoic acids (1.22) with moderate to high 
enantioselectivities (Equation 1.5).23 Borhan remains the most active contributor in the area 
of enantioselective chlorocyclizations and continues to study the mechanistic aspects of 
these reactions in detail.21,33,69 
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Similar to chlorolactonization reactions, reports of successful catalysts for 
enantioselective fluorolactonizations have remained scarce. The first example came from 
Rueping, who utilized a combination of (DHQ)2PHAL (1.19) and Selectfluor
® (1.30) to 
generate a fluorinated isobenzofuran in modest yield (50%) and low enantioselectivity 
(27% ee).25 The only catalytic, highly enantioselective fluorolactonization using an 
electrophilic fluorine source reported thus far was achieved by Hamashima using catalyst 
1.29, although the method could only produce fluorinated isobenzofuranones 1.28 
(Equation 1.6).26 Jacobsen recently reported a method for asymmetric fluorolactonization 
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using a chiral aryl iodide catalyst and a nucleophilic fluoride source that delivered 
fluorinated isochromanones with generally high enantioselectivity.27 
 
 
Bromo- and iodolactonizations have received much greater attention from the 
synthetic community, and a wider variety of catalysts have been reported. Since Borhan’s 
initial report, a number of groups have demonstrated the utility of (DHQD)2PHAL (1.19) 
as a catalyst for bromolactonization reactions. Hamashima and Hennecke both employed 
1.19 for the desymmetrization of prochiral substrates through bromolactonization, work 
that will be discussed later in this chapter. Armstrong surveyed the ability of 1.19 to 
promote a small variety of olefinic acids that were generally aryl substituted, and in some 
cases the catalyst demonstrated good enantioselectivity.19 Yeung has arguably been the 
largest contributor to the area of organocatalytic enantioselective bromolactonizations, and 
his work will also be discussed in detail later in this section. Another major contribution 
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came from Fujioka with his catalyst 1.32. The C3-symmetric trisimidazoline catalyst 1.32 
was first reported to induce bromolactonizations of 5-aryl-substituted-5-hexenoic acids 
1.30 to afford δ-lactones 1.31 via a 6-exo cyclization mode (Equation 1.7), and it was later 
shown to also work well with tri- and tetrasubstituted olefinic acids.3,13 
 
 
For iodolactonizations, Jacobsen’s tertiary aminourea catalyst 1.36 promoted 
enantioselective iodolactonizations of 5-substituted-5-hexenoic acids 1.34 with moderate 
to excellent selectivities (Equation 1.8).4 Hansen later disclosed the squarimide catalyst 
1.38, which also induced iodolactonizations of the same substrates, but the selectivities 
were lower than with 1.36 (Equation 1.9).16 Johnston’s catalyst 1.41 promoted 
iodolactonizations of 5-substituted-5-hexenoic acids (1.30) with generally high 
enantioselectivities (Equation 1.10).11 Ishihara reported the iodolactonization of a unique 
substrate class using catalyst 1.44, which promoted the lactonization of benzyl-substituted-
4-pentenoic acids 1.42 with good enantioselectivities (Equation 1.11).  
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1.2.2 Yeung 
Yeung has been the most prolific contributor to the field of enantioselective 
bromolactonizations, and his work is worthy of discussion in detail because it is the most 
competitive with the methodology developed in our group. Yeung reported his first-
generation catalyst 1.48, which promoted bromolactonizations of 4-substituted-4-
pentenoic acids 1.46 (Equation 1.12).6 The thiocarbamate cinchona alkaloid catalyst 1.48 
was the result of screening a variety of different catalyst structural motifs, as well as a 
number of different structural modifications of the cinchonidine core features. The majority 
of alkenoic acid substrates 1.46 investigated were aryl substituted pentenoic acids, and for 
electron neutral or electron deficient arenes, the enantioselectivity was generally 70–91% 
ee. However, typical of these reactions, the conversion of substrates that contained electron 
rich arene rings proceeded with poor enantioselectivity (e.g. R = p-MeO-Ph, 28% ee). 
Yeung also demonstrated a limited number of examples where the olefin was substituted 
with an alkyl group, and for bulky groups (1.46, R = t-Bu, Cy) the selectivities were good 
(82–93% ee), while the methyl substituted substrate (1.47, R = Me) was poorly tolerated, 
and the corresponding lactone was afforded in only 41% ee. Notably, this was the first 
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report of a highly enantioselective catalytic halolactonization of an alkyl substituted 
olefinic acid.  
 
 
Yeung next investigated the bromolactonization of E-6-aryl-5-hexenoic acids 1.49, 
another common substrate for halolactonization reactions (Equation 1.13).7 Yeung 
discovered that catalyst 1.48 did not provide the same degree of high selectivity it displayed 
for 4-substituted-4-pentenoic acids 1.46. Another screen of structural modifications to the 
catalyst revealed that 1.51 was a superior catalyst for this class of substrates, and the aryl-
substituted olefinic acids 1.49 were converted to the corresponding bromolactones 1.50 
with 61–94% ee.  
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Yeung then explored a subset of 5-substituted-4(Z)-pentenoic acids, a substrate 
class that yet to be explored. Once again, Yeung found that structural modification of the 
catalyst was required before good selectivity could be achieved. Ultimately, catalyst 1.54 
was found to provide the highest degree of selectivity for the bromolactonizations of 1.52, 
which proceeded via a 5-exo cyclization mode to the corresponding γ-lactones 1.53 
(Equation 1.14).9 Again, mostly aryl substituted alkenoic acids were explored, but Yeung 
did investigate two alkyl substituted substrates, specifically 1.52 R = i-Pr, Cy, which were 
converted to the corresponding lactones with 1.53 R = i-Pr, Cy, 53% and 75% ee 
respectively.  
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Yeung later developed a new class of proline based second generation catalysts, but 
again he was unable to find a universal catalyst to promote varied substrates. The N-methyl 
substituted catalyst 1.55 promoted 6-exo cyclizations of primarily aryl substituted acids 
1.30 with 85:15–96:4 er (Equation 1.15). For pentenoic acids 1.46, the N-allyl substituted 
catalyst 1.56 delivered the corresponding bromolactones 1.47 with 87:13–96:4 er 
(Equation 1.16).14 
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1.2.3 Summary 
The introduction of asymmetric C-X bonds is an important and challenging task for 
synthetic chemists, and in recent years, great strides have been made in developing new 
catalytic methods to achieve these transformations. The field of enantioselective 
halolactonization in particular has seen explosive growth. Since the seminal reports of 
efficient catalytic enantioselective halocyclization by Gao and Borhan, there has been a 
myriad of new catalysts reported. Despite the many advances in the field and novel 
catalysts that have been developed, the substrate scope of each is typically limited, 
especially for fluoro- and chlorolactonizations. Additionally, there were several gaps in the 
methodology when we initiated our work that we sought to address with a new catalyst. 
One major deficiency in the art was the lack of examples of a halolactonization that 
proceeded via an exo mode of ring closure to give a lactone bearing a new C-X bond at a 
stereogenic secondary carbon atom. Although during the course of our investigations, 
Yeung disclosed halolactonizations of this type,9 but he primarily showed aryl substituted 
alkenoic acids, and in the case of alkyl substituted alkenoic acids, the enantioselectivities 
were modest (Equation 1.13). Hence, creating a new secondary C-X bond at a stereocenter 
by halolactonization of an alkene was an unsolved problem. Additionally, there were no 
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reported catalysts that could perform both bromo- and iodolactonizations. With the 
exception of 1.19, all other catalysts were halogenating reagent specific. This presented us 
with an opportunity to develop a catalyst that would expand the substrate scope and offer 
a unified approach towards halolactonization reactions. Accordingly, we set to the task of 
solving these unmet challenges.  
1.3 MARTIN GROUP HALOLACTONIZATION METHODOLOGY1 
1.3.1 Catalyst Development 
The development of an enantioselective halocyclization reaction is inherently 
difficult due to the reversibility of halonium ion formation, and its propensity to transfer 
X+ to another olefin prior to bimolecular nucleophilic capture.56–58,70 The most successful 
catalysts have addressed this issue through inclusion of both Lewis/Brønsted acid and 
Lewis/Brønsted base functionalities. The bifunctional nature of these catalysts is a critical 
component of their design, with the Lewis basic functionality enabling the coordination of 
the substrate and stabilization of the halonium ion; the Lewis acidic moiety enables the 
coordination of the halogenating reagent. When we began designing our catalyst, we 
envisaged incorporating some well-established bifunctional motifs from known catalysts 
onto a chiral binaphthyl backbone, which despite its ubiquity in enantioselective reactions, 
had not yet been applied to the development of a halocyclization catalyst (Equation 1.17).   
                                                 
1 This section is based on the forthcoming publication: Klosowski, D. W.; Hethcox, J. C.; Paull, D. H.; 
Fang, C.; Donald, J. R.; Shugrue, C. R.; Pansick, A. D.; Martin, S. F. Enantioselective Halolactonization 
Reactions using BINOL-derived Bifunctional Catalysts: Methodology, Diversification, and Applications J. 
Org. Chem. 2018, Accepted, In Press. The work in this section was done by the authors Hethcox, J. C.; 
Paull, D. H.; Fang, C.; Donald, J. R.; Shugrue, C. R.; Pansick, A. D; and Martin, S.F. 
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After a survey of reported catalysts, we reasoned that a basic nitrogen atom would 
be required to coordinate the carboxylic acid, and a Lewis acidic group such as a thiourea, 
urea, or thiocarbamate would be required to activate the halogenating reagent. The initial 
goal was to prepare derivatives of catalyst 1.68 (Scheme 1.3), which bears the requisite 
functionalities previously mentioned. The amidine group was selected rather than a tertiary 
amine because bromine is known to rapidly oxidize tertiary benzylic amines.71 
Additionally, the phenyl group was included at the 3-position of 1.68 to increase the steric 
bulk around the proposed catalophore, a strategy that has been shown to enhance 
stereoselectivity on other BINOL derivatives.72  
Towards this end, catalyst 1.67 was prepared from R-BINOL (1.57) in eight steps,15 
beginning with installation of methoxymethyl ether (MOM) protecting groups onto both 
phenols (Scheme 1.3). Lithiation of 1.59 with tert-butyllithium (t-BuLi) followed by 
lithium-halogen exchange with I2 delivered 1.60, which was used in a Suzuki coupling with 
phenylboronic acid to deliver 1.61. After removal of the MOM protecting groups, the 
benzylic primary amine moiety of 1.65 was installed through a three-step sequence, first 
through treatment of 1.62 with triflic anhydride to form triflate 1.63, which was used in a 
nickel catalyzed cyanation to afford 1.64, and the resultant nitrile moiety could be reduced 
through treatment with borane to finally deliver 1.65. The amidine moiety could then be 
easily formed through treatment of 1.65 with 1.66, affording 1.67 in eight steps and 35% 
overall yield from 1.57. Unfortunately, all subsequent efforts to convert the phenol moiety 
of 1.67 into thiocarbamate 1.68 were unsuccessful. 
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Scheme 1.3 Preparation of catalyst 1.67 from R-BINOL (1.57) 
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Despite this initial setback, it was hypothesized that 1.67, which contains an acidic 
phenolic hydroxyl group, might serve as an effective catalyst for bromolactonizations. In 
order to test this idea, however, it was first necessary to identify bromolactonization 
reaction conditions that gave minimal amounts of background reaction. Initial screenings 
revealed that stirring solutions of 5-phenyl-4(E)-pentenoic acid (1.69) in PhMe/CH2Cl2 
(1:1) containing 2,4,4,6-tetrabromobenzoquinone (TBCO, 1.72) at temperatures less than 
–40 °C for 14 h gave negligible amounts of racemic lactones 1.70 and 1.71, hence, TBCO 
was determined to be the optimum brominating reagent in our initial studies 
(Equation1.18).  
 
To our delight, we discovered that 1.69, in the presence of 1.67, could be converted 
to 1.73 with some enantioselectivity. A solvent screen revealed that PhMe/CH2Cl2 (2:1) 
provided the highest selectivity, and with optimal reaction conditions identified, 1.69 was 
converted to 1.73 in 95% yield and 97:3 er (Equation 1.19).  
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1.3.2 Effects of Catalyst Modification 
With the successful conversion of 1.69 to 1.73 with high enantioselectivity, the 
focus was shifted to olefinic acid 1.74, another common test substrate for 
bromolactonizations. Gratifyingly, we found that in the presence of 1.67, 1.74 was cyclized 
to 1.75 in 95% yield and a slightly diminished er of 86:14.  
 
In order to identify analogs of 1.67 that might be superior cataylsts, a series of 
analogs (1.76–1.85) was prepared, and we surveyed their ability to promote the 
lactonization of 1.74 (Table 1.1). We discovered that under the conditions for 
bromolactonization, 1.67 underwent facile bromination to give the 6-bromo analog 1.76 in 
high yield (Equation 1.21). Unsurprisingly, we found that 1.76 catalyzed the 
bromolactonization of 1.74 with the same enantioselectivity as 1.67 (Table 1.1, Entry 2).  
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The effect of electron withdrawing groups on the binaphthyl scaffold was evaluated 
through the 6-nitro analogx 1.77, which was unable to promote the bromolactonization of 
1.74 (Table 1.1, Entry 3). The steric requirements were probed next through analogs with 
substituents at the 3- and 3’-poisitions of the binaphthyl core, as well as on the amidine 
group (R1,R4, and R3 respectively). The phenyl group at R1 of 1.67 was initially included 
to help create a sterically biased catalytic pocket, but catalyst 1.78 (R1, R4 = H, R3 = Me), 
which lacks the phenyl group at R1, promoted the bromolactonization of 1.74 with nearly 
identical selectivity to that of 1.67 (84:16 vs 86:14), suggesting the phenyl group may not 
be necessary (Table 1.1, Entry 4). Increasing the size of the R1 substituent to triphenylsilyl 
(1.79, Table 1.1, Entry 5) or 2,4,6-triisopropylphenly (TRIP) (1.80, Table 1.1, Entry 6) led 
to signification erosion of enantioselectivity. Catalyst 1.81, which bears an additional 
phenyl group at the 3’-position (R1, R4 = Ph, Table 1.1, Entry 7), catalyzed the 
bromolactonization of 1.74 with similar selectivity to that of the parent catalyst, and the 
additional phenyl group was deemed unnecessary. A cursory examination of altering the 
substituent on the amidine group (R3) revealed that the methyl derivative provided the best 
selectivity. Changing R3 to a phenyl group (1.82, Table 1.1, Entry 8) did not significantly 
enhance selectivity, and incorporation of a t-butyl group (1.83, Table 1.1, Entry 10) lead to 
significant erosion of selectivity. Finally, to assess the importance of the bifunctional 
nature of the catalyst, derivative 1.85 was prepared, where the acidic phenolic group of 
1.78 was methylated (Table 1.1 Entry 11). This modification lead to a complete loss of 
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selectivity, suggesting that the acidic phenol in the catalyst is imperative for 
enantioselectivity. Although there were a number of catalyst derivatives that showed 
similar selectivity to the parent catalyst 1.67, there were instances throughout the method 
development where 1.67 was superior, and so it was used uniformly in the subsequent 
experiments.  
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Table 1.1 Effects of catalyst modification on the conversion of 1.74 to 1.75a 
 
 
Entry Cat. R1 R2 R3 R4 R5 erb 
1 1.67 Ph H Me H H 86:14 
2 1.76 Ph H Me H Br 86:14 
3c 1.77 Ph H Me H NO2 NR 
4 1.78 H H Me H H 84:16 
5 1.79 Ph3Si H Me H H 74:26 
6 1.80 TRIPd H Me H H 50:50 
7 1.81 Ph H Me Ph H 85:15 
8 1.82 Ph H Ph H H 82:18 
9 1.83 H H Ph H H 87:13 
10 1.84 H H t-Bu H H 62:38 
11 1.85 H Me Me H H 50:50 
aReactions run on 0.10 mmol scale and all reactions gave >90% conversion.ber determined by chiral HPLC; 
absolute stereochemistry of 1.75 was assigned by correlation of optical rotation with those previously 
reported.4,6 cNR = no reaction. dTRIP = 2,4,6-triisopropylphenyl. 
1.3.3 Halolactonization Reactions 
At the time of these investigations, no catalyst was known to promote 
enantioselective halolactonizations with more than one halogen. It was therefore intriguing 
whether or not 1.67 may promote other enantioselective halolactonizations. Initially, the 
chlorolactonization of 1.74 using 1.67 and 1.76 with N-chlorosuccinimide (NCS) and 1,3-
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dichloro-5,5-dimethylhydantion (DCDMH) in a variety of solvents was explored. 
However, consistent with other reports, the reactions proceeded with low conversions and 
poor enantioselectivities.6,9 We then turned our attention to iodolactonizations, and 
gratifyingly we discovered that the iodolactonization of 1.74 with N-iodosuccinimide 
(NIS) in the presence of 1.67 delivered the corresponding iodolactone in good yield and 
with high enantioselectivity (93:7 er). Optimization of the reaction conditions revealed that 
the iodolactonization of 1.74 was slightly faster in the presence of 1.76, and the reaction 
times could be further decreased by increasing the temperature to –20 °C from –40 °C with 
no loss of enantioselectivity (Equation 1.22). This slight operational advantage lead to 1.76 
as the catalyst of choice for iodolactonization reactions. Because Jacobsen had reported 
that use of iodine as an additive in iodolactonization reactions had beneficial effects on 
selectivity,4 we tested the effect of adding catalytic amounts of iodine. However, the 
inclusion of iodine (1–10 mol %) had little to no effect on the iodolactonization of 1.74. 
Notably however, the effect of iodine as an additive was not consistent, and some reactions 
benefitted from catalytic amounts of iodine.  
 
 
With a standard set of conditions identified for both bromo- and iodolactonizations, 
we evaluated catalysts 1.67 and 1.76 on a wider variety of benchmark substrates. 4-
Substituted-4-pentenoic acids are commonly employed as substrates to demonstrate the 
efficacy of enantioselective halolactonization reactions, and thus we evaluated the abilities 
of 1.67 and 1.76 to catalyze the halolactonizations of 1.74 and 1.46a–e. (Table 1.2). The 
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bromolactonizations of acids 1.46a and 1.46b, substituted with electron withdrawing arene, 
proceeded in good yield and with high enantioselectivity (Table 1.2, Entries 3,5), showing 
a slight increase in selectivity compared to alkenoic acid 174 (Table 1.2, Entry 1). This 
same effect was not observed for the iodolactonization of 1.46a, which was converted to 
iodolactone 1.87a with similar selectivity as its phenyl counterpart 1.86 (Table 1.2, Entry 
2); however, the generality of this electronic effect was not rigorously determined. 
Conversely, an electron donating group (R = p-OMe-Ph, 1.46c) lead to a significant 
reduction in enantioselectivity for both the bromo- and iodolactonization (Table 1.2, 
Entries 6,7). 4-Alkyl-4-pentenoic acids also underwent facile iodolactonization, but steric 
effects are important, and the reaction is more selective for larger alkyl groups (Table 1.2, 
Entries 8,9).  
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Table 1.2 Halolactonization of 4-substituted-4-pentenoic acidsa  
 
Entry Acids R Product Yield (%) erb 
1 1.74 Ph 1.75 99 86:14 
2 1.74 Ph 1.86 89 93:7 
3 1.46a p-NC-Ph 1.47a 92 94:6 
4 1.46a p-NC-Ph 1.87a 73 90:10 
5 1.46b m-NC-Ph 1.47b 89 91:9 
6 1.46c p-MeO-Ph 1.47c 70 58:42 
7c 1.46c p-MeO-Ph 1.87c 90 74:26  
8 1.46d Me 1.87d 96 65:35 
9 1.46e t-Bu 1.87e 91 83:17 
aReactions run on 0.10 mmol scale. Conditions for bromolactonization: 10 mol % 1.67, 1.2 equiv TBCO in 
PhMe/CH2Cl2 (2:1) at −50 °C. Conditions for iodolactonization: 10 mol % 1.76, 1.2 equiv NIS in 
PhMe/CH2Cl2 (2:1) at −20 °C.  ber determined by chiral HPLC; absolute stereochemistry of 1.75 and 1.86 
were assigned by correlation of optical rotation with previously reported,4,6 and other assignments are based 
upon analogy. cResults obtained with 10 mol % I2, 93% yield, 82:18 er. 
  In continuation of our evaluation of benchmark substrates, we next examined the 
halolactonizations of a small variety of trans-5-aryl-4-pentenoic acids (Table 1.3). 
Unsaturated acids 1.88a and 1.88b underwent bromolactonizations in the presence of 1.67 
and TBCO via 6-endo cyclizations in good yield and with high enantioselectivities (Table 
1.3, Entries 2 and 3). Iodolactonization of 1.69 afforded a mixture (1:1.3) of 6-endo and 5-
exo products 1.90a and 1.91a, respectively (Table 1.3, Entry 1). Iodolactonization of 1.88c 
(R = p-OMe-Ph) gave the 6-endo product 1.90c selectively with moderate 
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enantioselectivity (87:13 er, Table 1.3, Entry 4), whereas the iodolactonization of 1.88d (R 
= p-NC-Ph) afforded the 5-exo product 1.91d with very little enantioselectivity (58:42 er, 
Table 1.3, Entry 5). With the exception of 1.69, the regioselectivity of the 
halolactonizations were in accord with the electronic bias of the substrate. Notably, the 
enantioselectivities obtained with 1.67 and 1.76 for all of the benchmark substrates we 
evaluated are comparable to those obtained with other catalysts.  
Table 1.3 Halolactonization of 5-aryl-4(E)-pentenoic acidsa 
 
Entry Acids R Product Yield (%) erb 
1 1.69 Ph 1.90a + 1.91a 89c 95:5c 
2 1.88a 2-Np 1.89a 97 96:4 
3 1.88b 2-thienyl 1.89b 92 94:6 
4 1.88c p-MeO-Ph 1.90c 89 87:13 
5e 1.88d p-NC-Ph 1.91d 94 58:42 
aReactions run on 0.10 mmol scale. Conditions for bromolactonization: 10 mol % 1.67, 1.2 equiv TBCO in 
PhMe/CH2Cl2 (2:1) at −50 °C. Conditions for iodolactonization: 10 mol % 1.76, 1.2 equiv NIS in 
PhMe/CH2Cl2 (2:1) at −20 °C.  ber determined by chiral HPLC; absolute stereochemistry of 1.89a,b were 
assigned by correlation of optical rotation with the previously reported values,7 and other assignments are 
based upon analogy. Cratio of 1.0:1.3 based upon 1H NMR analysis; the er for 1.91a was 52:48. eReaction 
performed for 14 h at –20 °C and 48 h at –10 °C in CH2Cl2/PhMe (1:1). 
The halolactonization of a set of 5-substituted-5-hexenoic acids was evaluated next, 
and we found that olefinic acids 1.92a–c cyclized via 6-exo lactonizations to give the 
corresponding δ-lactones (Table 1.4). The phenyl substituted substrate 1.92a underwent 
bromolactonization in good yield (78%), but poor enantioselectivity (62:38 er)(Table 1.4, 
Entry 1). The iodolactonization of 1.92a showed improved results, and lactone 1.94a was 
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delivered in high yield (98%) and with moderately increased enantioselectivity (76:24 er) 
(Table 1.4, Entry 2). The halolactonizations of the methyl substituted acid 1.92b proceeded 
with similarly enantioselectivity for both the bromo- and iodolactonizations, affording 
lactones 1.93b and 1.94c in 82:18 er and 79:21 er respectively (Table 1.4, Entries 3 and 4). 
Similarly, the halolactonizations of 1.92c proceeded to give the the oxanones 1.93c and 
1.94c with near identical enantioselectivity, 85:15 and 84:16 respectively (Table 1.4, 
Entries 5 and 6).  
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Table 1.4 Halolactonization of 5-substituted-5-hexenoic acidsa 
 
Entry Acids R X Product Yield (%) erb 
1 1.92a Ph CH2 1.93a 78 62:38 
2c 1.92a Ph CH2 1.94a 98 76:24 
3 1.92b Me CH2 1.93b 90 82:18 
4d 1.92b Me CH2 1.94b 89  79:21  
5 1.92c Ph O 1.93c 94 85:15 
6e 1.92c Ph O 1.94c 91 84:16  
aReactions run on 0.10 mmol scale. Conditions for bromolactonization: 10 mol % 1.67, 1.2 equiv TBCO in 
PhMe/CH2Cl2 (2:1) at −50 °C. Conditions for iodolactonization: 10 mol % 1.76, 1.2 equiv NIS in 
PhMe/CH2Cl2 (2:1) at −20 °C.  ber determined by chiral HPLC; absolute stereochemistry of 194a was 
assigned by correlation of optical rotation with previously reported,4 and the other assignments are based 
upon analogy. cResults obtained with 10 mol % I2, 95% yield, 85:15 er. dResults obtained with 10 mol % I2, 
90% yield, 80:20 er. eResults obtained with 10 mol % I2, 89% yield, 90:10 er. 
At the outset of our investigations, the formation of chiral alkyl halides via 6-endo 
halocyclization modes was known. Our initial exploratory studies showed that our catalyst 
was similarly effective in promoting these cyclizations to generate C-X containing 
stereocenters. However, enantioselective halolactonizations in which a new C-X bond is 
produced at a secondary carbon atom via a 5-exo cyclization was unprecedented at the time 
of our investigations. We were intrigued if catalysts 1.67 and 1.76 could promote such 
reactions, and so we investigated the halolactonization of a representative selection of 5-
alkyl-4(Z)-pentenoic acids (Table 1.5). In the event, the bromo- and iodolactonizations of 
acids 1.52a–i proceeded via a 5-exo cyclization to furnish the corresponding γ-lactones in 
generally high yields and with high enantioselectivities (≥95:5 er). The unsaturated acid 
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1.52a (R = Et, Table 1.5, Entry 1) was the only substrate that cyclized with a modest er 
(85:15), suggesting, branching on the carbon atom attached directly to the olefin might play 
a role in determining selectivity. The iodolactonization of aryl substituted acids 1.52f–i 
also underwent cyclization via a 5-exo mode to form the iodolactones (1.95f–i) with high 
enantioselectivity (≥98:2). The γ-lactones 1.53aؘ–e and 1.95b–i contain two contiguous 
stereogenic centers, one of which bears a carbon-halogen bond. Notably, the Z-olefin 
geometry is important for the alkyl substituted olefinic acids, because the corresponding 5-
alkyl-4(E)-pentenoic acids cyclized with selectivity ranging from 50:50 er to 78:22 er. 
Collectively, the cyclizations of 1.52a–i represent the first examples halolactonizations that 
occur via a 5-exo mode of ring closure to give products in which new C–O and C–X bonds 
are formed at contiguous stereogenic centers with a high degree of enantioselectivity.  
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Table 1.5 Halolactonization of 5-substituted-4(Z)-pentenoic Acidsa 
 
Entry Acids R Product Yield (%) erb 
1 1.52a Et 1.53a 90 85:15 
2 1.52b i-Pr 1.53b 94 97:3 
3 1.52b i-Pr 1.93b 93 97:3 
4 1.52c i-Bu 1.52c 87 95:5 
5 1.52c i-Bu 1.93c 94 98:2 
6 1.52d t-Bu 1.52d 97 97:3 
7 1.52d t-Bu 1.93d 99 97:3 
8 1.52e Cy 1.52e 94 98.5:1.5 
9 1.52e Cy 1.52e 97 98:2 
10 1.52f Ph 1.93f 93 98.5:1.5 
11 1.52g p-NC-Ph 1.93g 95 99:1 
12 1.52h p-Cl-Ph 1.93h 89 98:2 
13 1.52i 2-Np 1.93i 94 98:2 
aReactions run on 0.10 mmol scale. Conditions for bromolactonization: 10 mol % 1.67, 1.2 equiv TBCO in 
PhMe/CH2Cl2 (2:1) at −50 °C. Conditions for iodolactonization: 10 mol % 1.76, 1.2 equiv NIS in 
PhMe/CH2Cl2 (2:1) at −20 °C. ber determined by chiral HPLC; absolute stereochemistry of 1.53d, 1.95d, and 
1.95f were determined by X-ray crystallography, and other assignments are based upon analogy. 
In a related set of experiments, we briefly examined the iodolactonizations of a set 
of 6-substituted-5(Z)-hexenoic acids 1.96a–d and found that the corresponding iodo δ-
lactones 1.97a–d were produced in high yields and with excellent enantioselectivities of 
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≥98:2 er (Table 1.6). Notably, these cyclizations also produce two adjacent stereogenic 
centers, one of which is a C-I bond.  
 
Table 1.6 Iodolactonization of 6-substituted-5(Z)-hexenoic acidsa 
  
Entry Acids R Product Yield (%) erb 
1 1.96a Ph 1.97a 89 99:1 
2 1.96b p-NC-Ph 1.97b 88 99:1 
3c 1.96c 2-Np 1.97c 93 98.5:1.5 
4c 1.96d t-Bu 1.97d 98 98:2 
aReactions run on 0.10 mmol scale. ber determined by chiral HPLC; absolute stereochemistry assigned 
based on analogy with 1.95d and 1.95f. cResults obtained after 38 h at –20 °C. 
1.3.4 Mechanistic Aspects 
The 5-exo halolactonization mode of aryl substituted olefinic acids 1.52f–i is 
perhaps surprising and worthy of mention. At first, one might anticipate that substrates 
such as 1.52f would be electronically biased towards a 6-endo cyclization, but the 
experimentally observed γ-lactones are consistent with the hypothesized transition state 
(Figure 1.2). Transition state 1.100 is expected to be favored relative to 1.98, because of 
the detrimental steric interaction present in 1.98 that prevents the benzylic stabilization of 
the iodonium ion or carbocation by the π electrons of the aryl group. The 5-exo 
cyclization mode is therefore favored due to steric and entropic reasons, and 1.101 is 
observed as the dominant product, rather than 1.99. 
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Figure 1.2 Exo-cyclization mode of 5-aryl-4(Z)-pentenoic acids 
Based on the results previously discussed, we devised a tentative working model to 
rationalize the stereochemical outcome for the enantioselective halolactonizations of 
unsaturated acids catalyzed by 1.67 and 1.76. We propose a Brønsted acid/base interaction 
between the carboxylate of the olefinic acid and either the naphthol moiety (e.g. in 1.102 
and 1.103) or the amidinium moiety (e.g. in 1.104 and 1.105). The bridged halonium ion 
can then be stabilized by a Lewis acid/base interaction with either the amidine (e.g. in 1.102 
and 1.103) or the naphthalenoxide moiety (e.g. in 1.104 and 1.105). The reaction pathway 
is then governed through the minimization of unfavorable steric interactions between the 
catalyst and the substrate. This can be achieved by orienting the steric bulk of the substrate 
away from the catalytic pocket created by the binaphthyl core, leading to either 1.102 or 
1.104 as the preferred transition states. It is still unclear which is the operative reaction 
pathway, however, important experimental evidence lends support to the transition state 
depicted in 1.102. During the course of our method development, we discovered that 
TBCO was not required as the brominating reagent during bromolactonizations, and the 
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bromolactones could be obtained in similar yield and selectivity when N-
bromosuccinimide (NBS) and 1,3-dibromo-5,5-dimethyl-hydantoin (DBDMH) were used 
as brominating reagents. Accordingly, amidines are known to transfer bromine from NBS 
to olefins,73 and the independence of our catalyst with respect to halogenating reagent 
offers support in favor of transition state 1.02, where the halogenated amidine could deliver 
“X+” to the olefin and then stabilize the incipient halonium.    
 
 
1.3.5 Applications to Methodological Problems 
At the beginning of our investigations, we identified a number of unmet synthetic 
challenges in the context of enantioselective halolactonizations. Inducing cyclizations that 
produced new C-X bonds at exogenic stereocenters was chief among them, but after 
achieving that goal, we moved on to other methodological gaps. Other problems that 
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needed to be solved included the desymmetrization of a prochiral substrate and  kinetic 
resolution of racemic substrates.  
The desymmetrization of a prochiral substrate was addressed through the 
bromolactonization of 1,4-dihydrobenzoic acid (1.108) in the presence of 1.67. In the 
event, the reaction proceeded to give lactone 1.109 in 73:27 er (Equation 1.23). Although 
the enantioselectivity of this reaction was initially modest, we discovered that the 
enantiopurity of 1.109 was easily improved to 99:1 er after a single recrystallization. 
Importantly, this was the first reported example of the desymmetrization of a prochiral 
substrate via an organocatalytic halocyclization reaction, although since our initial report, 
there have been several other examples of desymmetrizing halocyclization reactions (vide 
infra). Additionally, the iodolactonization of 1.108 could be effected using catalyst 1.76, 
but the resultant iodolactone was unstable. However, the utility of 1.76 as a catalyst to 
promote kinetic resolutions of racemic olefinic acids is demonstrated via the 
iodolactonizations of 1.110 (Equation 1.24) and 1.112 (Equation 1.25), and the 
corresponding iodolactones were obtained with moderate to good selectivity.  
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Another important extension of our halolactonization methodology is to the 
synthesis of enantioenriched cis-1,2-disubsubstituted epoxides, a functional group that is 
typically difficult to access in the absence of directing groups. We discovered that 4(Z)-
alkenoic acids can be readily converted into the corresponding epoxides by a facile two-
step process, first through an enantioselective iodoloactonization, followed by treatment of 
the enantioenriched iodolactone with a carbonate base in methanol in methanol (MeOH) 
as exemplified in the conversion of 1.52e to 1.114 (Scheme 1.4).   
 
 
Scheme 1.4 Two-step preparation of enantioenriched epoxides from 4(Z)-alkenoic acids.  
 
1.4 DESYMMETRIZATION VIA ASYMMETRIC HALOLACTONIZATION REACTIONS 
1.4.1 Introduction 
The desymmetrization of prochiral substrates through catalytic enantioselective 
halocyclization reactions has remained a challenging area of interest for organic chemists.64 
This class of reactions represents a powerful tool that offers rapid construction of useful 
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chiral building blocks. For example, the desymmetrization of 1,4-cyclohexadienoic acids 
provides chiral molecules with three contiguous stereocenters with dense 
functionalization.15,74 The desymmetrization of prochiral substrates through 
organocatalytic haloetherfication reactions has seen recent advances,38 but reports of 
desymmetrizing organocatalytic halolactonization reactions remains scarce.74–76 During 
the course of our enantioselective halolactonization method development, we demonstrated 
the first desymmetrization of a prochiral olefin via catalytic enantioselective 
halolactonization through the conversion of 1.108 to 1.109 (Equation 1.23). Prior to our 
work, enantioselective desymmetrizations via halolactonization had only been carried out 
using chiral auxiliaries, and while some of these methods were able to achieve excellent 
selectivities,76–79 the necessity of the auxiliary requires the additional step of attaching it to 
the substrate. Since our seminal report however, there have been several additional 
examples of asymmetric catalytic desymmetrizing halolactonization reactions, which will 
be summarized herein. 
1.4.2 Hennecke 
As part of his ongoing interest in desymmetrizing halofunctionalization reactions,35 
Hennecke developed conditions for the enantioselective bromolactonization of alkynes,13 
a substrate that previously presented a challenge for enantioselective halolactonizations. 
Normally the resulting 2-bromoenol lactone would be formed with no new stereocenters, 
however, a symmetrical starting material made an asymmetric cyclization possible. 
Hennecke explored a number of organocatalysts from the literature for this transformation, 
including the trisimidazoline catalyst reported by Fujioka11 along with other cinchona 
alkaloid scaffolds. Ultimately, the best results were obtained using (DHQD)2PHAL (1.19), 
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and Hennecke demonstrated the desymmetrization 1.115 to produce 1.116 in good yield 
(76–98%) and with high selectivity (86:14–98:2 er) (Equation 1.26). While the exact 
mechanism of the reaction remains unknown, Hennecke speculates that the brominated 
quinuclidine of the catalyst delivers a bromonium ion to the alkyne, while the nucleophilic 
attack of the carboxylic acid is directed through a hydrogen bonding interaction with the 
pyridizine moiety of the catalyst.  
 
 
1.4.3 Desymmetrization of 1,4-Cyclohexadienoic Acids 
In 2012, Hamashima reported the use of (DHQD)2PHAL as an effective catalyst 
for the desymmetrization α-substituted cyclohexadienes.74 The reaction was optimized on 
substrates 1.117a–d, where the alcohol protecting group varied in steric demand. The 
catalyst did not give any enantio-enriched product when the free alcohol 1.117a was used 
(Table 1.7, Entry 1), and the Boc protected 1.117b provided only modest enantioselectivity 
(Table 1.7, Entry 2). The catalyst tolerated substrates 1.117c and 1.117d, both of which 
contained alcohols protected with large silyl groups, and the corresponding bromolactones 
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were delivered with high degrees of selectivity (91 and 88% ee respectively) (Table 1.7, 
Entries 3 and 4). 
 
Table 1.7 Desymmetrization of 1.117a–d via bromolactonization with 1.19. 
 
 
Entry Acid R Product Yield (%) ee (%)a 
1 1.117a H 1.118a 70 0 
2 1.117b Boc 1.118b 84 45 
3 1.117c TIPS 1.118c 87 91 
4 1.117d TBDPS 1.118d 93 88 
 
Hamashima then explored the substrate scope of this reaction, probing the catalyst’s 
tolerance of substitution at the 1- and 4-positions of the cyclohexadiene ring (Figure 1.3). 
Hamashima found the methyl substituted lactone 1.119 could be obtained in good yield 
and selectivity (89%, 81% ee), but lactones 1.120 and 1.121, which bore the more sterically 
demanding OMOM groups, were obtained with good selectivity, but in diminished yields 
(34% and 46% respectively).  Further exploration of substitution at the α-position resulted 
in lactones 1.222 and 1.23, both of which were afforded with lower selectivity than 1.117. 
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When the substrate was electronically biased towards 5-exo cyclization through methyl 
substitution at the γ-position, lactone 1.124 was given with only 37% ee.  
 
 
Figure 1.3 Substrate scope of desymmetrizations of cyclohexadienes with 1.19 
Hamashima also demonstrated the formation of a γ-lactone through the one-carbon-
homologated cyclohexadiene 1.125 (Equation 1.27). This substrate was converted under 
his standard reaction conditions to give 1.126 with good enantioselectivity (92% ee). 
Finally, Hamashima showed an efficient kinetic resolution of 1.127 using catalyst 1.19, 
which afforded 1.128 and 1.129 with good enantioselectivities (Equation 1.28). 
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While the substrate scope of Hamashima’s desymmetrization is limited, there have 
been no other reports of catalysts that are able to effect halolactonizations for this substrate 
class. For comparison to our catalyst, we briefly explored α-substituted cyclohexadienoic 
acids similar to those used by Hamashima, but a variety of our catalysts were unable to 
provide the corresponding bromolactones with any enantioenrichment. Hamashima did not 
report any desymmetrizations of 1,4-dihydrobenzoic acid (1.108), but Armstrong disclosed 
this reaction in 2013 while surveying the ability of 1.19 to promote a small variety of 
bromolactonizations of alkenoic acids.75 Under reaction conditions similar to those used 
by Hamashima, Armstrong found that 1.108 was converted to 1.109 in the presence of 1.19 
in low yield (40%) and poor selectivity (30% ee) (Equation 1.29). Even though our catalyst 
1.67 could not effectively promote the bromolactonizations of α-substituted substrates, it 
appears that we have a niche in the ability to promote the desymmetrization of 1.108.  
 
1.4.4 Johnston 
Johnston recently reported the desymmetrization of cyclopentenoic acids which 
were promoted by the chiral Brønsted base catalyst 1.132 (Equation 1.30).80 Generally, the 
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catalyst tolerated aryl substituted cyclopentenoic acids (1.130 R = aryl) well, and the 
corresponding iodolactones (1.131) were delivered with good selectivity (89–94% ee). The 
catalyst also readily tolerated alkyl substituted acids (1.130 R = i-Pr, Bn, Me) with only 
slightly diminished selectivities (86–87% ee) compared to the aryl substituted acids. The 
ester (1.130, R = CO2t-Bu) and thioester (1.130, R = C(O)St-Bu) substituted acids however, 
displayed significantly lower selectivities, and the iodolactones were obtained with 64% 
and 74% ee respectively. The catalyst did not tolerate unsubstituted cyclopentenoic acids, 
and in the case of 1.130 R = H, no product was afforded under the reaction conditions.  
 
 
1.4.5 Summary 
The recent explosion of catalytic enantioselective halolactonizations has paved the 
way for a variety of novel desymmetric transformations through this reaction mode, 
allowing the conversion of prochiral or meso-compounds to optically active halolactones 
with good enantioselectivities. Despite recent progress, this has remained a challenging 
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area in catalytic enantioselective halolactonization research, as evidenced by the relatively 
few examples of reported desymmetrization methods compared to the number of catalysts 
capable of promoting asymmetric halolactonizations of alkenoic acids. The 
desymmetrization of prochiral substrates remains a powerful tool for synthetic chemists 
however, and the importance of generating stereogenic C–X bonds for the pursuit of 
halogenated natural products will continue to inspire new developments in this field.    
1.5 ASYMMETRIC EPOXIDATION OF UNACTIVATED Z-DISUBSTITUTED OLEFINS 
In order to better understand the significance of the ability to easily access 
enantioenriched cis-1,2-disubstituted epoxides from the corresponding enantioenriched 
halolactones obtained from our method, a brief overview of asymmetric epoxidations is 
required. Epoxides are versatile synthetic intermediates that are one of the most useful 
building blocks in organic synthesis. Epoxides easily undergo stereospecific ring-opening 
reactions that can be used to form bifunctional molecules and quickly build structural 
complexity.81–83 Additionally, this functional group is prevalent in a wide variety of natural 
products and biologically relevant molecules. Consequently, there has been great interest 
in the development of methods for the preparation of enantiopure epoxides. The 
enantioselective epoxidation of olefins using metal catalysis has seen widespread success 
and is arguably one of the most important synthetic techniques that has emerged in the last 
in 40 years.81 Indeed, Barry Sharpless was awarded the 2001 Nobel Prize as a compliment 
to his contributions to the field.  
Asymmetric epoxidations of cis-olefins conjugated to an alkyne, aryl group, or 
another alkene generally proceed with good selectivity for both organocatalytic and metal 
based catalytic methods.81,84 However, the direct asymmetric epoxidation of cis-1,2-
dialkyl-substitued olefins (1.134 R1, R2 = alkyl) remains a challenging area of research, 
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and there have been few successful reports of such a transformation (Equation 1.31). 
Aliphatic substituted olefins are challenging substrates for asymmetric epoxidations in part 
due to their low reactivity towards electrophilic oxidants. Additional complications arise 
in the difficulty for catalysts to achieve good enantioface differentiation for substrates of 
this type.  
.  
 
Jacobsen was the first to describe a highly selective asymmetric epoxidation of a 
simple cis-disubstituted olefin in 1991.85,86 Jacobsen explored a small variety of aryl 
substituted cis-olefins and showed that substrates such as 1.136 could be converted into the 
corresponding epoxide using catalyst 1.137 in 65–96% yield and with 92–98% ee. The 
only non-conjugated alkene that Jacobsen explored was the spirocyclic cyclohexene x, 
which underwent epoxidation in moderate 65% yield with 89% ee   
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In these initial studies, Jacobsen rationalized the selectivity of these Mn-salen 
catalysts with a steric model, where the substrate would interact with the catalyst in a 
manner that would minimize unfavored steric interactions.83,85 However, later 
investigations by Katsuki revealed that steric factors alone do not explain the observed 
enantiomeric ratios, and he hypothesized that the conjugated nature of the olefin plays a 
role in determining the epoxidation selectivity.87 Katsuki expanded Jacobsen’s 
investigations into asymmetric epoxidations non conjugated cis -1,2- -disubstituted olefins 
with substrates 1.141 and 1.143 (Scheme 1.5). Substrate 1.141 was converted to 1.142 with 
good selectivity, 82% ee, but the yield was low at 23%. The straight chain alkyl substituted 
1.143 was converted to 1.144 in poor yield of 13% and with poor enantioselectivity, 44% 
ee.  
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Scheme 1.5. Asymmetric epoxidations of 1.141 and 1.143 with catalyst 1.145. 
Significant progress was not made until years later when Katsuki reported the chiral 
titanium complex 1.147 as an effective catalyst for asymmetric epoxidations of 
unfunctionalized olefins (Figure 1.4).88 Using catalyst 1.147, Katsuki described 
epoxidations of a variety of aliphatic olefins, including the cis-disubstituted olefins of 
1.134 that correspond to products 1.150–1.152. These substrates were generally converted 
in 49–85% yield and with 70–92% ee. The catalyst displayed better selectivities for the 
terminal olefins which led to products 1.148 and 1.149 in 82 and 92% ee respectively. The 
cis-disubstituted olefins were converted with moderate selectivities, exemplified by 1.152 
which was obtained in only 70% ee. 
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Figure 1.4. Asymmetric epoxidations of unfunctionalized olefins with 1.147. 
Not long after Katsuki’s innovations, Shi reported efficient epoxidations using his 
organic chiral dioxirane catalyst 1.153. This catalyst was shown to promote the alkyl 
substituted olefin 1.154 to 1.155 in 52% yield and 64% ee (Equation 1.34). Selectivities 
improved substrates which were substituted with alcohols or carboxylic acids, as 
exemplified in equations 1.35 and 1.36. The alcohol containing substrate 1.156 was 
converted to 1.157 in 89% yield and 82% ee (Equation 1.35). Interestingly, 1.158 
underwent an intramolecular cyclization under the reaction conditions to afford the 
hydroxy lactone 1.159 in 75% yield and 91% ee (Equation 1.36). After probing a variety 
of other substrates, Shi concluded that the cis-olefins required two substituents with 
 48 
substantially different hydrophobic or electronic properties to obtain good selectivities. 
Shi’s method was lacking in that there was no universal catalyst for all the substrates he 
explored, and different substitutions required different derivatives of 1.153 to obtain good 
selectivity. 
 
 
1.6 SUMMARY AND CONCLUSIONS 
The bifunctional catalysts 1.67 and 1.76 were the first to incorporate a binaphthyl 
moiety as part of the catalyst design for an asymmetric halocyclization reaction.  We have 
shown that both 1.67 and 1.76 promote highly selective asymmetric bromo- and 
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iodolactonizations of a diverse array of olefinic acids. As part of these investigations, we 
were able to make a number of contributions to advance the field of enantioselective 
halolactonization reactions. Significantly, these catalysts were the first to induce highly 
enantioselective halolactonizations of alkyl substituted olefinic acids via exo cyclization 
modes to give halolactones bearing exogenic enantioenriched secondary C–X bonds. 
Additionally, with the exception of 1.19, these are the only catalysts reported that are able 
to effect more than one type of halolactonization mode, offering the beginnings of a more 
unified approach to enantioselective halocyclization reactions.  
In addition to expanding the substrate scope for enantioselective halolactonization 
reactions, we were also able to address some of the methodological gaps present in the field 
when we entered this area of research. Importantly, we demonstrated that 1.67 and 1.76 
promote desymmetrizations and kinetic resolutions with good levels of enantioselectivity. 
We further exemplified the utility of 1.76 by its application to the enantioselective 
synthesis of (Z)-1,2-alkyl epoxides from iodolactones generated from 4(Z)-pentenoic acids. 
As part of our ongoing interest in natural product synthesis, we wished to apply our 
halolactonization methodology to relevant synthetic problems in the field. Specifically, we 
planned to demonstrate the utility desymmetrizing 1,4-dihydrobenzoic acid through the 
enantioselective synthesis of F-ring fragments of the kibdelone natural products. 
Additionally, we were aware that the asymmetric introduction of epoxides to 1,2-
disubstitued cis olefins is a challenging transformation in the absence of directing groups. 
Our halolactonization methodology offered one solution to this problem, and we planned 
to showcase this strategy through an enantioselective synthesis of (+)-disparlure, an 
important insect pheromone for the management of gypsy moths.   
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Chapter 2: Applications of Enantioselective Halolactonization 
Reactions2 
2.1 KIBDELONE C – INTRODUCTION AND ISOLATION 
The kibdelones are hexacyclic tetrahydroxanthone natural products discovered by 
Capon in 2007.89 They are members of a growing class of natural products that is 
characterized by their highly oxygenated hexacyclic polyaromatic scaffolds. This class of 
natural products has attracted considerable attention from the synthetic community due to 
their interesting structures and biological activities.90 
Kibdelones A–C (2.1–2.3) were isolated from a rare Australian actinomycete 
genus, Kibdelosporangium sp (Figure 2.1). The structures were assigned after extensive 
NMR studies, and the three congeners differed only in the oxidation states of the B 
(qunione vs hydroquinone) and C (saturated vs unsaturated) rings. The isolation studies 
also revealed that kibdelone C could spontaneously oxidize to kibdelones A and B under 
aerobic conditions. Characteristic of this family of natural products, the kibdelones 
displayed potent biological properties, which included antibacterial and nematocidal 
activities, as well as cytotoxicity against a panel of human cancer cells. Their potent 
anticancer activity in particular was striking, as all three compounds displayed GI50 values 
of <5 nm in cell lines derived from lung, colon, ovarian, prostate, breast and other tumor 
types. The biological mechanism of action for this cytotoxicity remains unknown, and it is 
                                                 
2 Sections of this chapter are based on previously published work completed by Daniel W. Klosowski that 
Prof. Stephen F. Martin acted as an advisor for. See: Klosowski, D. W.; Martin, S. F. Enantioselective 
Synthesis of F-Ring Fragments of Kibdelone C via Desymmetrizing Bromolactonization of 1,4-
Dihydrobenzoic Acid. Synlett 2018, 29, 430–432 and Klosowski, D. W.; Martin, S. F. Synthesis of (+)-
Disparlure via Enantioselective Iodolactonization. Org. Lett. 2018, 20, 1269–1271. 
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unclear if kibdelones A–C are equally active, or if they interconvert under the conditions 
of the biological assays.89,91,92 
 
Figure 2.1 Kibdelones A–C  
The combination of unique structural features and potent biological activities of the 
kibdelones drew the attention of the synthetic community, culminating in two 
enantioselective total syntheses of kibdelone C (2.3). Porco completed a synthesis of (+)-
kibdelone C,93 and the antipode (–)-kibdelone C was completed by Ready.92,94 A major 
challenge for both groups during their respective syntheses was the preparation of the 
polyhydroxylated chiral F-ring of the natural product. As part of our work in the area of 
enantioselective halolactonization reactions, we applied the desymmetrization of 1,4-
dihydrobenzoic acid via enantioselective bromolactonization to the synthesis of two 
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synthons of the F-ring subunits of kibdelone C.95 In order to provide context for our work 
in this area, a summary of the previous syntheses of F-ring fragments of kibdelone C as 
well as the general strategies towards this natural product will be discussed.  
2.2 PREVIOUS SYNTHESES OF F-RING SUBUNITS OF KIBDELONE C 
2.2.1 Porco’s F-Ring for (+)-Kibdelone C 
For his synthesis of (+)-kibdelone C, Porco envisaged a late stage coupling of the 
ABCD fragment 2.4 and the chiral F-ring 2.7 through an oxa-Michael/retro-Michael 
Friedel–Crafts annulation sequence (Scheme 2.1) The construction of the F-ring 2.5 relied 
on a diastereoselective intramolecular halo-Michael aldol reaction of ynoate 2.6, which 
would ultimately arise from the commercially-available, enantiopure alcohol 2.7. 
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Scheme 2.1 Porco’s synthetic strategy towards (+)-kibdelone C. 
Porco’s synthesis of F-ring fragment 2.5 commenced with a Dess–Martin 
periodinane oxidation of the enantiopure alcohol 2.7 to give aldehyde 2.8 (Scheme 2.2). 
Chelation controlled addition of the zinc acetylide 2.9 to 2.8, followed by benzyl protection 
of the resulting alcohol and removal of the silyl protecting group with tetrabutylammonium 
fluoride (TBAF) delivered 2.11 in 60% yield over three steps. The free alcohol of 2.11 was 
then oxidized to the carboxylic acid through a two-step sequence, beginning with oxidation 
to the aldehyde with 2-iodoxybenzoic acid (IBX) followed by a Pinnick oxidation. Further 
treatment with methanol and sulfuric acid (H2SO4) delivered the methyl ester 2.12 with 
concomitant removal of the acetonide protection group. The secondary alcohol of 2.12 was 
then selectively benzylated, through benzylidene formation with 2.13, followed by 
treatment with trimethylsilyl chloride (TMSCl) and sodium cyanoborohydride (NaCNBH3) 
to provide 2.14 in 76% yield over two steps. The unprotected primary alcohol was oxidized 
to the aldehyde 2.15, and the stage was set for Porco to investigate the key step to form 
2.16, which would be achieved through an intramolecular halo-Michael aldol reaction. The 
desired transformation proceeded smoothly after treatment of 2.15 with magnesium iodide, 
which delivered the desired diastereomer 2.16 in 78% yield, with only minor amounts of 
2.17 being isolated.  
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Scheme 2.2. Porco’s synthesis of F-ring fragment 2.16 
The diastereoselectivity of this reaction can be rationalized through the proposed 
transition states 2.18–2.21 (Figure 2.2). Michael addition of iodide ion to the ynoate 2.15 
leads to the reversible formation of the β-iodoallenoate diastereomers 2.18 and 2.19, the 
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former of which can undergo cyclization via transition state 2.20 resulting in the minor 
product 2.17.The latter diastereomer 2.19 however can react via intermediate 2.21, in 
which leads  to the major product 2.16. Porco speculated that the preference for 2.16 over 
2.17 might be due to the stabilizing chelation of the benzyl ether and aldehyde with MgI2 
that is possible in transition state 2.21. Alternatively, the product ratio could be a reflection 
of the relative thermodynamic stability of 2.16 and 2.17 if epimerization by a retro-halo 
Michael aldol process can occur under the reaction conditions.  
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Figure 2.2 Mechanistic rationale for the observed diastereomeric ratio of 2.16 and 2.17 
With F-ring fragment 2.16 in hand, Porco attempted to couple it with 2.4 to generate 
2.22, but unfortunately the reaction was unsuccessful under a variety of palladium- and 
copper-catalyzed conditions (Equation 2.1).  
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Porco changed his strategy and instead targeted the acetonide 2.5 for use in an oxa-
Michael reaction, reasoning that the unhindered free allylic alcohol of 2.5 would impart 
better reactivity than its bulky benzyl protected counterpart 2.16. After screening a variety 
of conditions, the protecting group swap was achieved in two steps, beginning with a global 
debenzylation through treatment with BCl3, followed by protection of vicinal diol moiety 
with 2,2-dimethoxypropane under acidic conditions to deliver 2.5 in 87% yield (Equation 
2.2).  
 
 
 
After extensive screening, Porco was able to achieve the oxa-Michael/retro-
Michael addition elimination sequence to prepare the vinylogous carbonate 2.23, albeit in 
moderate yield (44%), through treatment of 2.4 and 2.5 with tribasic potassium phosphate 
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in DMSO (Scheme 2.3). The final E ring was then formed from 2.23 through a 2 step 
soaponification–Friedel–Crafts acylation sequence to afford 2.25. 
 
Scheme 2.3 Connection of ABCD-rings 2.4 and F-ring 2.5 and E-ring formation 
Porco prepared the F-ring fragment 2.5 in 13 steps and 15% overall yield.93 The 
oxa-Michael/retro-Michael strategy for preparing the vinylogous carbonate 2.23 relied on 
the elimination of the halogen atom of 2.5. The installation of halogen atoms at the β-
position of enoates is not a trivial task, and indeed there are no reported methods for a one-
step general transformation of this type. Accordingly, the use of 2.5 in his synthesis 
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required Porco to construct the F-ring fragment from a linear precursor, accounting in part 
for the lengthy synthetic sequence. Porco relied on a diastereoselective intramolecular 
halo-Michael aldol reaction (Scheme 2.2, 15 to 16) as the key step in the preparation of 
2.5, which worked well in terms of yield and diastereoselectivity. Prior to Porco’s work, 
transformations of this type had been previously investigated, but the 1,3-diol moiety of 
2.5 does add additional complexity that is not present in earlier examples.96 Porco’s choice 
of starting materials and strategy allowed him to rapidly construct the framework of 2.5, 
which contained all of the requisite carbon atoms after only the second step. However, the 
rest of the synthesis is mired in oxidation–reduction sequences and protecting group 
manipulations, with these two types of transformations comprising 11 out of the 13 total 
steps required to prepare 2.5 from 2.7.  
2.2.2 Hudlicky’s Synthesis of Porco’s F-Ring 
Hudlicky significantly shortened the synthesis of Porco’s F-ring fragment 2.5 
through a microbial dihydroxylation of methyl 2-halobenzoates (Scheme 2.4). Whole cell 
fermentation of 2.26 (X = Br) or 2.27 (X = I) with toluene dioxygenase overexpressed in 
E. coli JM 109 (pDTG601A) gave the mixture of diols, 2.28 (desired) and 2.29 (undesired)  
for X = Br in a 3.5:1 ratio, and 2.30 (desired) and 2.31 (undesired) for X = I in a 1:4 ratio. 
The interesting selectivity of the diol formation can be explained by Boyd’s rule, which 
states that the largest group directs the enzymatic dihydroxylation.91 In the case of 2.27 
where X = I, the large iodine atom directs the dihydroxylation, resulting in the undesired 
product as the major diastereomer. For the case of  2.26 where X = Br, the methyl ester is 
the directing component, leading to greater selectivity for the desired diastereomer.91 The 
desired diol 2.28 was carried on and protected as the acetonide through treatment with 2,2-
dimethoxypropane under acidic conditions to deliver 2.32. The final alcohol was installed 
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using a Mukaiyama hydration to afford 2.33 in only three steps from 2.26. While the 
enzymatic dihydroxylation of 2.26 significantly shortened the synthesis to Porco’s F-ring 
fragment, it was low yielding, providing the bromo-analogue 2.33 in only 2.2% overall 
yield.97 
 
Scheme 2.4 Hudlicky’s synthesis of Porco’s F-ring fragment. 
2.2.3 Ready’s F-Ring for (–)-Kibdelone C 
Ready planned a convergent approach to (–)-kibdelone C, where 2.34 could be 
synthesized from the AB-DEF ring system 2.35, which would be accessed through the 
smaller subunits 2.36–2.39 (Scheme 2.5). He planned to couple the D and F rings together 
through lithiation of the iodocyclohexene 2.39, followed by nucleophilic addition into 
aldehyde 2.38.  
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Scheme 2.5 Ready’s synthetic strategy for (–)-kibdelone C. 
 
The synthesis of Ready’s F-ring fragment began with Birch reduction of 2.40 to 
give the symmetrical silyl enol ether 2.41 in 82% yield (Scheme 2.6).92,94 Following work 
previously established by Myers for the synthesis of trans-diols, the Shi epoxidation of 2.41 
with catalyst 2.42 followed by treatment with BH3•THF smoothly delivered 
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polyhydroxylated cyclohexane 2.45 in 68% yield, as a single observable enantiomer and 
diastereomer. The highly selective epoxide reduction proceeds through the proposed 
intermediate 2.44, where borane first acts as a Lewis acid to promote the epoxide ring-
opening and then delivers a hydride intramolecularly to provide 2.45. This reaction 
installed all of the requisite oxygen atoms for the F-ring, with the correct stereochemistry 
between the C2 and C4 oxygen atoms. The alcohol at C1 was introduced with the incorrect 
stereochemistry and requires epimerization, while the C5 alcohol provides a handle for 
introducing the desired olefin. Towards these goals, 2.45 was tosylated to give 2.46 in 71% 
yield. The C1 alcohol was then oxidized under Swern conditions, which resulted in the β-
elimination of the tosyl group to afford the enone 2.47.  Iodination of the α-position of the 
enone, followed by Luche reduction afforded the desired F-ring fragment 2.48 in seven 
steps and 30% overall yield from 2.40. While Ready’s synthesis of 2.48 did not contain 
any novel chemistry, it was an efficient and high yielding preparation of the target F-ring 
fragment. 
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Scheme 2.6. Ready’s synthesis of F-ring fragment 2.48 
With the desired fragment prepared, Ready investigated the connection between the 
D and F rings to construct the tetrahydroxanthone E ring.92 Preliminary studies revealed 
that carbonylative Stille couplings between 2.49 and various F-ring precursors 2.50 were 
ineffective, showing no desired product formation (Equation 2.3). Interestingly, fully 
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protected F-rings could be metalated to give intermediates such as 2.53, but no addition to 
the electron rich, sterically encumbered aldehyde 2.52 was observed (Equation 2.4). It was 
hypothesized that the protected allylic alcohol of the 1,2-diol moiety might be causing 
steric crowding during the addition. To test this theory, Ready investigated the use of 2.48 
in the nucleophilic addition to aldehyde 2.54. Deprotonation of the free alcohol of 2.48 
with methyl lithium, followed by conversion to the vinyl lithium with t-BuLi, generated a 
nucleophile that was capable of adding to 2.54 to give the benzyl alcohol 2.55 in 80% yield 
as an inconsequential 1:1 mixture of diastereomers (Scheme 2.7).  The tetrahydroxanthone 
E ring was then cyclized through oxidation of 2.55 followed by immediate treatment with 
perchloric acid in a t-BuOH acetone solvent system to form the acetonide protected 2.56. 
The remaining free alcohol of 2.56 was protected as the methoxy methyl (MOM) ether 
2.57 in preparation for further elaboration to (–)-kibdelone C. 
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Scheme 2.7 Connection of 2.54 and 2.48 and conversion to 2.57 
2.3 MARTIN GROUP STRATEGY 
2.3.1 Introduction and Synthetic Approach 
As part of our ongoing interest in polycyclic  xanthone natural products such as IB-
0020898,99 and citreamicin η,100 we planned a synthetic approach to the kibdelone natural 
products. At the outset of our investigations, it was clear that the F-ring subunits of the 
kibdelones were not easily accessed, as exemplified by Porco’s 13 step sequence to prepare 
2.5 (Scheme 2.5). Therefore, we saw ample opportunity to improve upon the previous 
syntheses of these compounds. We envisaged a strategy that would achieve the two goals 
of 1) rapidly constructing F-ring subunits that could be applied towards the synthesis of the 
kibdelone natural products, and 2) demonstrating the synthetic utility of our 
enantioselective catalytic halolactonization methodology through an application to a 
synthetic problem. We devised a synthetic plan, where F-ring derivatives such as 2.62 
could be accessed in only five steps from 1,4-dihydrobenzoic acid as outlined in Scheme 
2.8. We previously demonstrated that we could access the enantiopure lactone 2.59 through 
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an asymmetric bromolactonization.15 We planned to install the 1,2-syn-diol moiety of the 
kibdelone F-rings through a dihydroxylation of 2.59, which we expected to proceed from 
the least hindered face to give 2.60. From here, treatment of 2.60 with methanolic base 
would give access to the enoate 2.61, which would then only require protecting group 
installations to complete 2.62, an F-ring very similar to the one used by Porco. 
Additionally, it seemed possible that we could elaborate 2.62 further to the halogenated 
fragments 2.63 and 2.64, possibly intercepting previously synthesized F-ring fragments. 
  
 
Scheme 2.8 Martin group synthetic plan for preparing kibdelone F-ring fragments. 
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2.3.2 Strategies for Halogen Atom Installation on Kibdelone F-ring Subunits 
2.3.2.1 β-Halogenation 
There exists few examples of the direct installation of halogen atoms to the β-
position of cyclohexenoates that would allow access to 2.63 from 2.62 in one step, but 
some limited precedent was available from Nicolaou101 that suggested the transformation 
would be possible. The lack of reported methods for this transformation indicated it may 
be challenging,  but this gap in methodology also presented us with an opportunity to 
develop novel chemistry.. 
The most relevant example for incorporating a halogen atom at the β-position of 
intermediate 2.62 in one step came from Nicolaou’s syntheses of diversonol and blennolide 
C (Equation 2.5).101 The synthesis of these natural products required the preparation of β-
brominated cyclohexenoate 2.66, which was achieved through treatment of 2.65 with 
bromine followed by triethylamine. While substrate 2.65 is notably different from 2.62 in 
the hybridization of the γ-position oxygen atom, it provided some evidence that our desired 
transformation was possible.  
 
 
Additionally, we saw an opportunity for the development of novel reaction 
conditions to achieve this β-halogenation in one step. There were several different 
speculative strategies that we deemed plausible as outlined in equations 2.6–2.8. Pursuing 
a strategy similar to that used by Nicolaou, we imagined if halogen addition across the 
olefin of 2.62 could be achieved through treatment with a dihalogen (X2), introduction of 
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a base to the reaction could result in a dehydrohalogenation to form 2.63 (Equation 2.6). 
Alternatively, if addition of an electrophilic halogen source (“X+”) resulted in formation of 
a halonium intermediate such as 2.68, the presence of base in the reaction could result in 
formation of the desired 2.63 (Equation 2.7). Another possible strategy would be through 
a nucleophilic addition of I– to the β-position of the enoate through exposure of 2.62 to 
trimethyl silyl iodide. This could result in the silylketeneacetal intermediate 2.69, which 
could then be oxidized to restore the enoate system (Equation 2.8).  
 
 
 
In the event these speculative strategies proved unsuccessful, we had sound 
precedent for the introduction of a chlorine atom to the β-position of 2.62 from Bartlett’s 
synthesis of (–)-2-chloroshikimic acid.102 Bartlett installed a vinyl chlorine atom at the β-
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position of the structurally related compound 2.70 in four steps, beginning with the 
conjugate addition of p-methoxythiophenol to 2.70 to provide a mixture (7:1) of 
diastereomers 2.71 and 2.72 in 98% yield (Scheme 2.9). The diastereomeric mixture was 
treated with sulfuryl chloride and then purified to give 2.73 in 78% yield. Thioether 2.73 
was oxidized with m-chloroperoxybenzoic acid (m-CPBA) to sulfoxide 2.74, which was 
thermally eliminated to give 2.75 in 66% yield on a small scale (150 mg), but diminished 
yields were observed on larger scales (1 g, 32%).103  
 
 
Scheme 2.9 Bartlett’s synthesis of β-chlorinated cyclohexenoate 2.75 
2.3.2.2 Hunsdiecker Halodecarboxylation 
While the possibility of preparing 2.63 was somewhat speculative, the synthetic 
path to 2.64 from 2.62 was more apparent. We planned to use a Hunsdiecker 
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halodecarboxylation reaction to access 2.64, a compound similar to Ready’s F-ring subunit 
(Equation 2.9).  
 
  
 
The classic Hunsdiecker reaction involves the preparation of alkyl halides from 
metal salts of aliphatic carboxylic acids (Equation 2.10).104 The original methodology was 
reported using silver carboxylate salts of aliphatic acids, but the reaction has since been 
shown to work with more stable thallium (I) and mercury (I) salts.105,106 Treatment of the 
metal carboxylate salt 2.77 with a dihalogen (X2) leads to the formation of the unstable 
acyl hypohalite 2.78, which undergoes homolytic cleavage of the O-X bond, leading to a 
radical decarboxylation to produce an alkyl radical. The radical is then trapped by a halogen 
source to yield an alkyl halide. Halodecarboxylation reactions have a wide substrate scope 
and generally proceed well for aliphatic primary, secondary, and tertiary carboxylic acids, 
as well as deactivated aromatic carboxylic acids.107 While there are numerous examples of 
halodecarboxylation reactions for cinnamic acids, there have been few successful 
applications for aliphatic vinylic carboxylic acids. Early reports employing silver salts of 
small unsaturated aliphatic carboxylic acids showed these substrates typically undergo 
lactonization or polymerization.104,108  
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The classic Hunsdiecker reaction is no longer widely used due to the technical 
difficulties with the preparation and purification of the silver carboxylate salts. The reaction 
is highly sensitive to trace amounts of water and the silver carboxylate salts are often 
difficult to dry due to thermal instability.106,109 There has been a number of improvements 
to the Hunsdiecker reaction that have led to increased yields and simplified procedures, 
including the Cristol–Firth,106 Kochi,110 and Suárez111 modifications (Figure 2.3). 
 
 
Figure 2.3 Summary of modifications to the Hunsdiecker halodecarboxylation 
The Barton–Hunsdiecker reaction has become one of the most commonly used 
modifications due to its wide functional group tolerance. The Barton modification utilizes 
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the thermal or photolytic decomposition of thiohydroxamate esters 2.81 to generate carbon 
radicals that can be trapped by a halogen source to give an alkyl halide (Scheme 2.10).107 
The thiohydroxamate esters are typically prepared by the reaction of acyl chlorides with 
2.80 or through a carbodiimide coupling with 2.80. The Barton–Hunsdiecker method 
tolerates a wide variety of functional groups due to the mild reaction conditions used to 
generate the carboxyl radical. 
  
 
Scheme 2.10. General Barton–Hunsdiecker reaction and mechanism of radical 
decarboxylation. 
Recently Streicher successfully demonstrated an application of the Barton–
Hunsdiecker reaction on a cyclohexenoic acid as part of an effort to synthesize shikimic 
acid derivatives.112 Streicher initially explored the halodecarboxylation of 2.87 as a model 
system, and he found that the use of 2,2,2-trifluoroethyl iodide (CF3CH2I) gave the best 
yields of 2.89 (Equation 2.11). Streicher screened a small variety of other halogenating 
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reagents including CCl4, CBr4, and 1,2-diiodoethane, but the yields were generally poor 
compared to CF3CH2I, affording 2.89a–c in 5–36% yield. In the simple model system, 2.87 
was converted to 2.89 in 64% yield, but the method was less successful on more complex 
substrates such as 2.90, which was converted to 2.91 in only 39% yield (Equation 2.12). 
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2.4 MARTIN GROUP SYNTHESIS OF F-RING SUBUNITS 
Before we could begin our syntheses of enantiopure F-ring fragments of the 
kibdelone natural products, there were several key questions about the desymmetrization 
of 1,4-dihydrobenzoic acid that needed to be addressed. We had previously shown that this 
desymmetrization could be carried out on small scale (0.1 mmol), at dilute reaction 
concentration (0.01 M), with 2,4,4,6-tetrabromo-2,5-cyclohexadienone (TBCO) as the 
brominating reagent; under these conditions extended reaction times (4 d) were required 
(Equation 2.13).  
 
 
 
In order for us to use enantiopure 2.59 as a starting material in a multi-step 
synthesis, optimization of these reaction conditions was necessary. Specifically, it was 
imperative that we demonstrate the reaction could be carried out on increased scale to 
produce synthetically useful quantities of 2.59. Additionally, we had only investigated the 
desymmetrization of 2.58 using the 3-substituted-phenyl catalyst ent-2.94. Previous 
catalyst modification studies revealed that the 3-unsubstituted catalyst ent-2.93 effected 
enantioselective halolactonizations olefinic acids with similar selectivities as its phenyl 
substituted counterpart ent-2.94. From a practical standpoint, 2.93 was a more attractive 
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catalyst for our method simply because it easier to prepare, requiring only five synthetic 
operations while 2.94 requires eight. Analysis of the stereochemistry of the F-ring of (+)–
kibdelone C revealed that we would need to promote the desymmetrization of 2.58 using 
the S-enantiomer of the BINOL-amidine catalysts. Accordingly, we prepared multigram 
quantities of catalysts 2.93 and 2.94 starting from enantiopure S-BINOL (2.92) using the 
previously established procedures from our lab (Equation 2.14).15 
 
 
With catalysts 2.93 and 2.94 in hand, our desymmetrization optimization studies 
commenced with the Birch reduction of benzoic acid. In the event, treatment of benzoic 
acid with sodium (3.5 equiv) in liquid ammonia according to a previously established 
procedure, resulted in only moderate yields of 2.58,113 with significant amounts of 
unreacted benzoic acid (2.95) recovered. Fortunately, this problem was easily solved by 
increasing the amount of sodium (6 equiv) used in the reaction, and 1,4-dihydrobenzoic 
acid (2.58) was obtained in 85% yield without any need for purification (90–95% pure by 
1H NMR) (Equation 2.15).  
 
 
 76 
With an effective protocol for preparing multigram quantities of 2.58 established, 
we began by simply repeating the previously reported results using catalyst 2.94. Under 
the same reaction conditions as before, it was immediately discovered that the reaction did 
not require four days, instead it went to completion after only 14 hours. Fortunately, the 
same enantiomeric ratio of 73:27 er was observed, and the enantioenrichment could indeed 
be increased after recrystallization to a single enantiomer (Equation 2.16). 
  
 
We next compared the ability of catalysts 2.93 and 2.94 to promote the 
bromolactonization of 2.58 to ascertain if the phenyl group of 2.94 was truly necessary. 
Additionally, we used the opportunity to probe the effects of the brominating reagent used. 
Previous studies indicated that the selectivity of the catalysts was independent of 
halogenating reagent, but to confirm this, we evaluated TBCO and N-bromosuccinimide 
(NBS) in this reaction. The ability to use a more common brominating reagent such as NBS 
would again improve the value of our method from a practical point of view. While TBCO 
is commerically available or easily prepared from tribromophenol, NBS is a more common, 
less specialized reagent. Comparison of catalysts 2.93 and 2.94 in this reaction with 5–15 
mol% catalyst loadings revealed that 2.94 universally performed better, with 73:27 er as 
the best selectivity obtained (Table 2.1). Catalyst 2.94 delivered a consistent 73:27 
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enantiomeric ratio at 10 mol % catalyst loadings, regardless of which brominating reagent 
was used (Table 2.1, Entries 4 and 8). The nor-phenyl catalyst 2.93 delivered lactone 2.59 
with diminished selectivities, ranging from 60:40 to 67:33, regardless of brominating 
reagent used (Table 2.1, Entries 1,3,5,7). Reduced selectivities were observed for both 
catalysts when only 5 mol % loadings were used, presumably due to increased background 
reaction, but the yields remained consistent throughout the reactions (63–73%) (Table 2.1 
Entries 1,2,5,6). Additionally, increasing the catalyst loading to 15 mol % showed no 
benefit for catalyst 2.94 (Table 2.1 Entry 10) however it did lead to increased selectivity in 
one instance for 2.93 (Table 2.1 Entry 9). Unfortunately, however, this increased selectivity 
was not consistent, and we experienced reproducibility issues in general with catalyst 2.93 
in this reaction. Therefore, we proceeded with catalyst 2.94 and NBS as the brominating 
reagent for future experiments.  
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Table 2.1 Evaluation of catalysts 2.93 and 2.94 for the desymmetrization of 2.58 
 
 
Entry “Br+” Catalyst Mol % Yield %a era 
1 TBCO 2.93 5 63 60:40 
2 TBCO 2.94 5 62 68:32 
3a TBCO 2.93 10 65 64:36 
4a TBCO 2.94 10 70 73:27 
5 NBS 2.93 5 68 60:40 
6 NBS 2.94 5 62 67:33 
7 NBS 2.93 10 72 63:37 
8 NBS 2.94 10 73 73:27 
9 NBS 2.93 15 68 74:26 
10 NBS 2.94 15 72 73:27 
aDetermined by chiral HPLC using chiracel OD-H, 1% i-PrOH/hexanes, 1 mL/min. 
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We next probed the tolerance of the reaction to increased reaction concentrations. 
Gratifyingly, we quickly discovered that increasing the reaction to 0.05 M or 0.1 M 
concentrations on a small scale (0.1 mmol) had no impact on the selectivity, and 2.59 was 
still obtained with 73:27 er (Equation 2.17). In retrospect, it would have been interesting 
to further explore the limits of the reaction concentration, but at the time, 0.1 M 
concentration was deemed suitable for our needs and we moved onto other, more pressing 
questions about the synthesis.  
 
 
 
Confident that our desymmetrization methodology would be scalable to 
synthetically useful quantities to prepare enantiopure F-ring fragments, we investigated the 
remaining steps of the synthesis using the racemate of 2.59. The next challenge in the 
synthesis was the conversion of bromolactone 2.59 to the diol 2.60. Identifying suitable 
conditions for the dihydroxylation of 2.59 proved to be non-trivial (Table 2.2). Standard 
dihydroxylation conditions114 (Table 2.2 Entry 1) proved to be too basic, and 
decomposition of the starting material was observed. It was clear that this reaction should 
proceed via a substrate controlled osmylation to the least hindered convex face of 2.59, 
ultimately favoring the desired product. Therefore, it seemed that the reaction should not 
require chiral ligands and we investigated reaction conditions with simple additives. 
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Switching to quinuclidine as a ligand and including a phosphate buffer to mitigate the 
basicity of the reaction conditions gave some of the desired product 2.60, but it was 
recovered in low yield (22%) and with low diastereoselectivity (1:1 dr) (Table 2.2 Entry 
2). Upjohn dihydroxylation conditions114 also provided some success, but again low yields 
due to significant formation of unidentified by-products and poor diastereoselectivity (4:1 
dr) were problematic (Table 2.2 Entry 3). Decreasing the reaction temperature to 0 °C with 
an increased reaction time showed no improvement (Table 2.2 Entry 4). Success was 
ultimately found through the use of citric acid as an additive, according to modified 
dihydroxylation conditions for electron deficient olefins reported by Sharpless.115 At room 
temperature, the reaction still gave poor yields and dr of 2.60, but significant unreacted 
starting material was still observed after three hours, with little to no by-products observed.  
Further optimization of the reaction conditions through decreased temperature delivered 
the desired diol 2.60 in 60% yield and >20:1 dr. It is worth mentioning that this reaction 
does require relatively high osmium catalyst loadings (10 mol %) to maintain the 
diastereoselectivity. Reactions with decreased catalyst loadings (1–5 mol %) lead to 
decreased diastereoselectivity.  Also worthy of note is that the purification of 2.60 by 
standard chromatography was initially problematic due to its high polarity. Fortunately, we 
discovered that the crude material could be purified simply through recrystallization in 
ethanol, eliminating the need for chromatographic purification. 
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Table 2.2 Dihydroxylation of 2.59 
 
Entry Reagents Solvents Time (h) T (°C) Yield (%) 
dra 
2.60:2.95 
1 
(DHQD)2Pyr, 
K3Fe(CN)6, 
K2CO3, 
K2OsO4•H2O, 
MeSO2NH2 
t-BuOH:H2O 
(1:1) 
3 rt NA NA 
2 
K2OsO4•H2O 
K3Fe(CN)6 
K2S2O8 
quinuclidine 
Na2HPO4 
MeSO2NH2 
t-BuOH:H2O 
(1:1) 
3 rt 22 1:1 
3 
 
K2OsO4•H2O, 
NMO 
acetone:H2O 
(1:1) 
3 rt 31 4:1 
4 
K2OsO4•H2O 
NMO 
acetone:H2O 
(1:1) 
16 0 35 4:1 
5 
K2OsO4•H2O 
NMO 
Citric acid 
t-BuOH:H2O 
(1:1) 
4 rt 34 3:1 
6 
K2OsO4•H2O 
NMO 
Citric acid 
t-BuOH:H2O 
(1:1) 
18 0 61 >20:1 
aRatio determined by 1H NMR of the crude reaction material. 
Fortunately, the next two synthetic steps proceeded with little trouble. When 2.61 
was treated with potassium carbonate in methanol, a multi-step cascade commenced, 
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beginning with the opening of the lactone to form 2.96, followed by β-elimination of the 
newly formed epoxide to give the desired triol 2.97 (Equation 2.18). Initial experiments at 
low temperature (0 °C) delivered mixtures of the epoxide 2.96 and the desired enoate 2.97. 
However, warming the reaction to room temperature gave clean conversion of 2.61 to 2.97 
with only unreacted potassium carbonate as the by-product.  
 
 
Initial efforts to protect the 1,2-diol moiety of 2.97 as an acetonide were low 
yielding under standard acetonide formation conditions,93 and 2.98 was obtained in only 
32% yield (Equation 2.19). This problem was attributed to the excess potassium carbonate 
that was being carried into the reaction with crude 2.97, which upon reaction with 
camphorsulfonic acid, produced water which inhibited the formation of the desired 
acetonide. Fortunately, the addition of 4 Å molecular sieves to the reaction led to a 
significant improvement in yield (75%) (Equation 2.20). With the successful preparation 
of 2.98, we had achieved an efficient synthesis to a viable kibdelone F-ring precursor in 
only five steps from benzoic acid. Notably, the formation of acetonide 2.98 was the first 
step of the synthesis that required purification by column chromatography. All of the 
previous reactions were purified by recrystallization, or the crude material was sufficiently 
pure to carry on to the next step.  
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To further demonstrate the utility of this method, we sought to prepare F-ring 
fragments similar to those used by Porco and Ready in their respective syntheses of 
kibdelone C. We first investigated the installation of a halogen atom at the β-position of 
enoate 2.98. Before proceeding however, we thought it prudent to protect the remaining 
free hydroxyl group of 2.98 to mitigate the possibility of detrimental side reactions. We 
planned to install a methoxymethyl ether (MOM) protecting group because it would allow 
for a global hydroxyl deprotection in the event that the protecting groups needed to be 
removed. Additionally, we sought to install a tert-butyldimethylsilyl ether (TBS) so that if 
needed, we would have a modular system where one protecting group could be selectively 
removed. The MOM protection of 2.98 proceeded with little trouble, and treatment of 2.98 
with MOMCl gave the desired product 2.99 in 95% yield.  
 
 
Installing the TBS protecting group, however proved to be more challenging. Initial 
experiments using TBSCl as the silylating reagent gave 2.100 in only 50% yield with 
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significant amounts of unreacted starting material being recovered, even after reaction 
times of 24 hours. This yield was improved by switching to the more reactive TBSOTf 
reagent, and 2.100 was isolated in 89% yield.  
 
 
 
 
 
With protecting groups in place, we turned our focus towards the β-halogenation 
2.99 and 2.100. Unfortunately, all of our efforts to achieve this transformation in a single 
step were unsuccessful (Table 2.3). Attempts to mimic the reaction conditions similar to 
those Nicolaou used through exposure of 2.99 or 2.100 to Br2 followed by treatment with 
triethylamine were unsuccessful and resulted in decomposition of the starting materials 
(Table 2.3, Entry 1). We suspected that the reaction of 2.99 or 2.100 with bromine led to 
the removal of the alcohol protecting groups, which could result in further detrimental side 
reactions, but none of the by-products could be identified. We next investigated 
electrophilic halogenating reagents, specifically NBS, NIS, and Barluenga’s reagent 
I(coll)2PF6.
 These reagents seemed promising in that they could provide an electrophilic 
halogen atom that would also produce an equivalent of base (succinate or collidine). 
Unfortunately, we observed no product formation with these reagents and only recovered 
unreacted starting material (Table 2.3, Entries 2–4), although we did not screen an 
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extensive number of more forcing conditions. Finally, we attempted a nucleophilic 
conjugate addition of iodine to the enoate moiety through reaction of 2.99 or 2.100 with 
TMSI, followed by addition of IBX (Table 2.3, Entry 5). Unfortunately, this reaction was 
also unsuccessful, and we only observed decomposition of the starting material. We 
suspect that protecting group stability was issue for these reaction conditions as well. The 
coordination of TMS to one of the acetal oxygen atoms could result in the removal of the 
protecting group, and then IBX would be able to oxidize any of the free alcohols. 
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Table 2.3. Conditions screened to prepare 2.101 
 
Entry Reagents Solvent T (0 °C) Time Resulta 
1 Br2; then Et3N CH2Cl2 0  
15 
min 
Decomp 
2 NBS 
THF or 
CH2Cl2 
0 to 
reflux 
12 h NR 
3 NIS 
THF or 
CH2Cl2 
0 to 
reflux 
12 h NR 
4 I(coll)2PF6 THF reflux 3 h NR 
5 TMSI; then IBX CH2Cl2 –78 to rt 4 h  Decomp 
aDecomp = intractable mixtures of products. NR = no reaction 
It became apparent that the β-halogenation of 2.99 or 2.100 in one step would be a 
significant challenge, so we turned our attention to the preparation of a chlorinated 
analogue through the methods previously established by Bartlett. In the event, the 
conjugate addition of lithium p-methoxythiophenolate to 2.99 proceeded in high yield 
(89%) to give 2.101 as a single diastereomer (Scheme 2.11). The diastereoselectivity of 
this reaction can be rationalized through the mechanism depicted in scheme 2.11. The 
lithium thiophenolate adds to the bottom face of the preferred half chair conformer 2.103. 
The resulting ester enolate 2.104 would then be protonated from the convex face, resulting 
in 2.102. Analysis of the 1H NMR spectrum of 2.102 reveals the C1 and C2 protons both 
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possess two coupling constants of 4.5 and 3 Hz respectively, suggesting that the thioether 
and methyl ester moieties adopt a diaxial configuration with each of the C1 and C2 protons 
being equatorial. 
 
Scheme 2.11. Conjugate addition of p-methoxythiophenolate to 2.99 and mechanistic 
rationale for stereochemical outcome. 
Unfortunately, however, we were unable to achieve the Pummerer type chlorination 
of 2.102. Treatment of 2.102 with sulfuryl chloride provided no evidence of 
productformation; only decomposition of the starting material was observed. We 
speculated that the protecting groups were again not stable to these reaction conditions, 
and we briefly attempted to achieve the chlorination using NCS, but to no avail (Equation 
2.24). 
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It was clear that the preparation of a chloro analogue of 2.5 was going to be non-
trivial and we ultimately decided to abandon our pursuit of intercepting Porco’s fragment, 
becausethe β-halogen of the enoate is not required for 2.98 to be used in a synthesis of a 
kibdelone natural product. Instead, we transitioned to preparing a vinyl halogenated 
fragment similar to the one used by Ready. 
Our elaboration of 2.99 to 2.110 commenced with the soaponification of methyl 
esters 2.96–2.98. This proved to be a surprisingly difficult transformation, due to protecting 
group instability and problems with epimerization. Initial experiments examining the 
conversion of the unprotected alcohol 2.96 to 2.104 with either sodium or lithium 
hydroxide in organic/aqueous solvent combinations resulted in diastereomeric mixtures 
that were the result of base promoted epimerization at the C6 stereocenter. Similarly, 
attempts to convert the protected alcohols 2.97 or 2.98 to the corresponding carboxylic acid 
under these conditions were also plagued by epimerization issues. In the case of 2.98, the 
TBS protecting group proved to be unstable and was removed during the soaponification. 
Cooling the reactions to 0 °C provided no improvement, and still diastereomeric mixtures 
of carboxylic acid products were observed. 
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Due to the instability of the TBS silyl ether and the likelihood that the alcohol would 
need a protecting group for the remaining steps, only the soaponification of the MOM 
protected alcohol 2.97 was investigated in future experiments. Switching to more mild 
conditions through treatment with potassium trimethylsilanolate, still resulted in significant 
epimerization of the C6 center. After screening a variety of conditions, we serendipitously 
discovered that soaponification of 2.97 with LiOH (1 M aqeous, 2 equiv) in CH3CN as the 
primary solvent, cleanly gave 2.105 as a single diastereomer in 87% yield. 
 
 
 
With this fortuitous finding and a route to 2.105 established, we next investigated 
the key Barton–Hunsdiecker halodecarboxylation reaction. Following the precedent from 
Streicher, we initially targeted the iodo derivative 2.109, which we would obtain using 
trifluoroiodoethane as the halogen source during the irradiation of 2.108. In an effort to 
keep the synthesis of 2.109 to as few steps as possible, we initially targeted a three step 
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one-pot procedure involving: 1) conversion of 2.105 to an acyl chloride; 2) formation of 
2.108; and 3) halodecarboxylation (Equation 2.28). Toward this end, we first investigated 
each one of these steps individually.  
 
 
Unfortunately, we discovered that conversion of 2.105 to acyl chloride 2.111 was 
problematic. Initial attempts to treat 2.105 with oxalyl chloride did not provide clean 
conversion to 2.111, and the product was accompanied with various unidentified by-
products (Equation 2.29). We speculated that the HCl generated during the reaction was 
interacting with the acid sensitive protecting groups, leading to deleterious side reactions. 
To mitigate this problem, the lithium salt of 2.105, generated from deprotonation with 
methyllithium, was treated  with oxalyl chloride, but the acyl chloride 2.111 was still only 
obtained in ca. 80% purity by 1H NMR analysis of the crude material (Scheme 2.12). 
Nevertheless, we carried this material forward in the formation of 2.108, which was then 
immediately irradiated with a 150 W electric flood lamp in the presence of CF3CH2I to 
deliver 2.109 in 22% yield. 
 
.  
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Scheme 2.12. Halodecarboxylation of 2.105 via formation of 2.108 
We were delighted to discover that the halodecarboxylation of 2.105 was possible, 
despite the poor yield, which we attributed to poor conversion of 2.111 to 2.108. 
Accordingly, we set to the task of optimizing this transformation. Fortunately, we found 
that an EDCI mediated coupling between 2.105 and 2.78 cleanly gave 2.108 in 85% yield, 
and the by-products from the reaction could be removed through an aqueous work up 
(Equation 2.30). 
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Unfortunately, even with efficient conversion of 2.105 to 2.108, the yield of the 
halodecarboxylation was still low, only providing 2.109 in a slightly improved yield of 
34%, with the only major identifiable by-product 2.112 being isolated in 15% yield 
(Equation 2.31).  
 
 
 
The undesired by-product 2.112 was presumably the result of a radical propagation 
between the vinyl radical of 2.108 and another equivalent of 2.108. We speculated that this 
side reaction could be suppressed by increasing the concentration of CF3CH2I, and we 
attempted the halodecarboxylation using this reagent as the solvent for the reaction. 
Unfortunately, this led to no improvement in yield, and 2.109 was isolated in 30% yield 
(Equation 2.32). 
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We next sought to make more drastic changes to reaction conditions through 
screening additional solvents and halogen sources. Unfortunately, despite screening a 
variety of halogen sources in CH2Cl2 or benzene, CF3CH2I still provided the best yield, 
with other reagents only giving minor amounts of product (10–25%) (Equation 2.33). 
Furthermore, attempts to drive 2.108 to radically decarboxylate under thermal conditions 
in the presence of AIBN also provided low yields of 2.109 or no product formation at all.  
 
 
Returning to reports from the original Baron literature revealed the use of Cl3CBr 
as a common solvent and bromine source for these radical brominations.107 Feeling like we 
had exhausted most other options, we attempted the conversion of 2.108 using this reagent 
as solvent. To our delight, we found that 2.108 was converted to 2.110 in 65% yield when 
Cl3CBr was used as solvent in this reaction (Equation 2.34). We found that the 65% yield 
was consistent and reproducible for the conversion of 2.108 to 2.110, but we were unable 
to improve this yield further. 
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2.5 SUMMARY OF MARTIN GROUP F-RING SYNTHESES 
A summary of the optimized transformations leading to the kibdelone fragments 
2.98 and 2.110 is provided in scheme 2.13.95 We have shown that desymmetrization of 1,4-
dihydrobenzoic acid (2.58) through enantioselective catalytic bromolactonization to give 
2.59 using the catalyst 2.94 may be easily upscaled without loss of efficiency or 
enantiomeric purity. This reaction was used to prepare synthetically useful quantities of 
2.59, which was elaborated into the two kibdelone fragments 2.98 and 2.110 in five (19% 
overall yield) and eight (9% overall yield) steps, respectively. Notably, only one step in the 
preparation of 2.98 requires purification via chromatography. Furthermore, the synthesis 
of 2.110 features a halodecarboxylation of a vinylic carboxylic acid, that proceeds in good 
yield.  
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Scheme 2.13. Synthesis of F-ring fragments for kibdelone C natural products.  
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2.6 (+)–DISPARLURE – INTRODUCTION 
The gypsy moth, Lymantria dispar, is a widespread forest pest that causes severe 
deforestation in Europe, Asia, and North America during outbreaks. This invasive insect 
was first introduced to North America by an amateur entomologist who traveled from 
France to Medford Massachusetts in 1868 or 1869.116 It has since become one of the most 
destructive exotic organisms on the continent, and despite many eradication efforts, the 
invasive insects persist. Since its introduction to North America, the gypsy moth has spread 
to small parts of Canada and a large portion of the north- to mid-Atalantic United States. 
There also exists a secondary population in Michigan that is the result of an independent 
accidental introduction of the insect.117 The gypsy moth is capable of causing severe 
ecological damage to infested areas because the insect is a highly polyphagous herbivore 
that will consume more than 300 different species of plants and trees. Additionally, the 
insect can have a serious economic impact in part due to the ecological damage it brings, 
but also in direct costs associated with managing the gypsy moth populations.118 For 
example, the United States spends roughly 12 million dollars annually on controlling gypsy 
moths. These programs have been successful though and the insects spread has been 
reduced by 60% since their implementation.119  
Although gypsy moth outbreaks only occur approximately every 10 years, constant 
monitoring and controlling the population of the insects remains important to prevent their 
spread. In the late nineteenth century, strategies for culling gypsy moth populations relied 
heavily on harmful pesticides such as lead arsenate, but with the many different discoveries 
of insect pheromones in the 1970s, most programs now rely on target specific mating 
disruptions to control the spread of gypsy moths.117 In fact, controlling the spread of gypsy 
moths in North America has been successful due to the availability of low cost pheromone 
based traps that are highly effective for detecting low density populations.119 
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Bierl identified disparlure as the sex attractant pheromone of the female gypsy moth 
in 1970, and Iwaki later proved the absolute stereochemistry of disparlure through the 
synthesis of both enantiomers, ultimately discovering that (+)-disparlure is more active 
than (–)-disparlure for the attraction of the insects (Figure 2.4).120 Interestingly, synthetic 
(+)-disparlure is able to attract male moths in field studies, but natural sources of the 
pheromone are more attractive, suggesting that there may be a synergistic effect between 
the two enantiomers. In its pure form, the antipode antagonizes the effect of (+)-disparlure 
and is slightly repellant to the male moths.121 The female moths release the pheromone into 
the wind in non homogenous plumes, which the male moths are able to detect with their 
highly sensitive antennae to follow the pheromone upwind to its source. Saturating areas 
with the moth pheromone can obfuscate the trail left by the female moths, ultimately 
preventing the male moths from mating and breeding.117,119 
 
 
Figure 2.4. The gypsy moth pheromone disparlure. 
Disparlure has attracted significant attention from the synthetic organic community 
due to its applications for managing gypsy moth populations and scarcity of natural 
sources. Since Bierl’s seminal reportn, there have been over 50 syntheses of disparlure, the 
most recent of which was reported in 2017.114,120–174 The introduction of the two 
stereocenters on the linear carbon chain of disparlure has been accomplished through a 
variety of synthetic methods including, asymmetric epoxidation,128,129,134,142,149,156,171 
asymmetric dihydroxylation,147,151,154 use of chiral stannanes,160 chiral sulfoxide 
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auxiliaries,141,144 enzymatic procedures,148,150,157 organocatalytic procedures,165,168 and 
utilization of chiral pool starting materials.120,152,164,166,170,173 Herein, we will highlight some 
syntheses of disparlure that are representative of these different strategies from over the 
years.  
2.7 SELECT PREVIOUS SYNTHESES OF DISPARLURE 
2.7.1 Iwaki’s Synthesis of (+)–Disparlure – Chiral Pool Starting Materials 
Iwaki reported the first enantioselective synthesis of (+)-disparlure in 1974 
(Scheme 2.14).120 L-glutamic acid (2.113) was deaminated with nitrous acid to give lactone 
2.114 in 80% yield. The carboxylic acid moiety of 2.114 was converted to the acyl chloride 
through treatment with oxalyl chloride, condensed with didecylcadmium, and the resulting 
ketone was reduced with sodium borohydride to give 2.115 as a mixture of diastereomers. 
The desired diastereomer was purified by column chromatography and recrystallization, 
and the alcohol protected as the tetrahydropyranyl (THP) ether with 2.116 to afford 2.117. 
The lactone moiety was then reduced to the corresponding lactol with diisobutylaluminum 
hydride (DIBAL-H) and treated with ylide 2.118 to afford Wittig product 2.119 in 74% 
yield over two steps. Finally, hydrogenation of 2.119 and epoxidation of 2.120 through a 
three-step sequence delivered (+)-disparlure 2.111 in 12 steps and 9% overall yield  
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Scheme 2.14. Iwaki’s enantioselective synthesis of (+)-disparlure. 
. Iwaki managed to complete the first enantioselective synthesis of disparlure, but 
his synthesis suffered from poor diastereoselectivity, low yield, and lengthy step count. 
Despite these short comings, his synthesis was still influential for many later approaches 
to disparlure. The lactone reduction-olefination-hydrogenation three step sequence 
(conversion of 2.117 to 2.120) has proven to be a useful strategy that has since been used 
in a number of syntheses of disparlure. Additionally, utilizing a 1,2-diol moiety as an 
epoxide precursor has also proven to be a strategy is that is prevalent in many asymmetric 
syntheses of disparlure.   
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2.7.2 Sharpless’ Syntheses of (+)-Disparlure – Asymmetric Epoxidation and 
Dihydroxylation 
Sharpless reported one of the most efficient enantioselective routes to (+)-
disparlure in 1981 utilizing his asymmetric epoxidation methodology (Scheme 2.15).128 
The dianion of propargyl alcohol 2.121 was alkylated with bromodecane to afford 2.122, 
which was partially hydrogenated to give the key allylic alcohol 2.123 in 84% yield over 
two steps. The enantioselective epoxidation of 2.123 proceeded in 80% yield and delivered 
epoxy alcohol 2.124 in 91% ee. The enantioenrichment of 2.124 was further increased to 
to >95% ee through recrystallization. Chromium oxidation of 2.124 led to aldehyde 2.125 
which was converted to 2.11 through Wittig olefination with ylide 2.126 followed by 
hydrogenation of the resulting olefin. Sharpless thus prepared (+)-disparlure (2.111) six 
steps and 30% overall yield. The hydrogenation of the resulting allylic epoxide after the 
Wittig olefination of 2.125 was slightly problematic for Sharpless because the substrate 
readily isomerized to a ketone by-product under the reaction conditions that was difficult 
to separate from 2.111. Isolation of pure 2.111 required treatment of the crude 
hydrogenation products with sodium borohydride and removal of the reduced ketone by-
product via column chromatography.  
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Scheme 2.15 Synthesis of (+)-disparlure via Sharpless asymmetric epoxidation. 
Despite complications in the olefin reduction, Sharpless’s strategy offers a high 
yielding efficient route to (+)-disparlure with a high degree of enantiopurity; indeed, this 
was the shortest catalytic enantioselective synthesis of (+)-disparlure prior to our work. 
Notably, the synthesis of (+)-disparlure became one of the first industrial applications of 
the Sharpless epoxidation. There have been a number of other reported syntheses utilizing 
the Sharpless epoxidation to set the requisite stereochemistry for (+)-disparlure but none 
have managed major improvements over the original route reported by Sharpless.156,171 
Sharpless later followed up with another synthesis of (+)-disparlure that utilized his 
dihydroxylation methodology to set the requisite stereochemistry of the pheromone 
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(Scheme 2.16).147 While this synthesis was not as short as his previous one, it offered an 
improvement in overall yield. The synthesis commenced from undecanal (2.127), which 
was treated with vinyl magnesium bromide to give the allylic alcohol 2.128 in 95%. 
Heating 2.128 in the presence of triethylorthoacetate and catalytic amounts of acid gave 
rise to a Johnson-Claisen rearrangement, affording 2.129 in 90% yield. Asymmetric 
dihydroxylation of 2.129 furnished a hydroxy lactone, the free alcohol of which was 
protected as a silyl ether to afford 2.130 in 85% yield over two steps. Lactone 2.130 was 
obtained with selectivity 95% ee, and the enantiopurity was further enhanced through 
recrystallization to give 2.130 as a single stereoisomer. Since Iwaki’s preparation of 
disparlure, hydroxy lactone intermediates such as 2.130 has become common in strategies 
towards asymmetric syntheses of disparlure. Sharpless elaborated lactone 2.130 to (+)-
disparlure through a commonly employed five step sequence. The lactone moiety of 2.130 
was partially reduced to the lactol, which was used in a Wittig olefination with ylide 2.118, 
and the newly formed alkene was hydrogenated to give 2.131 in 78% yield over three steps. 
The synthesis was then completed through mesylation of the free alcohol of 2.131, 
followed by epoxidation after removal of the silyl protecting group with 
tetrabutylammonium fluoride (TBAF), which delivered (+)-disparlure (2.11) in nine steps 
and 43% overall yield from undecanal (2.127).  
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Scheme 2.16. Synthesis of (+)-disparlure via Sharpless asymmetric dihydroxylation. 
2.7.3 Tsuboi’s Synthesis of (–)-Disparlure – Enzymatic Resolution 
Tsuboi’s strategy towards (–)-disparlure (2.112) utilized an enzymatic chiral 
resolution of the key intermediate 2.135 to set the epoxide stereochemistry of the natural 
product (Scheme 2.17). Tsuboi’s synthesis commenced with a Darzen’s type condensation 
between undecanal (2.127) and dichloroacetate 2.132 which delivered the halogenated 
epoxide 2.133 in 74% yield. This intermediate underwent smooth thermal rearrangement 
in the presence of alumina to give 2.134 in 84% yield. The ketone moiety was then reduced 
with sodium borohydride to give 2.135, which was subjected to a lipase mediated 
enzymatic kinetic resolution to afford 2.137 with 91% ee. Reduction of the ester of 2.138 
with sodium borohydride delivered the 1,2-diol 2.138, which upon exposure to NaOEt in 
 104 
EtOH underwent epoxidation to afford 2.139 in 61% yield over two steps. The free alcohol 
of 2.139 was activated as a leaving group through tosylation, and then 2.140 was alkylated 
with cuprate 2.141 to afford (–)-disparlure in eight steps and 9% overall yield.  
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Scheme 2.17. Tsuboi’s synthesis of (–)-disparlure via enzymatic chiral resolution. 
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2.7.4 Kim’s Synthesis of (+)-Disparlure – Proline Organic Catalysis 
Kim reported an efficient route to (+)-displarlure in 2009 that relied on asymmetric 
proline catalysis to set the epoxide stereochemistry of disparlure (Scheme 2.18).168 Kim 
used a proline catalyzed asymmetric α-aminooxylation of dodecanal (2.142) with an in situ 
indium catalyzed allylation to deliver 2.144 as a 4:1 mixture of diastereomers. The major 
anti diastereomer 2.144 was carried forward through cross metathesis with 2.145, which 
was accompanied with  N-O bond cleavage to deliver diol 2.146 in 50% yield. 
Hydrogenation of the alkene moiety of 2.146, followed by a three step epoxidation 
sequence afforded (+)-disparlure 2.11 in six steps and 23% yield from 2.142.  
 
Scheme 2.18. Kim’s synthesis of (+)-disparlure via proline catalysis. 
 107 
Kim’s strategy for (+)-disparlure was efficient in step count; it established the 
requisite stereochemistry and carbon framework of (+)-disparlure in only two steps, but 
the key step suffered from poor yield and diastereoselectivity. Additionally, the three step 
epoxidation sequence from the 1,2-diol moiety of 2.147 is a clumsy transformation that has 
plagued many syntheses of disparlure. 
 
2.7.5 Satoh’s Synthesis of (+)-Disparlure – Chiral Sulfoxide Auxiliary 
Satoh reported the shortest enantioselective synthesis of (+)-disparlure to date using 
an optically active sulfoxide auxiliary to impart chirality (Scheme 2.19).144 Chlorination of 
2.148 with N-chlorosuccinimide (NCS) delivered optically pure chloroalkyl sulfoxide 
2.149 after recrystallization. Deprotonation of 2.149 with lithium diispropylamine (LDA) 
and alkylation with iododecane delivered 2.150 in 75% yield as a mixture of diastereomers. 
Deprotonation of 2.150 with LDA followed by nucleophilic addition to 6-methyl-1-
heptanal (2.151) delivered 2.152 and 2.153 as a separable mixture of diastereomers, and 
the desired 2.153 was isolated in 39% yield. Chlorohydrin 2.153 was treated with 
potassium tert-butoxide to give 2.154, and finally, removal the sulfoxide auxiliary with n-
butyllithium gave (+)-disparlure 2.111 in five steps and 11% overall yield.  
 108 
 
Scheme 2.19. Satoh’s synthesis of (+)-disparlure. 
Satoh’s use of sulfoxide auxiliary offers an expeditious route to (+)-disparlure, 
however the auxiliary provides poor diastereoselectivity in the alkylation reactions, and the 
synthesis ultimately suffers from low yield. Additionally, the auxiliary is consumed during 
the synthesis, further detracting from the efficiency of the synthesis. 
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2.7.6 Summary of Previous Syntheses 
Disparlure has been the target of synthetic investigations for the last 40 years. 
Despite over 50 syntheses of this natural product, there remains room for improvement. 
Most approaches to 2.11 that use chiral pool starting materials are lengthy and low yielding, 
and the enzymatic resolution strategies offer little improvement. Kim’s synthesis of 2.11 
was efficient in terms of step count, but ultimately suffered from poor diastereoselectivity 
in the key step, and consequently poor overall yield. Satoh’s synthesis represents the 
shortest enantioselective synthesis to date, but it too suffers from low over yield and poor 
selectivity in the key step. Satoh’s synthesis also suffers from the stoichiometric 
incorporation of a chiral auxiliary that later requires removal to complete the natural 
product. Sharpless’ syntheses represent the state of the art for enantioselective variants, 
and indeed these have proven to be powerful methods for establishing stereochemistry of 
epoxides. Nevertheless, we devised a synthetic sequence to 2.11 that we thought would 
have an advantage over past syntheses in terms of step count and yield. 
2.8 ENANTIOSELECTIVE SYNTHESIS OF (+)-DISPARLURE VIA ASYMMETRIC 
IODOLACTONIZATION 
2.8.1 Synthetic Approach 
We planned an approach where (+)-disparlure (2.111) could be prepared from the 
cis-epoxde 2.155, which would be produced from the reductive opening of the 
enantioenriched iodolactone 2.156 (Scheme 2.20). Our synthesis relied on the ability of 
catalyst 2.94 to promote the iodolactonization of cis-alkenoic acid 2.158 in good yield and 
with high enantioselectivity.  
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Scheme 2.20. Martin group synthetic approach to (+)-disparlure. 
At the outset of our investigations however, it was unclear if 2.158 was would be a 
suitable substrate for our halolactonization methodology. Previous studies in our group on 
revealed that unbranched alkyl-substituted cis-alkenoic acids such as 2.159 cyclized to 
iodolactones with only moderate selectivity (85:15 er) (Equation 2.35). Accordingly, we 
set to the task of evaluating the efficacy of this crucial transformation. 
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2.8.2 First Generation Synthesis 
We first set out to prepare 2.158 through the most straightforward method available 
in order to test the iodolactonization reaction as quickly as possible. Our first-generation 
synthesis commenced with the protection of pent-4-yn-1-ol (2.161) as the THP ether, 
followed by the alkylation of the lithiated alkyne of 2.162 with iododecane, which provided 
2.163 in 81% yield over two steps (Scheme 2.21).175 Subjecting 2.163 to the acidic reaction 
conditions of the Jones oxidation led to in situ removal of the THP protecting group and 
oxidation of the resulting alcohol to the carboxylic acid 2.164 in good yield (82%). Initial 
attempts to partially reduce the alkyne moiety of 2.164 to the cis-alkenoic acid 2.158 with 
Lindlar’s catalyst delivered an inseparable mixture of cis and trans olefins (~9:1 cis:trans 
by 1H NMR). Fortunately, semi-hydrogenation of 2.164 with P2-Ni in a hydrogen 
atmosphere cleanly gave 2.158 in 85% yield.  
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Scheme 2.21. First generation synthesis of 2.158.  
 
With 2.158 in hand, we investigated the key enantioselective halolactonization. 
Gratifyingly, we found the iodolactonization of 2.158 in the presence of 2.94 proceeded 
smoothly to deliver 2.156 in 81% yield and 90:10 er (Equation 2.36). Similar to our 
previous iodolactonizations,10 we found that the inclusion of I2 further enhanced the 
enantioselectivity of the reaction, and 2.156 was obtained in 85% yield and 95:5 er 
(Equation 2.37).  
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With proof-of-principle for an enantioselective synthesis of (+)-disparlure 
established, we investigated the remaining steps to elaborate 2.156 to 2.111 (Scheme 2.21). 
Fortunately, treatment of iodolactone 2.156 with DIBAL led to clean conversion to 2.165, 
which was used directly in a Wittig olefination with ylide 2.118 to deliver 2.166 as an 
inconsequential mixture of cis and trans isomers. Initially, selective reduction of the alkene 
moiety of 2.166 was problematic due concomitant opening of the epoxide when Pd/C was 
used as the catalyst.176 However, after screening a variety of solvents and reaction 
conditions, we discovered that the reduction could be achieved using Pt2O in hexanes to 
afford (+)-disparlure in 90% yield.  
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Scheme 2.21 First generation synthesis of (+)-disparlure 
In our first-generation synthesis, we prepared (+)-disparlure in eight steps from 
2.161. While this was useful as a proof of principle exercise, a more efficient synthesis was 
desirable to remain competitive with the plethora of previous syntheses. One area that 
required improvement was the lengthy preparation of the Z-olefinic acid 2.158, which 
required four steps from commercial materials. The most appealing approach for preparing 
2.158 was inspired by a previously reported one-step procedure for the synthesis of (Z)-4-
alkenoic acids.177 We planned a regioselective opening of β-propiolactone (2.171) with the 
vinyl cuprate 2.170, which would arise from the carbocupration of acetylene with the alkyl 
cuprate 2.168, generated from iododecane (2.167), ultimately affording 2.158 in one step. 
(Scheme 2.22) 
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Scheme 2.22. Synthetic strategy for the one-step preparation of 2.158 
2.8.3 Carbocupration of Acetylene  
The addition of an organometallic carbon–metal bond to a carbon–carbon 
unsaturated system, leading to a new organometallic species that can be further 
functionalized is known as a carbometallation reaction (Equation 2.38). Organocuprate 
reagents are the most efficient for carbometallation of alkynes, and the addition occurs in 
syn fashion to provide reliable access to vinyl copper derivatives.178,179 The carbocupration 
of alkynes generally proceeds with high stereo- and regioselectivity, and consequently, it 
has become a versatile reaction for the stereospecific construction of di-, tri-, and tetra-
substituted olefins.179 The reaction has been shown to work with various organocopper 
reagents, including organocopper species derived from Grignard reagents (RCu•MgX2), 
Gilman-type cuprates (R2CuLi), and organocopper–zinc mixed species (RCu(CN)ZnX).179  
 
 
The regioselectivity of carbocupration reactions is determined by the substitution 
of the alkyne.178 For the carbocupration of monosubstituted alkynes there are two possible 
regioisomers, referred to as the “linear” 2.173 and branched” 2.174 products (Scheme 
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2.24). In the presence of a chelating heteroatom (X = SR’, NR’2, OR’), the linear 
vinylcuprates (2.173) can dominate as the major product of the carbocupration, although 
the selectivity between linear and branched products can be poor. In the absence of a 
directing group, (i.e. X = H or alkyl), the reaction is highly selective for the branched 
products of type 2.174. Generally, the carbocupration proceeds in a syn addition manner, 
although there can be exceptions.178,179 The remarkable stereoselectivity of this reaction 
has made it a valuable synthetic tool for the stereospecific construction of substituted 
olefins, and it has been implemented in a number of natural product syntheses.158,180  
 
 
Scheme 2.23. Regiochemical outcomes in the carbocupration of alkynes 
For the carbocupration of acetylene, its simplistic nature obviates any concern for 
regiochemical outcomes of the R–Cu addition, and it has become a useful reaction for the 
preparation of Z-disubstituted olefins. Importantly, Gilman type cuprates exhibit 
carbocupration reactivity in the presence of acetylene, and deprotonation of the alkyne is 
not observed.178,180 The mechanism for the carbocupration of acetylene is still under debate 
in part due to the lack of information concerning the real structure of organocopper clusters 
in solution.181 However, ab initio and density functional theoretical investigations from 
Nakamura and Morokuma have provided evidence for a possible mechanism.182 They 
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systematically studied the methylcupration of acetylene using five different organocopper 
species – MeCu, Me2Cu–, Me2CuLi, Me2CuLi•LiCl, and (Me2CuLi)2, – all of which have 
been invoked in discussions of carbocupration mechanisms. From this study, some general 
conclusions about the possible reaction pathways can be drawn. The addition of the MeCu 
organocopper reagent can only occur via a four-centered transition state consisting of 
nucleophilic addition of anionic methyl group (2.176, Equation 2.39). However, the 
activation energy of C–C bond formation in this pathway is large (43.6 kcal/mol), since the 
covalent CH3–Cu bond must be cleaved. Therefore, a neutral RCu organocopper reagent is 
not a sufficiently reactive nucleophile for the carbocupration of acetylene.182  
 
 
 
For the clustered lithium cuprates, such as R2CuLi•LiX, a different mechanism 
appears to be operative.182 Notably, synthetic copper reagents that are prepared from the 
reaction of organolithium reagents with copper (I) halides almost always exist as the 
R2CuLi•LiX species and are believed to be dimeric in solution.183,184 The mechanism for 
these cuprates can be described as a copper-assisted carbolithiation followed by intracluster 
transmetallation that proceeds via a “trap-and-bite” pathway (Scheme 2.24). The electron 
rich cuprate first binds tightly to acetylene through a two-electron donation from the copper 
atom to “trap” the alkyne 2.181. The binding of acetylene to the copper liberates an R group 
and opens the cluster, allowing the cuprate to “bite” the alkyne 2.183. This C–C bond 
forming reductive elimination is believed to be the rate determining step of the reaction, 
and after formation of 2.184, transmetallation results in the vinyl cuprate 2.185.182 
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Scheme 2.24. Theoretical mechanism of carbocupration of acetylene for clustered 
cuprates (R2CuLi•LiX) as proposed by Nakamura and Morokuma. 
We became interested in the carbocupration of acetylene as part of a one-step 
strategy to prepare the key olefinic acid 2.158. Fujisawa reported a general method for the 
one-pot synthesis of various (Z)-4-alkenoic acids by the ring opening reaction of β-
propiolactone with di-(Z)-1-alkenylcuprates generated from the carbocupration of 
acetylene (Scheme 2.25).177 Fujisawa prepared a series of  5-alkyl-4(Z)-pentenoic acids 
2.189 substituted with straight aliphatic chains of increasing size, ranging from butyl to 
nonyl in good yield (80–90%) through this one-pot method. Interestingly, as the size of the 
alkyl chain increased, it was necessary to increase the number of equivalents of acetylene 
used to form the cuprate 2.188, and up to a 6.6:1 molar ratio of acetylene:2.187 was 
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required for R = n-C9H19. When the molar ratio of acetylene:2.187 was < 4:1 for alkyl 
chains longer than R = n-C4H9, diminished yields of the desired product was observed, in 
part due to side reactions that led to 2.190 and 2.191. By-product 2.190 is the result of the 
direct reaction of 2.187 with propiolactone 2.171, which did not first react with acetylene. 
In contrast, the by-product 2.191 is the result of an additional carbocupration reaction 
between 2.188 and acetylene, followed by nucleophilic opening of 2.171.  
 
 
Scheme 2.25 One-step method for the preparation of Z-alkenoic acids reported by 
Fujisawa. 
The synthetically useful yields reported by Fujisawa for this reaction prompted us 
to examine this strategy for the preparation of 2.158, which would drastically shorten our 
synthesis of (+)-disparlure (2.111). Admittedly, we had a number of concerns about this 
reaction, specifically, that it was a four-step one-pot operation that relied on highly reactive 
and sensitive intermediates. The multi-step operation would also be potentially difficult to 
troubleshoot, as there would be many chances for the reaction to go awry. Despite these 
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concerns, the promise of a one-step synthesis of 2.158 was too tempting to ignore and we 
embarked on a carbocupration journey of our own.  
2.8.4 Second Generation Synthesis 
We began our efforts to optimize our synthesis of (+)-disparlure by attempting to 
replicate the procedures reported by Fujisawa for the one step preparation of (Z)-4-alkenoic 
acids. Our initial attempts to form the Grignard reagent 2.193 from either bromodecane 
(2.192) or iododecane (2.167) revealed that, in our hands, the reagent was not stable at 
concentrations greater than ca. 0.3 M. Titration of freshly prepared solutions of 2.193 in 
THF or Et2O revealed that the actual concentration of Grignard reagent deviated 
significantly from the targeted concentration (Table 2.3). The formation of the desired 
Grignard 2.193 appeared to be more reliable when Et2O was used as solvent and when 
iododecane (2.167) was used as the starting alkyl halide (Table 2.4, Entries 2, 3–5). We 
speculated that higher concentrations might be resulting in undesired side reactions such 
as Wurtz type couplings.. Therefore, we instead decreased the targeted concentration to 0.5 
M, which proved to be more reliable, and we were ultimately able to reproducibly form 
2.193 with concentrations of 0.3 M.  
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Table 2.4. Optimization of the preparation of Grignard reagent 2.193 
 
Entry Reagent X Solvent 
Target C10H21MgX 
[M] 
Titrated C10H21MgX 
[M]a 
1 2.192 Br THF 1  0.17  
2 2.192 Br Et2O 1  0.2  
3 2.167 I THF 1  0.185  
4 2.167 I Et2O 1  0.25  
5 2.167 I Et2O 0.5  0.3  
aReagent titrated using 1,10-phenanthroline and sec-butanol. 
 
With a method established to generate 2.193, we next investigated the formation of 
the vinyl cuprate 2.194. Disappointingly, after treating freshly prepared 2.193 with CuI 
followed by bubbling acetylene into the reaction mixture, we found no evidence of 
carbocupration upon quenching the reaction (Equation 2.40). After aqueous work up, only 
decane was recovered, with evidence of olefin incorporation based on the 1H NMR 
spectrum of the crude reaction material. 
 
 
While it was still unclear why we did not observe carbocupration of acetylene, we 
speculated that the stability of the Grignard reagent may be problematic based on our initial 
difficulty in forming 2.193. We changed our strategy and instead, we pursued the Gilman 
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type cuprate (C10H21)2CuLi, which we would prepare from lithiated decane and a copper 
(I) salt. Gratifyingly, we found the formation of 2.195 proceeded smoothly when 
iododecane (2.167) was treated with two equivalents of t-butyllithium (t-BuLi) (Equation 
2.41). Furthermore, we confirmed the formation of 2.195 through the reaction with an 
equimolar amount of benzaldehyde (2.196), which resulted in near complete conversion to 
2.197 based on the 1H NMR spectrum of the crude reaction material (Equation 2.42).  
 
 
 
Confident in the nature of our organolithium species, we returned to the 
carbocupration investigations using reaction conditions similar to those reported by 
Fujisawa. Unfortunately, we again saw no evidence of carbocupration, and upon quenching 
the reaction with methanol and removal of the solvent, we again observed no incorporation 
of vinyl protons in the 1H NMR spectrum of the crude reaction material, and primarily 
decane was observed (Equation 2.43). 
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With few clues to ascertain why the reaction was not working, we decided to trouble 
shoot the problem using phenylacetylene (2.200) and 1-hexyne (2.201) as model systems. 
Acetylene was proving to be problematic because it was difficult to precisely control the 
stoichiometry of the gas introduced to the reaction mixture, meaning we had little control 
over a reaction parameter that was shown to be important by Fujisawa. Thus, we set to the 
task of screening conditions for the formation of cuprate 2.199 and the subsequent 
carbocupration with either 2.200 or 2.201 (Table 2.5). We found that under a variety of 
conditions, no carbocupration was ever observed when CuI was used as the Cu (I) salt. 
Attempting the carbocupration of 2.200 or 2.201 in THF, THF/DMS, or Et2O was 
universally unsuccessful when CuI was used (Table 2.5, Entries 1–6), which indicated that 
the formation of the alkyl cuprate 2.199 was problematic. House previously reported the 
purity of copper (I) salts in the formation of organocurpates from organolithium reagents 
is critical,183 and despite using freshly purified and rigorously dried CuI, we suspected this 
could have been an issue. To solve this problem, investigated the crystalline complex 
CuBr•DMS as an alternative copper source, which can be easily purified by 
recrystallization in dimethyl sulfide (DMS).183 Again however, we observed no 
carbocupration of 2.200 or 2.201 with 2.199 when the reactions were executed in 
THF/DMS as the solvent (Table 2.5, Entries 7,8). However, to our delight, we found that 
the carbocupration of 2.200 with 2.199 proceeded smoothly in Et2O to provide 2.202 in 
ca.70% yield (Table 2.5, Entry 9). This model reaction confirmed that 2.199 was indeed 
being formed as desired, and we could resume our attempts to affect the carbocupration of 
acetylene. 
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Table 2.5 Optimization of the carbocupration of 2.200 and 2.201 model systems.  
 
Entry Cu(I) salt Solventa Alkyneb T °C (ii) Resultc 
1 CuI THF 2.200 –78 to –25 NR 
2 CuI THF 2.201 –78 to –25 NR 
3 CuI THF/DMS (20:1) 2.200 –78 to –25 NR 
4 CuI THF/DMS (20:1) 2.201 –78 to –25 NR 
5 CuI Et2O 2.200 –78 to –25 NR 
6 CuI Et2O 2.201 –78 to –25 NR 
7 CuBr•DMS THF/DMS (20:1) 2.200 –45 NR 
8 CuBr•DMS THF/DMS (20:1) 2.201 –45 NR 
9 CuBr•DMS Et2O 2.200 –45 ~70% 2.202 
aSolvents were degassed by sparging with nitrogen gas prior to use.  b2.1 equivalents of 
alkyne used. cNR = No reaction 
 
Newly confident in our ability to generate 2.199, we continued our investigations 
of the carbocupration of acetylene. Disappointingly though, we still did not observe any 
evidence for acetylene carbocupration, despite the new reaction conditions to form 2.199 
(Equation 2.44). Again, we were left with little information as why the reaction was failing, 
but we speculated that a solvent screen maybe beneficial. Solvents have been reported to 
play important roles in these reactions,179 and indeed, we observed this first hand in our 
own carbocupration model studies. Unfortunately, executing the reaction in a variety of 
different solvents including THF, Et2O, and mixtures of THF/DMS and Et2O/DMS still 
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resulted in no observable carbocupration of acetylene. We decided that the only variable 
left to investigate was the source and stoichiometry of acetylene.  
 
 
We had been conducting our studies using acetylene obtained from a commercial 
source stored in a gas cylinder. Acetylene in commercial gas cylinders is typically 
dissolved in liquid acetone, which aides in safe storage. To introduce acetylene to the 
reaction mixture, it was first transferred from the storage tank to a balloon, and then passed 
through two empty flame dried flasks under inert atmosphere that were cooled to –78 °C, 
which served as condensers to remove any residual acetone. Despite rigorous efforts to 
exclude air, we reasoned this somewhat elaborate reaction assembly increased the chance 
for atmospheric oxygen to be introduced to the reaction mixture, which has been shown to 
oxidize organocuprates.185 Therefore we sought to change our acetylene source and we 
planned to introduce acetylene that was generated from the reaction of calcium carbide 
with water. This approach was also attractive because we would have more control over 
the stoichiometry of acetylene introduced by controlling the amount of water added to the 
solid calcium carbide. The gas generated from this reaction could simply be passed through 
a drying tube prior to being bubbled into the solution of 2.199. 
Gratifyingly, this alternative method for introducing acetylene proved effective. 
We finally enjoyed some success when six equivalents of acetylene were introduced into a 
solution of 2.199 over a one-hour period at –45 °C, and we observed ca. 50% formation of 
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2.204 (Equation 2.45). When larger ratios of acetylene (12:1 acetylene:2.199) were used, 
significant formation of 2.205 was observed.  
 
 
 
While we only observed modest incorporation of acetylene to 2.199 we were 
heartened by this success, and eager to see if 2.198 would react with β-propiolactone 
(2.171) to generate 2.158. Disappointingly though, when 2.198 was treated with 2.171, 
only ~10% of the desired product 2.158 was isolated, along with 25% of 2.206. The 
remainder of the material recovered was 2.207, which was formed during the aqueous work 
up of the reaction. The low yield of 2.158 was attributed to poor formation 2.198, and 
despite extensive efforts to optimize the carbocupration, we found the generation of 2.198 
to be erratic and difficult to consistently reproduce. Consequently, we were never able to 
improve the yield of 2.158 via this four-step one-pot method, and we ultimately had to 
abandon our pursuit of this strategy in our synthesis of disparlure. 
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Setting aside our disappointment, we instead pursued a more reliable and practical 
two step preparation of 2.158. We planned to alkylate the dianion of commercially 
available 4-pentynoic acid (2.207) with iododecane to provide 2.164, which could then be 
reduced to 2.158 as we demonstrated previously. In the event, initial attempts to prepare 
2.164 through treatment of 2.207 with n-BuLi followed by addition of 1.1 equivalents of 
iododecane resulted in a mixture of 2.164 and 2.208 with minor amounts of returned 
starting material (Equation 2.46). We attempted to optimize the yield of 2.164 through 
screening solvents, as well as temperatures and rates of addition of iododecane, but we 
were never able to suppress the formation of 2.208. Rather than attempt to mitigate the 
formation of 2.208, we instead increased the stoichiometry of iododecane to 2.5 equivalents 
to drive the reaction to complete formation of 2.208 (Equation 2.47). We could then 
soaponify the ester by-product formed in situ by addition of 2 M LiOHaq after the starting 
material had been consumed, and in this fashion 2.164 was obtained in 85% yield. 
 
 
 
 
One final innovation we had for the synthesis was the direct preparation of 2.166 
from 2.156 (Equation 2.48). The purity by which the DIBAL reduction of 2.156 proceeded, 
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prompted us to investigate a one-pot transformation of 2.156 to 2.166. To our delight, we 
found that after the partial reduction 2.156 was complete, addition of a freshly prepared 
solution of 2.118 led to formation of 2.166, albeit in a slightly diminished yield of 62%.  
 
 
 
 
2.8.5 Summary 
A summary of the optimized reactions for our enantioselective synthesis of (+)-
disparlure is provided in scheme 2.27.186 The ability of catalyst 2.94 to provide rapid access 
to enantioenriched cis-epoxides is a powerful synthetic method as we have exemplified 
through the preparation of 2.11. To the best of our knowledge, our preparation of 2.11 
represents the shortest catalytic enantioselective synthesis of this natural product to date, 
which required five steps from 2.207 and proceeded in 33% overall yield.  
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Scheme 2.27. Enantioselective synthesis of (+)-disparlure.  
2.9 SUMMARY AND CONCLUSIONS 
Enantioselective halolactonization reactions represent powerful tools for synthetic 
organic chemists. The desymmetrization of 1,4-dihydrobenzoic acid via 
bromolactonization, for example, converts a prochiral starting material to a complex 
enantioenriched product which contains three contiguous stereocenters. We demonstrated 
that this method is readily applicable to synthetically useful scales, and we applied it to 
efficient syntheses of F-ring fragments of the kibdelone natural products. Furthermore, the 
ability to prepare enantioenriched cis-disubstituted epoxides from enantioenriched 
halolactones fills a gap in synthetic methodology that has yet to be addressed by direct 
catalytic methods for epoxidations of olefins. Application of this method to the synthesis 
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of (+)-disparlure culminated in the shortest enantioselective synthesis to date, despite over 
40 years of research around this natural product.   
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SYNTHESIS OF PHOTOCAGED COMPOUNDS FOR LABELING 
NEURONS BASED ON FUNCTION  
CHAPTER 3: PHOTOLABILE PROTECTING GROUPS 
3.1 INTRODUCTION 
Photolabile protecting groups (PPGs) are light reactive functional groups that can 
be attached to a given molecule to render it chemically and or biologically inert. These 
protecting groups are unique in that their removal is accomplished through irradiation with 
light without the need for chemical reagents. These unique protecting groups allow for 
precise temporal and spatial control over chemical reactions and the release of active 
compounds. Although PPGs were originally designed by synthetic chemists, applications 
in chemical synthesis have been minimal.187 However, photoremovable protecting groups, 
referred to as “cages” or “photocages” by biologists, represent an excellent method for 
rendering a compound biologically inert that can be activated externally via light. There 
have been numerous exciting applications of these protecting in the realm of biology 
including, the control of protein functions, cellular stimulation, regulation of gene 
expression, and neuronal stimulation or inhibition. These applications have been covered 
in multiple recent reviews.188–195  
The photochemical efficiency of the deprotection of a PPG is often described using 
the quantum yield as a quantitative metric. The quantum yield of substrate release (Φrel) is 
equal to the amount of released substrate, nrel/mol, divided by the number of photons 
absorbed at the irradiation wavelength λ, np/mol (Equation 3.1). Alternatively, the quantum 
yield of release can be described in terms of relative rates for the photochemical processes. 
That is, the quantum yield of release (Φrel) is equal to the rate constant of substrate release 
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from the excited state (krel) divided by the sum of all of the rate constants of other potential 
photochemical pathways from the excited state (Σ k) (Equation 3.2). 
 
Φrel =  
𝑛𝑟𝑒𝑙
𝑛𝑝
 (3.1) 
 
Φrel =  
krel
Σ k
 (3.2) 
Photolabile protecting groups first appeared in the literature in the early 1960’s with 
the seminal reports from Barltrop,196 Barton,197 Sheehan,198 and Patchornik and 
Woodward.199 Barltrop was the first to investigate the first use of a light reactive group as 
a potential new protecting group strategy. Barltrop described the deprotection of Cbz-
glycine (3.1) through irradiation with UV-light (254 nm) in aqueous solution, which led to 
the efficient removal of the carbamate protecting group, yielding benzyl alcohol (3.2) and 
glycine (3.3) (Equation 3.3).200 These early reports set the stage for what has today grown 
into an extensive field of research, with hundreds of new PPGs reported in the literature to 
date.193 
 
 
 
The promising biological applications of photolabile protecting groups has 
reignited the synthetic community’s interest in developing novel PPGs. The design of a 
photoremovable protecting group will depend on its desired application, but for biological 
systems there are several concerns to address.193,201  
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1) The substrate, the caged substrate, and the photochemical by-products should 
all have good aqueous solubility and be stable in the targeted media in the 
absence of light. 
2) The photochemical reaction should be efficient with regard to quantum yield 
and release of the substrate. Furthermore, the departure of the substrate from 
the protecting group should be a primary photochemical process. 
3) The release of the target compound must be faster than the biological response 
under investigation.  
4) The photoproducts should be stable to the photolysis environment and nontoxic 
or harmful to the biological system under investigation.  
5) The PPG should have a strong absorbance above 300 nm, where irradiation is 
less likely to be absorbed by, and cause harm to, the biological system under 
investigation. 
6) The synthesis of a caged substrate should be high yielding and purification of 
the caged compound should be facile. It is important that the caged material can 
be isolated cleanly, with no contamination of uncaged substrate. 
While it is difficult for one PPG to meet all of these criteria, they are important to 
consider when designing novel photocages or planning a biological study involving one. 
However, the quest to design the ideal photolabile protecting group is ongoing and reports 
of new classes and derivatives of PPGs are constant. Herein we will highlight some of the 
most popular PPGs, grouped by common structural features. 
3.2 O-NITROPHENYL PHOTOLABILE PROTECTING GROUPS 
3.2.1 o-Nitrobenzyl Photolabile Protecting Groups 
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The 2-nitrobenzyl (NB, 3.4) derivatives are the most widely used class of 
photoremovable protecting groups. Since the pioneering work of Baltrop200 and 
Woodward,199 these groups have been studied in detail and the photodeprotection 
mechanism is well understood. Numerous analogues of o-nitrobenzyl based PPGs have 
been developed, and their applications spawn a broad array of scientific areas.193,202 Despite 
their ubiquity, this class of PPGs has a number of inherent disadvantages, which are better 
understood through a discussion of the deprotection mechanism. 
 3.2.1.1 Mechanism of Deprotection 
The popularity of the o-nitrobenzyl PPGs has led to detailed investigations of the  
deprotection mechanism over the years.203–207 The photodeprotection mechanism is highly 
dependent on solvent, pH, and the nature of the leaving group. The photolysis begins with 
the photoexcitation of 3.5, which is followed by rapid (~100 fs) internal conversion to the 
lowest singlet excited state 3.6 (Scheme 1). The excited state hydrogen transfer (ESHT) 
then proceeds through either the excited singlet state (3.6), or an excited triplet state after 
inter-system crossing (3.7), to form the aci-nitro tautomers 3.9 and 3.10.  The barrier for 
retautomerization of 3.9 back to 3.5 is relatively slow, but in some solvents (MeOH, 
CH3CN), the equilibration between 3.9 and 3.10 by proton exchange between oxygen 
atoms is competitive with reformation of 3.5. In aqueous solutions the equilibrium between 
tautomers 3.9 and 3.10, and the cyclization to give 3.11 is faster than the reverse reaction 
to reform 3.5. The cyclization of the aci-nitro tautomer 3.10 to 3.11 is irreversible, and this 
 135 
intermediate will decay via 3.12 to ultimately form the nitroso aldehyde 3.13 with 
concomitant release of the substrate (X-H). 
 
 
Scheme 3.1. Photodeprotection mechanism of o-nitrobenzyl photolabile protecting 
groups 
The mechanism of deprotection for the NB class of PPGs reveals a number of 
problems associated with this photocage, many of which are due to the nitroso by-product 
3.13. The o-nitroso aromatic aldehydes and ketones typically absorb more strongly than 
the parent PPG at the deprotection wavelengths. This is problematic in that the nitroso by-
products can act as a filter, blocking the irradiation and interfering with the release of the 
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compound of interest. In some cases, the reactive nature of the 3.13 can result in a number 
of side-reactions, the most problematic of which is the condensation with primary 
amines.208 This becomes problematic for the protection of amino-containing compounds 
due to the potential for the released substrate to condense with 3.13, which effectively 
diminishes the efficiency of the deprotection and prevents the released substrate from 
participating in the biological response under investigation. Indeed, this undesirable side 
reaction was observed by Givens and Bayley during their studies of photoreleased 
peptides.209,210 Furthermore, the nitroso side products can be toxic towards biological 
systems, which can limit their applicability in some biological studies.193  
Part of the appeal of the NB class of PPGs is their ability to release a wide range of 
leaving groups such as phosphates, carboxylates, carbonates, carbamates, thiolates, 
phenolates, and alkoxides. However, the nature of the leaving group impacts both the rate 
and quantum yield of the deprotection. For a good leaving group such as a phosphate, 
release of the leaving group is synchronous with the formation of the aci intermediate 3.10 
and has kinetics on the order of milliseconds. However, for a poor leaving group such as 
an alkoxide, the rate of deprotection can be dependent on the collapse of the hemiacetal 
3.12. At neutral pH, the decay of 3.12 was found to be many orders of magnitude slower  
than the decay of the aci intermediates 3.9 and 3.10.205,211 Therefore, it is generally not 
suitable to directly release alcohols from the NB photocage in a study of fast biological 
events. One solution to circumvent the slow deprotection rates of poor leaving groups such 
as alcohols and amines is to use carbonyl linkers to instead protect them as carbonates or 
carbamates (3.14) (Equation 3.4). In general, these are good leaving groups and will lead 
to efficient deprotection. After photorelease, the carbonate or carbamate (3.16) will 
undergo thermal fragmentation to provide the parent alcohol or amine (3.17).  
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3.2.1.2 o-Nitrobenzyl Photolabile Protecting Group Derivatives 
Since the seminal reports of NB PPGs, a plethora of derivatives have been 
developed with aims to improve photochemical properties of this class. These new 
compounds were developed with the intent to increase quantum yield and release rate and 
to shift the effective absorbance to longer wavelengths, some of which are highlighted here 
(Figure 3.1). The structural modifications to the NB (3.4) class of PPG can be characterized 
by changes to the aromatic chromophore and substitution at the benzylic carbon. One early 
effort by Patchornik and Woodward focused on circumventing the formation of the 
problematic nitroso benzaldehyde 3.13.199 Methyl substitution at the benzylic position 
resulted in the 1-(2-nitrophenyl)ethyl (NPE, 3.18) derivative. Photochemical 
rearrangement of this derivative led to the corresponding 2-nitrosoacetophenone, which is 
less prone towards amine condensation. They were able to use this protecting group to 
demonstrate efficient release of amino acid protecting groups.199 The 2,6-dinitrobenzyl 
(DNB, 3.19) derivative was designed to enhance the production of the aci-nitro 
intermediates 3.9 and 3.10, and ultimately improve the photochemical efficiency of leaving 
group release. This proved to be an effective strategy and the DNB group displayed an 
improved quantum yield over the classic NB PPG, which was attributed to an increase in 
statistical probability of forming aci-nitro intermediates rather than electronic effects from 
the presence of an additional nitro group.212,213 The 6-nitroveratryl (NV, 3.20) and the 
closely related 6-nitropiperonylmethyl (NP, 3.21) derivatives were designed for a 
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bathochromatic shift of the effective irradiation wavelength. However, the increased 
absorbance of these groups is not converted to increased photochemical efficiency, and the 
quantum yield of NV is typically an order of magnitude less than that of NB. The increased 
absorbance of the NV group is speculated to lead to unproductive photochemical events 
that do not contribute to release of the leaving group. Nevertheless, the NV and NP PPGs 
are among the most widely used NB derivatives.193,202  
The nitrodibenzofuran (NDBF, 3.22) derivative represents a significant 
improvement in photochemical efficiency compared to the original NB PPG. This 
derivative was first reported by Ellis-Davies for the photochemical release of calcium ions, 
and it was shown to undergo photolysis 16–160 times faster than other NB derivatives.214 
The enhanced photochemical properties of this cage have made it an attractive PPG, and it 
has since been applied to a number of biological studies including photoregulation of 
siRNA and peptide activation.215,216 
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Figure 3.1. Select examples of o-nitrobenzyl photolabile protecting groups. 
3.2.2  2-(2-Nitrophenyl)ethyl Photolabile Protecting Groups 
 
Hasan developed a one carbon homologue of the NB protecting groups that, despite 
structural similarity, has a markedly different deprotection mechanism.217 The small 
structural change also resulted in a significant improvement in photochemical efficiency 
over the NB counterparts. Initially, the phenethyl photocage analogues only offered a slight 
improvement in the release of carbonate leaving groups when compared to NB PPGs. 
However, addition of a methyl group to the benzylic position of the nitro phenethyl 
photocages considerably added to the efficiency of deprotection.217 For example, in a 
photocaging study of 5’-O-nucleoside carbonates, 3.23 released the substrate with a higher 
quantum yield (Φrel =0.042) than an NB analogue (Φrel = 0.033). However, caging the 
substrate with 3.24 added considerably to the efficiency and resulted in a 10 fold increase 
in quantum yield (Φrel = 0.35).218 In addition to the increased photolysis efficiency, the 2-
(2-nitrophenyl)ethyl (NPE) derived PPGs are also more suitable for the release of amine 
containing substrates compared to the NB PPGs, because the photochemical by-product is 
unreactive towards amines. 
The mechanism of deprotection for 2-(2-nitrophenyl)ethyl (NPE) PPGs has not 
been extensively studied, but the observed nitrostyrene by-product 3.28 is consistent with 
the proposed pathway.217 Irradiation of 3.25 leads to intramolecular hydrogen abstraction 
and from the excited state, and formation of the aci-nitro intermediate 3.26. Deprotonation 
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of 3.26 by solvent results in the expulsion of the leaving group and the formation of the 
nitrostyrene by-product 3.28. The NPE groups , the formation of the unreactive 
nitrostyrene by-product 3.28 rather than the nitroso aldehydes/ketones by-products of the 
NB PPGs makes this class more suitable for the release of amine containing substrates.   
 
 
Scheme 3.2. Photodeprotection mechanism for the 2-(2-nitrophenyl)ethyl-based PPGs 
Recent modifications to the NPE core structure have focused on extending the 
maximum absorbance to longer wavelengths (Figure 3.2).219,220 The amino-nitro biphenyl 
derivatives 3.30 and 3.31, for example, exhibit a strong absorbance (λmax = 400 nm, ε = 
7,500 M-1cm-1) in the visible light region. The R groups incorporated at the aniline nitrogen 
atom serve as effective solubilizing handles for increased aqueous solubility of caged 
compounds. These compounds have been applied in a recent example of the photorelease 
of the neurotransmitter GABA. 221 
 
 141 
 
Figure 3.2. Select derivatives of the 2-(2-Nitrophenyl)ethyl PPG class 
3.2.3 o-Nitroanilide Photolabile Protecting Groups 
 
The o-nitroanilide class of PPG was first reported by Amit and Patchornik in the 
1970s as an efficient light sensitive protecting group for esters and carboxylic acids.222,223 
The size of the fused nitrogen heterocycle proved important for the reactivity of the 
protecting group, and indoline analogues were found to release carboxylic acids very 
efficiently.222 Since the seminal reports, the mechanistic aspects of the photo-deprotection 
have been the focus of a number of studies.193,224 Early isotopic investigations concluded 
that the reaction is a rearrangement rather than a solvolysis, as no isotope incorporation 
was observed upon photolysis in H2
18O as solvent.223 Photoexcitation of 3.33 leads to an 
acyl migration from the indoline nitrogen atom of 3.33 to one of the nitro group oxygen 
atoms, forming the highly reactive N–O acyl intermediate 3.34 (Scheme 3.3). Interestingly, 
the deprotection pathway is solvent dependent, and diverges at this point depending on the 
reaction media. In organic solution (path A, red arrows), intermediate 3.34 undergoes 
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nucleophilic attack either by solvent (alcohol or water) or by an external nucleophile to 
release 3.35 along with formation of the nitro indoline 3.36. Alternatively, in aqueous 
solution (path B, blue arrows), a deprotonation occurs at the 2-position of 3.34 to release a 
carboxylic acid (3.37) along with formation of the nitroso indole by-product 3.39. 
Substitution of the aromatic ring of 3.33 has been shown to influence the efficiency of 
deprotection to a certain extent.225  
 
 
Scheme 3.3. Photodeprotection mechanism for the o-nitroanilide class of PPG. 
The nitroanilide PPGs have not found widespread application, perhaps due to the 
limited scope of the functional groups that can be protected. However, their ability to 
protect carboxylic acids and the reactive nature of 3.34 has resulted in important 
applications for the protection and synthesis of amino acids.226 Additionally, nitroanilides 
have been shown to efficiently release the neurotransmitter GABA, which has proven 
useful for the interrogation of GABA receptor function.227 
 143 
3.3  ARYLCARBONYL PHOTOLABILE PROTECTING GROUPS 
3.3.1 Phenacyl Photolabile Protecting Groups 
 
The photocages in this family are grouped based on their structural similarity; they 
share a common phenacyl core, and the leaving group is attached to the α-position of the 
carbonyl group. Despite the structural similarities, small variations in substitution at the 
phenacyl core can alter the deprotection mechanism drastically. The mechanism is also 
influenced by the nature of the leaving group and the reaction conditions, such as solvent. 
This class of PPGs can efficiently release good leaving groups such as phosphates, 
sulfonates, carbonates, and carbamates.193,194  
3.3.1.1 p-Hydroxyphenacy Photolabile Protecting Groupsl 
The p-hydroxyphenacyl (pHP, 3.40) class of PPG was first reported by 
Givens228,229 in 1996, and it has since proven useful in numerous applications including 
neurobiology and enzyme catalysis.193,194 The pHP group has a number of advantages over 
other classes of PPGs. First, the release of substrates is very fast, with rate constants on the 
order of krel > 10
8 s-1. The deprotection also typically proceeds with high quantum yields, 
with only one significant by-product. Finally, the hydrophilicity of the pHP protecting 
group typically leads to caged products that have good water solubility, an important 
property for biological applications.  
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The photodeprotection upon irradiation of 3.40 at 250-320 nm in neutral aqueous 
media is proposed to proceed through the excited triplet state, forming the spirodiketone 
3.42 and expelling the leaving group (LG-H) (Scheme 3.4). Intermediate 3.42, deemed the 
Favorskii intermediate, is prone to hydrolytic ring opening, which yields p-hydroxyphenyl 
acetic acid (3.43). The structural rearrangement following the photoexcitation of 3.40 
closely resembles the classical ground state Favorskii rearrangement of α-haloketones, 
hence why this reaction has been coined the photo-Favorskii rearrangement. This unique 
deprotection mechanism has been the center of a number of studies.194 The efficiency of 
the photochemical deprotection is highly dependent on the nature of the leaving group. As 
a general rule, leaving groups with a pKa < 11 work well, while alcohols and amines with 
pKa’s above that threshold are usually not successfully released.194 
 
 
Scheme 3.4.Photodeprotection mechanism of the p-hydroxyphenacyl PPG. 
Other important advantages of the pHP protecting group are associated with the by-
product 3.43. Unlike the photochemical products of the o-nitrobenzyl class, 3.43 is 
essentially transparent above 290 nm and therefore does not interfere with the absorbance 
of the starting material (3.40). Additionally, p-hydroxyphenylacetic acid (3.43) is 
photochemically stable and biologically inert, making the pHP group an attractive 
photocage for biological applications.  
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3.3.1.2 Benzoin Photolabile Protecting Groups 
The benzoin class of PPG was first reported by Sheehan in the 1960s.228 Early 
studies quickly revealed that the deprotection efficiency significantly improved through 
the use of a 3’,5’-dimethoxybenzoin group. The release of carboxylates and phosphates 
from DMB (3.41) proceeds quickly to quantitatively afford the desired product and 3.47 
(Scheme 3.5). The reactions proceed smoothly in both polar and apolar solvents and the 
deprotection mechanism was found to be independent of the nature of the leaving group. 
Thus, poor leaving groups such as amines and alcohols can be released directly with the 
DMB protecting group.  
 
 
Scheme 3.5. Photodeprotection mechanism for the 3’,5’-dimethoxybenzoin class of PPG. 
While there are no photochemical reasons that prevent the use of a particular 
leaving group with DMB, the preparation of certain derivatives can be difficult. A common 
strategy for the protection of alcohols and amines with DMB PPGs is to start from 3.48 
and convert it to the activated acylating reagent 3.49 through treatment with 
carbonyldiimidazole or phosgene. However, 3.49 is prone to intramolecular cyclization to 
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give 3.52, which is not useful for the preparation of photocaged compounds. Furthermore, 
the reaction of 3.49 with primary amines will form the carbamate 3.50, which can also 
undergo an unproductive intramolecular cyclization to give 3.51, which is photochemically 
inert (Scheme 3.6).188 Additionally, the hydrophobicity of the DMB core often results in 
caged compounds with poor aqueous solubility, thus further limiting the adoption of this 
PPG for biological studies.193 
 
 
Scheme 3.6 Problematic side reactions when protecting alcohols and amines with DMB. 
3.3.2 Deprotection Via Photoenolization  
The addition of alkyl groups to the aromatic core of the arylcarbonyl class of PPG 
results in deprotection mechanism that differs from the phenacyl PPGs. Unlike the 
phenacyl aryl carbonyls, the following protecting groups are classified by deprotection 
mechanism rather than structural similarity. The releasing mechanism for these PPGs 
involves hydrogen abstraction, photoenolization, and ground-state transformation to the 
enol to release the compounds of interest.  
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3.3.2.1 2-Methyl-Substituted Acetophenones 
The 2-alkyl-substituted acetophenones were reported by Klán and Wirz as PPGs 
for the release of a variety of good leaving groups including carbonates, carbamates, 
phosphates, and sulfonates.230,231 Upon irradiation at 250–280 nm, 3.53 is excited to its 
singlet state 3.54 (Scheme 3.7). After an intersystem crossing (ISC) to the excited triplet 
state 3.55, a 1,5-hydrogen abstraction occurs, yielding the biradical 3.56. This intermediate 
will decay into the two isomeric enols 3.57 and 3.58. The (Z)-photoenol 3.57 is also formed 
from the enolization of the excited singlet state 3.54, but this intermediate is short lived 
and quickly undergoes a sigmatropic rearrangement to regenerate the starting material 3.53. 
The (E)-photoenol 3.58 however, requires an intermolecular protonation to quench, and is 
therefore persistent enough to undergo intramolecular cyclization to afford the deprotection 
by-product 3.59 and the released substrate (H-LG). The mechanism of deprotection for 
3.53 reveals why this class of PPG is best suited for good leaving groups. Given that the 
leaving group is expelled via SN2 displacement through an intramolecular cyclization of 
3.58, poor leaving groups such as phenols, alcohols and amines are not good candidates 
for use with this class of PPG.  
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Scheme 3.7 Photodeprotection mechanism of the 2-methylacetophenone PPG. 
The 2-methyl-acetophenones have a number of disadvantages associated with them 
when compared to other PPGs that have limited their applications to only a few examples 
of photoresponsive polymers.193,227 Compared to other classes of PPGs, the quantum yields 
and release rates for the 2-methyl-acetophenones are low. Additionally, the deprotection 
of 3.53 requires irradiation with UV light, which has limited its use for in vivo biological 
studies because the deprotection wavelength will cause DNA damage to the cells.. The 
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hydrophobicity of 3.53 typically results in caged compounds that have poor aqueous 
solubility, which has further limited its applications in biological systems. 
3.3.2.2 2-Ethylene-Subtituted Arylcarbonyl Photolabile Protecting Groups 
Ullman reported an alternative strategy for the arylcarbonyl PPG core where the 
leaving group was attached to the alkyl branch of the phenyl group.232 Irradiation of the 2-
ethylene-substitued aryl carbonyl 3.60 leads to the formation of the photoenol 3.61, which 
can tautomerize back its keto form, expelling the leaving group (H-LG) and forming the 
styrene by-product 3.62.233 The deprotection is not greatly affected by the solvent, and the 
reaction is typically slow with low photochemical efficiency. Efficient deprotections can 
be achieved for some good leaving groups such as tosylates, but with poor leaving groups, 
elimination of the leaving group is the rate determining step and it is competitive with 
protonation of 3.61 to reform 3.60.202 Attempts to improve the photochemical properties 
of 3.60 through structural modifications did not result in significantly better PPGs than the 
parent compound.234 Consequently, the use of this class of PPG has been minimal since its 
discovery. 
 
 
Scheme 3.8. Photodeprotection mechanism for the ethylene-substituted arylcarbonyl PPG 
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3.3.2.3 Intramolecular Lactonization 
A relatively recent example of an interesting photoenolization reliant release of 
alcohols was reported by Gudmundsdottir in 2003.235 Upon irradiation with UV light, 3.63 
is converted to the photoenol 3.64 via the triplet excited state (Scheme 3.9). This 
intermediate then undergoes a [2+2] cycloaddition to give the benzocyclobutanol 3.65. 
Subsequent intramolecular lactonization results in the release of a free alcohol in high 
chemical yield (90%) and the formation of 3.66. The ability to directly release a free 
alcohol is a rare trait for a photolabile protecting group, however, 3.63 has not been widely 
applied to many areas, likely due to the long reaction times (hours) to achieve the high 
yielding release of alcohols.   
 
 
Scheme 3.9. Photodeprotection mechanism of 3.63 via intramolecular lactonization 
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3.4 COUMARIN BASED PHOTOLABILE PROTECTING GROUPS 
 
 
The coumarin class of photolabile protecting groups was first discovered by Givens 
in his studies on the photoreactivity of coumarins releasing phosphate esters.236 This 
relatively new class of photocages has attracted considerable attention because it offers 
distinct advantages that include large absorption coefficients at longer wavelengths (λmax = 
350–475 nm) and fast release rates. However, these advantages are offset by coumarin’s 
marginal quantum yields and low aqueous solubility. Since the seminal report, there has 
been a wide variety of modified coumarin PPGs  that have sought to address these 
disadvantages.193,237  
3.4.1 Mechanism of Deprotection 
The mechanism of deprotection for the coumarin protecting groups is proposed to 
occur via heterolytic bond cleavage from the excited singlet state 3.69 (Scheme 3.10).238,239 
The decay of excited 3.69 back to the ground state 3.68 via fluorescence and nonradiative 
deactivation is competitive with the productive heterolytic cleavage to give 3.70. While it 
is possible 3.70 could arise from the homolytic cleavage of 3.69 followed by single electron 
transfer, mechanistic studies have revealed little evidence for this pathway. In the event of 
formation of a singlet radical pair from 3.69, one would expect hydrogen abstraction 
products derived from the excited triplet radical pair after intersystem crossing. However, 
in mechanistic studies of phosphate leaving groups with coumarin protecting groups, only 
trace amounts of these products were detected. Additionally, no phosphorescence, which 
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would be characteristic if there were significant population of any triplet states, could be 
detected.239 Once the ion pair 3.70 has formed, it is possible for ion recombination to occur 
and return the starting material 3.68. Product formation is proposed to occur in two steps, 
beginning with the escape of the ions from the solvent cage, followed by nucleophilic 
capture of the coumarin cation 3.71 by solvent to deliver 3.72 and the deprotected material 
(H-LG).239 
 
Scheme 3.10 Photodeprotection mechanism for the coumarin PPGs 
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One major disadvantage of the coumarin PPGs is inherent with the photosolvolytic 
mechanism of deprotection. The propensity for recombination of the newly formed ions 
upon heterolytic cleavage of 3.69 is increased with poor leaving groups such as phenols, 
alcohols, thiols and amines. Masking poor leaving groups through carbonate or carbamate 
linkers is not always effective because the decarboxylation of the released substrate can be 
slow and often becomes rate limiting, which significantly reduces the apparent rate of 
release.193 Hence, this class of PPG is best suited for good leaving groups such as 
phosphates and sulfonates. Although, the release rates for these good protecting groups are 
among the fastest available for a PPG, making the coumarin family a useful group for 
monitoring very fast physiological events.187  
3.4.2 Select Examples of Coumarin PPG Derivatives 
The utility and distinct advantages of the coumarin family of protecting groups has 
drawn significant attention to this class of PPG, culminating in the development of a broad 
array of coumarin derivatives.193,194,202 The 6-bromo-7-hydroxycoumarin-4-methyl group 
(BHCM, 3.73) was an interesting early derivative that resulted in a 50 nm redshift of the 
maximum absorbance (λmax = 370 nm) compared to the methoxy coumarin (MCM, 3.68) 
(λmax = 320 nm). The BHCM derivative also offered the added benefit of increased aqueous 
solubility due to the acidic phenol moiety.240,241 Another improvement came from the 
incorporation of the 7-amino substituent, exemplified by the diethylaminocoumarin 
(DEAC, 3.74) derivative, which resulted in a further red shift of the maxiumum absorbance 
(λmax = 390 nm).242,243  
The innovation of incorporating an amino group to the coumarin core offered a new 
synthetic handle to install solubilizing groups to address the poor aqueous solubility of the 
coumarins. The BCMAC (3.75) derivative was designed with this idea in mind and was 
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successful in providing significant improvements in aqueous solubility.193 Ellis-Davies 
reported the use of DEAC450 (3.77), with a goal to shift the maximum absorbance further 
into the visible region, as well as address the poor aqueous solubility of the coumarins.244 
The clever design of 3.77 with the extended conjugation of enone moiety in combination 
with the solubilizing amino acid group resulted in a photocage with a maximum absorbance 
well into the visible region (λmax = 450 nm) as well as improved aqueous solubility. The 
thio-DEAC (3.76) derivative also resulted in a photocage with a high absorptivity in the 
visible region (λmax = 470 nm). This photocage was successfully used for light regulated 
protein expression in zebra fish.245 
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3.5 BODIPY DERIVED PHOTOLABILE PROTECTING GROUPS 
 
The BODIPY-based family is an emerging class of PPG that absorbs light in the 
visible region (λmax 520–560 nm). The photolysis of BODIPY PPGs is proposed to occur 
via a heterolysis mechanism similar to the coumarin PPGs. Excitation of 3.78 results in 
heterolytic cleavage, and the cation 3.79 is then trapped by solvent. The nature of the 
deprotection mechanism leaves the BODIPY with similar challenges as the coumarin PPGs 
with regard to the release of poor leaving groups.   
 
Scheme 3.11. Photodeprotection of BODIPY PPGs via heterolytic cleavage. 
Initial reports (Y = alkyl) of BODIPY PPGs disclosed slow (hours) deprotection of 
carboxylic acids,246 but Feringa and Szymański recently reported the efficient release of 
amines through carbamate linkers within 10 minutes of irradiation at 520 nm (Equation 
3.5) as monitored by ultra performance liquid chromatography (UPLC).247 This class of 
PPG is still new and has yet to be applied to any biological studies, but it strong absorption 
at longer wavelengths makes it an attractive alternative to other well established classes of 
PPGs.  
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3.6 BIOLOGICAL APPLICATION OF PHOTOCAGES: LIGHT CONTROLLED GENE 
EXPRESSION 
Light represents a unique tool in the study of genes and regulating cellular processes 
because of the non-invasive spatial and temporal control it can provide.248 Photocages have 
proven to be invaluable tools for the regulation of gene expression via small molecules. 
Biologically active molecules can be rendered inert through chemical modification with 
photolabile protecting groups, and upon irradiation with non-damaging light (> 360 nm), 
the compound can be quickly released and perform its cellular function. The photocaging 
of small molecules that regulate heterologous gene expression systems has become a 
powerful tool for controlling cellular processes.249  
3.6.1 Overview of Small Molecule Regulated Gene Expression Systems 
Over the last few decades, a variety of heterologous gene expression systems that 
are regulated by small molecules have been developed.250–253 In general, these systems take 
advantage of specific interactions between prokaryotic repressor protein/operon pairs to 
create systems where gene expression can be induced in response to specific small 
molecules in eukaryotic cells. For most of these expression systems there exists both an 
“expression-ON” and an “expression-OFF” variant. This nomenclature refers to gene 
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expression being turned on or off in the presence of the repressor ligand. Although 
mechanisms can vary between systems, typically for an expression-ON system, there is a 
repressor protein that binds to its operator downstream of a constitutive promoter, thereby 
inhibiting transcription of the target gene of interest (A, Figure 3.3). Introduction of the 
repressor ligand leads to a protein binding event that causes a conformational change in the 
protein, ultimately resulting in the dissociation of the repressor from its operator through a 
process known as derepression. Once the repressor is removed, transcription of 
downstream genes is free to occur (B, Figure 3.3).254 
In contrast, the expression-OFF systems, are designed to prevent transcription of 
downstream genes in the presence of the repressor ligand. These systems are typically 
created through fusing a transactivation domain with a repressor protein. The hybrid 
activator-repressor binds to its operator upstream of a promoter and initiates gene 
transcription (C, Figure 3.3). When the repressor ligand is present however, it binds to the 
repressor which results in derepression and inhibition of gene transcription (D, Figure 
3.3).254 
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Figure 3.3 Generic examples of expression-ON and expression-OFF systems 
A) Expression-ON system in the absence of ligand. The repressor protein binds to 
its operator downstream of a constitutive promoter inhibiting transcription of downstream 
genes. B) Expression-ON system in the presence of ligand. The repressor ligand binds to 
the repressor protein resulting in derepression and gene transcrtiption is intiated. C) 
Expression-OFF system in the absence of ligand. The hybrid repressor-transactivator is 
free to bind to its operator and transcription of downstream genes occurs. D) Expression-
OFF system in the presence of ligand. The repressor ligand binds to the hybrid repressor-
transactivator and causes derepression and thereby inhibiting transcription of genes.  
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3.6.2 Tetracycline Dependent Gene Expression 
3.6.2.1 Tetracycline Resistance in Bacteria 
 
 
Figure 3.4 Select tetracycline derivatives. 
The tetracyclines (Figure 3.4) are a family of antibiotics that act by binding to the 
bacterial ribosome, which interrupts polypeptide chain elongation and ultimately killing 
the bacterial cell.255 Many bacteria have developed mechanisms of resistance to this 
antibiotic, the most common of which involves a membrane associated protein (TetA) that 
exports the antibiotic out of the cell before tetracycline (Tc, 3.84) can inhibit translation.256 
The expression of the TetA protein is tightly regulated by the tetracycline repressor protein 
TetR, which binds with high specificity to two palindromic DNA operators, tetO1 and 
tetO2, containing the genetic information for the TetR and TetA proteins. Tetracycline 
(3.84) is believed to enter the cell by diffusion across the cytoplasmic membrane in its 
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neutral form, after which, the keto-enol moiety forms a complex with Mg2+ to give the 
bioactive [Tc-Mg]+ complex 3.87 (Equation 3.6). The [Tc-Mg]+ complex (3.87) binds to 
the TetR protein with high affinity, inducing a conformational change in the protein and 
causing a rapid disassociation from the DNA operators, ultimately allowing transcription 
of TetR and TetA. The induced TetA protein integrates into the cytoplasmic membrane 
where it can export 3.87 from the cell.255  
 
 
3.6.2.2 TetON Gene Expression  
Gossen took advantage of the highly specific [Tc-Mg]+ -TetR-tetO interactions of 
bacteria cells to develop the “TETON” expression system as a tool to regulate gene 
expression in eukaryotic cells.257–259 Four DNA sequences of the wild type TetR protein 
were mutated so that the protein’s binding to the tetO operon could only occur when a 
tetracycline antibiotic was bound to the protein. This reverse TetR (rTetR) protein was then 
fused with the transactivator protein VP16 from the Herpes simplex virus to create a hybrid 
protein (rtTA) that would initiate gene transcription upon its binding to the tetO operator. 
Thus, binding of a tetracycline ligand to the rtTA protein results in the protein-ligand 
complex biding to the tetO operator, and transcription of downstream genetic information 
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is initiated. Target genes of interest, such as fluorescent reporter proteins, can be placed 
downstream of the tetO operon, and their transcription will ultimately be controlled by the 
presence of a tetracycline antibiotic.  
Gossen demonstrated control over expression of luciferase, a fluoresecent reporter 
protein, in HeLa cells with his tetracycline dependent system. He tested several tetracycline 
analogues and he found that doxycycline (Dox, 3.85) and anhydrotetracycline (ATc, 3.86) 
were the most potent stimulators of luciferase activity, while tetracycline (Tc, 3.84) was a 
only moderate effector.257,259  
The TETON system has since become a powerful tool for regulating gene expression 
in cells and transgenic animals. The low toxicity of the tetracyclines and their high affinity 
for the TetR protein, has enabled the use of these antibiotics at concentrations that cause 
no appreciable adverse effects in transgenic animals, avoiding the problems associated with 
many other gene regulation systems.250 
3.6.2.3 Photocaged Doxycycline: Light Controlled TetON 
Cambridge developed a light-controlled variant of the TETON system using 
doxycycline (3.85) caged with the UV-labile NV (3.20) o-nitrobenzyl PPG.260,261 The 
synthesis of these protected Dox compounds was non-trivial however, owing to the many 
different reactive unprotected functional groups of 3.85. The NV protecting group was 
converted into a reactive alkylating agent through condensation with hyrdrazine, followed 
by oxidation of the resultant hydrazone with MnO2 to afford the diazo compound 3.87 
(Equation 3.7). Treatment of 3.85 with freshly prepared 3.87 afforded 3.88 as a mixture 
(1:1) of diastereomers in 8% yield (Equation 3.8).  
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The caged doxycycline derivatives 3.88 were then incubated with hippocampal 
cells obtained from transgenic mice that were designed for tetracycline dependent 
expression of green fluorescent protein (GFP). Surprisingly, Cambridge found that one of 
the caged doxycycline diastereomers of 3.88 maintained bioactivity, inducing significant 
expression of GFP even in the absence of light, despite only differing in the stereochemistry 
of the benzylic methyl group of the photocage. Fortunately, the diastereomers could be 
separated via HPLC and the bioinactive isomer was used in the gene expression 
studies.260,261 Incubation of the hippocampal cells with 3.85 led to widespread expression 
of GFP, whereas incubation with the bioinactive diastereomer of 3.88 resulted in little to 
no expression of the fluorescent reporter. Irradiation of the cell cultures incubated with 
inactive 3.88 using a 290–370 nm pulse of light resulted in photolysis of the NV cage, 
release of active 3.85, and expression of GFP.  
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Cambridge was also able to demonstrate light activated expression of GFP in 
embryos of the transgenic mice using the whole-embryo culture system. After removal of 
10.5 day old embryos, and incubation with 3.85, widespread expression of GFP was 
observed. Incubation with the bioinactive isomer of 3.88 resulted in some background 
expression of GFP, but it was minimal. However, photoactivation of the embryos incubated 
with 3.88 through UV irradiation resulted in significant expression of GFP.  
Cambridge’s work with light activated TetON indicates that the system should be 
applicable wherever the standard TetON system is functional. This light activated variant is 
valuable in that it offers a high degree of spatial and temporal control over expression of 
target genes. This could be a valuable tool for probing and manipulating complex 
biological systems.  
3.6.3 ERYTHROMYCIN DEPENDENT GENE EXPRESSION 
3.6.3.1 Erythromycin Antibiotic Resistance  
 
Erythromycin (3.89, Ery) is a 14-membered macrolactone antibiotic that exhibits 
antibiotic activity by altering ribosome function in a manner that prevents prokaryotic 
protein synthesis.262 Many strains of bacteria have developed resistance to macrolide 
antibiotics through mechanisms that include ribosome modification, efflux of the drug, and 
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enzymatic modification of the antibiotic itself.263 One method of resistance found in E. coli 
relies on a 2’-phosphotransferase enzyme, Mph(A), that inactivates erythromycin through 
phosphorylation of the 2’-desoasamine hydroxyl group. The mphA gene is regulated by the 
repressor protein MphR(A) that binds to its operator (ETR) upstream of its own promoter, 
PmphR, and the mphA gene cluster to regulate transcription of Mph(A) and itself. 
Erythromycin binds to MphR(A) to induce a conformation change that causes 
disassociation from the operator, initiating transcription of Mph(A) and MphR(A), 
conferring the bacteria with erythromycin resistance only when the antibiotic is 
present.262,263 
3.6.3.2 Photocaged Erythromycin: Light Controlled EryON 
Deiters used the specificity of the MphR(A)/ETR/PmphR interactions to create an 
expression-ON system for bacterial cells where the transcription of target genes was 
controlled by the erythromycin antibiotic (A,B Figure 3.3).262 The PmphR promoter was 
placed upstream of the ETR operator so that the repressor MphR(A) inhibited transcription 
of target genes in the absence of 3.89.  This system was further enhanced to achieve spatial 
and temporal control over gene expression through incorporation of a photocaged 
erythromycin derivative, which ultimately created an inducible gene expression method 
controlled by light. Dieter’s efforts towards the goal of a light activated EryON system began 
with attempts to prepare photocaged derivatives of 3.89 directly, but he was unable to do 
so for reasons not specified.262 Instead, he directed efforts towards caging the 9-oxime 
analog of erythromycin 3.90 that was confirmed to retain biological activity. Towards this 
goal, the ketone moiety of 3.89 was condensed with hydroxyl amine to give 3.90 in 50% 
yield. Alkylation of 3.90 with 6-nitropiperonyl chloride (3.91) delivered the caged 
erythromycin derivative 3.92 in 87% yield (Scheme 3.11).262 
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Scheme 3.11. Preparation of photocaged erythromycin derivative 3.92. 
Deiters then used 3.92 to demonstrate light controlled expression of GFP in E. coli 
cells. The oxime 3.90 was shown to induce expression of GFP in the absence or presence 
of UV irradiation, while the caged derivative 3.92 only displayed significant expression of 
GFP in the presence of UV irradiation. While Deiters only demonstrated this light activated 
EryON system in prokaryotic cells, there have been several other examples of MphR(A) 
regulated systems in mammalian cells.251,264 Therefore, it is possible that this light activated 
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variant demonstrated by Deiters could be applied to mammalian systems for investigating 
more complex biological environments.  
3.7 SUMMARY OF PHOTOLABILE PROTECTING GROUPS 
Since the seminal reports of photolabile protecting groups, the field has grown 
dramatically and the applications of PPGs now span many different scientific 
disciplines.193,202 Photolabile protecting groups have been widely adopted in the field of 
biology because of their potential to elucidate better understandings of complex biological 
systems. PPGs have become invaluable tools for time-resolved studies of chemical 
processes in living cells. The potential biological applications of PPGs have been one of 
the main driving forces for the invention of new protecting groups and chromophores. 
Addressing the demands of dynamic in vivo events in living organisms will be a constant 
motivator and source of inspiration for new photocages. The recent upsurge in development 
of new PPGs has been driven by demands for better sensitivity, faster release rates, 
increased aqueous solubility, and better absorption properties. Furthermore, new 
photocages are constantly being developed because there exists no one PPG that will meet 
the demands for every application. A wide selection of PPGs is therefore important, so that 
an appropriate PPG will be available for a given application.   
Select examples from some of the most common classes of PPGs are shown in 
Figure 3.5. The o-nitrobenzyl groups 3.20 and 3.21 remain the most popular PPGs by far. 
Their inherent disadvantages are offset by their ability to release a wide variety of groups 
and the ease by which caged substrates can be prepared from readily available commercial 
precursors. Nitrodibenzofuran 3.22 represents an important innovation for this class of PPG 
that will likely see continued use in the future. The 2-(2-nitrohpenyl)ethyl PPGs 
exemplified by 3.30 are gaining popularity as well.221 These cages typically display 
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efficient deprotections and the aniline nitrogen provides a functional handle for the 
installation of solubilizing groups. The phenacyl cages 3.40 and 3.41  are especially useful 
in photochemical electrophysiology studies due to their fast release rates194,234 Applications 
of these cages remain somewhat limited however due to the lack of derivatives that decage 
upon irradiation with visible light. Finally, the coumarin and BODPIY cages 3.77 and 3.78 
both represent promising new classes of PPGs. Their fast deprotection rates and absorbance 
of long wavelengths make them attractive choices for biological applications. However, 
both of these classes are limited by their photosolvolysis mechansim, making them only 
applicable to good leaving groups. Nonetheless, the coumarins have already been applied 
to a number of biological studies, and it is likely that the BODIPY cages will as well.  
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Figure 3.5. Select examples from most common classes of PPGs 
The design of sophisticated and more demanding biological applications will 
continue to drive discovery of new derivatives and classes of PPGs. Increasing the 
usefulness of photocages will lead to exciting advances in the fields of drug delivery, 
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materials science, molecular biology, and neurobiology. With regard to neurobiology, we 
are currently working towards a genetic method for light controlled labeling of active 
neurons as part of a collaborative effort with Dr. Boris Zemelman. This system will rely 
on a gene expression gate that is controlled by photocaged small molecules, which has 
given us first-hand experience in designing and synthesizing caged molecules for use in a 
biological investigation. If successful, this method could lead to an unprecedented 
understanding of the brain and neural networks associated with cognitive and behavioral 
states.  
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Chapter 4: Synthesis of Photocaged Ligands 
4.1 INTRODUCTION  
Recent developments in the field of neuroscience have indicated that collections of 
individual neurons work together to form larger structures, and it is these ensembles of 
neurons that are the true units of function that make up neural circuits.265 Consequently, 
the elucidation of groups of neurons that are responsible for cognitive and behavioral 
events has become a fundamental goal of neuroscience.265 However, identifying the 
underlying cellular ensembles that support mental states is not a simple task. Although 
there have been great advances in recent years for non-invasive brain imaging techniques 
such as positron emission tomography (PET) and functional magnetic resonance imaging 
(fMRI), these methods lack the spatial and temporal resolution required to study intricate 
neuronal circuitry. Therefore, new methods for interrogating the brain at the cellular level 
are critical for us to gain a deeper understanding of its functions.266  
4.2 NOVEL METHOD FOR IDENTIFYING ACTIVE NEURONS 
4.2.1 Overview of Proposed Method 
In collaboration with the Zemelman research group, we are working on the 
development of a novel method to label neurons with spatial and temporal control using 
light. We plan to employ this system in live, awake mice to identify the neuronal networks 
that support specific behaviors and cognitive events. To achieve this goal, we will gate the 
gene expression of neurons that is normally carried out by the cyclic adenosine 
monophosphate (cAMP) response element-binding protein (CREB) using prokaryotic 
repressor protein/operator pairs. The expression gate will be controlled by the presence of 
the small molecule repressor ligands that bind to these repressor proteins to open the gate 
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and allow transcription of downstream genes. We will prepare light sensitive derivatives 
of the repressor ligands to ultimately create a gene expression gate that is regulated with 
light. The labeling of active neurons is achieved by placing genetic information encoding 
for reporter proteins, such as green fluorescent protein (GFP), downstream of the operators. 
Consequently, if the neuron is active and the expression gate is open, it will be tagged 
through the expression of a fluorescent reporter. The control over cellular transcription 
with visible light in this fashion grants this system a high temporal resolution that will 
allow for the labeling of neurons on a behaviorally relevant time scale. 
4.2.2 Generic Genetic Components of Neuron Labeling System 
The genetic construct to label active neurons, which is currently being designed and 
developed by Dr. Boris Zemelman, consists of three main generic components; 1) Promoter 
X, 2) Operator X, and 3) a reporter (A, Figure 4.1). The Promoter X is a DNA sequence 
that acts as a secure binding site for a particular transcription factor. Upon activation of the 
neuron, the transcription factor will bind to Promoter X in order to initiate the transcription 
of downstream genes. Operator X is a DNA sequence that acts as a binding site for a 
specific repressor protein, and will be placed immediately downstream of Promoter X. In 
the absence of repressor ligand, the repressor protein will remain bound to its operator, 
blocking transcription of downstream gene sequences. Introduction of a repressor ligand 
will result in a binding event that induces a conformational change in the protein, liberating 
the repressor from the DNA sequence, ultimately allowing transcription of downstream 
genes. This creates a gene expression “gate” where the repressor protein acts as a gate that 
prevents gene expression when it is bound to the DNA operator, or that is to say, the gate 
is “closed” (B, Figure 4.1). The repressor ligand acts a “gate key” where binding of the 
ligand to its protein releases the repressor from the DNA binding site and “opens” the gate, 
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and gene transcription can occur (C, Figure 4.1). Finally, for the purpose of this work, the 
reporter will be represented by green fluorescent protein (GFP). While the basic functions 
of all three of these components will not change, this system is versatile in its design. Any 
number of specific genes can be substituted for each generic component to best fit our goals 
as the project progresses. 
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Figure 4.1 Basic components of the proposed neuron labeling system and their functions.  
 
A) The gene expression gate consists of three generic components: 1) Promoter X, 2) 
Operator X, and 3) a reporter protein. Upon activation of the neuron, the transcription factor 
binds to Promoter X to initiate gene transcription. The repressor protein acts as a “gate” 
and binds to Operator X. The repressor ligand acts as a “gate key” and will liberate the 
repressor protein from its DNA binding site to “open” the gate and allow gene transcription. 
B). Depiction of the repressor protein bound to its operator and the gate is “closed” 
preventing transcription. C). Depiction of the repressor ligand binding to the repressor 
protein, thereby releasing it from its binding site and “opening” the gate, allowing gene 
transcription to occur. 
4.2.2.1 Transcription Factor and Promoter X 
For our investigations, we plan to use the cAMP response element binding protein 
(CREB) as the transcription factor and the cAMP response element (CRE) as Promoter X. 
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CREB is found in all neurons, and is phosphorylated in response to a number of cellular 
signals such as cAMP or elevated calcium upon activation of the neuron.267 The 
phosphorylated CREB (pCREB) then binds to the cAMP response element (CRE) DNA 
sequence to initiate transcription of downstream genes. However, by placing a prokaryotic 
operator immediately adjacent to CRE, we can create a system where the gene expression 
of neurons is gated by the presence of a repressor protein. Gating the expression of genes 
by pCREB offers a distinct advantage in that the presence of pCREB is a near universal 
indicator of neuronal activation. Therefore, the use of pCREB in this labeling method 
should ensure that all active neurons are tagged during the behavioral event under 
investigation. 
4.2.2.2 Prokaryotic Operator/Repressor Pairs 
The operator/repressor component of the system is critical for exerting control over 
expression of the reporter protein. At the outset of our studies, we identified a number of 
possible prokaryotic operator/repressor protein pairs with ligands that control derepression 
that would be applicable to our gated gene expression system (Figure 4.2).253,268,269 
Specifically, we wished to investigate the tetracycline dependent repressor TetR, the 
erythromycin dependent repressor MphR, and the vanillic acid dependent repressor VanR. 
All of these repressor proteins have been modified and incorporated into expression-ON 
and expression-OFF type systems for use in mammalian cells,251,253,257 some of which were 
discussed previously (Chapter 3, Section 3.6). However, in contrast to those gene 
expression systems, gene expression in this labeling method is not initiated by the presence 
of the repressor ligand. The prokaryotic operator/repressor pair will simply gate gene 
expression that has been initiated in response to a cellular event that has triggered the 
phosphorylation of CREB. This is an essential element of the labeling method that will 
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allow us to identify neurons that are activated in response to behavioral events. Therefore, 
we wish to take advantage of the natural prokaryotic mechanisms and only use the wild 
type operator/repressor pairs in our system.  
While the origins of the tetracycline and erythromycin repressor/operator pairs 
were described in the previous chapter (Chapter 3, Section 3.6), the VanR protein has not 
yet been discussed and is worth mentioning. The VanR/VanO repressor/operator pair 
originates from the metabolic pathways of the fresh water bacterium Caulobacter 
crescentus.253 Vanillic acid (4.4) is produced as a by-product of the fungal oxidative 
cleavage of lignin of decaying plant material.270 C. crescentus can convert vanillic acid 
(4.4) into useful metabolites that can ultimately be converted into energy.271 This metabolic 
pathway is inert in the absence of vanillic acid due to the transcriptional repressor protein 
VanR, which remains bound to its respective operator, VanO, upstream of the genes that 
encode for the corresponding monooxygenase required to metabolize vanillic acid. 
However, when C. crescentus encounters vanillic acid (4.4), the ligand will bind to VanR 
causing derepression and transcription of downstream genes can occur. The specific 
interactions of the VanR/VanO pair have since been exploited for control of gene 
expression in mammalian cells.253  
While were interested exploring all of the repressor/small molecule pairs shown in 
Figure 4.2 for our gene expression gate, only doxycycline and erythromycin have been 
previously rendered biologically inactive with respect to their repressor proteins through 
chemical modification with a photolabile protecting group.261,262 Hence, these two 
repressor protein/ligand pairs represent promising start points for our investigations. While 
anhydrotetracycline (4.2) has not been previously rendered inert with respect to TetR, it 
was shown to be a strong binder to the repressor protein and is a possible alternative to 
4.1.272 Additionally, the vanillic acid/VanR system was an attractive alternative because 
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the relative simplicity of 4.4, in contrast to the complex chemical environments of 4.1, 4.2, 
and 4.3, would facilitate the preparation of caged derivatives. While the task of preparing 
photocaged erythromycin was a concurrent, independent investigation within our lab,273 
we also investigated the preparation of photocaged derivatives of vanillic acid, 
doxycycline, and anhydrotetracycline (vide infra).  
 
 
Figure 4.2. Select small molecule/repressor protein pairs 
4.2.3 Implementation of Proposed Method 
A summary of the proposed neuron labeling method is depicted in Figure 4.3. We 
plan to use CRE, tetO, and GFP as the generic components Promoter X, Operator X, and 
the reporter (Figure 4.1) respectively. The genetic information for these components can 
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be introduced into the neurons of mice via virus, and with this neuron labeling method in 
place, we will be able to study their brain function on a cellular level. The mouse neurons 
will be activated in response to a cognitive or behavioral event of interest, resulting in the 
formation of pCREB and its binding to CRE to initiate gene transcription. However, the 
gene expression will be gated by the TetR protein which will bind to the tetO operon 
upstream of the GFP reporter and prevent transcription (A, Figure 4.3). The caged-Dox 
ligand can then be introduced via local injection. The concentration of the caged ligand 
will be a critical parameter to explore. It is important that there is enough ligand present to 
elicit a sufficient signal from the reporter upon uncaging, however, excess ligand will result 
in over reporting of the fluorescent protein leading to false labeling. Furthermore, low 
concentration of the ligand will also be important so that it can quickly diffuse away after 
binding to the repressor protein, thereby reestablishing the expression gate and turning off 
gene transcription. In the absence of light, introduction of the caged Dox ligand will not 
induce transcription of the fluorescent reporter. However, upon illumination of the mouse 
brain with visible light, Dox will be released from the cage and will be free to bind to TetR. 
This will induce a conformational change in the protein, causing it to dissociate from the 
DNA sequence, and the expression gate will be opened. After TetR is removed, pCREB 
will be free to transcribe protein in activated neurons (B, Figure 4.3). Put simply, if the 
neuron is active and the caged-Dox is present in the cell, irradiation with visible light will 
result in GFP production, labeling the active neuron (C, Figure 4.3). However, in the 
absence of light, the neuron will remain unlabeled.  
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Figure 4.3. Summary of the proposed method in practice 
A) Depiction of the closed expression gate where transcription is blocked by the repressor 
protein TetR. B). Depiction of the labeling method in action. Uncaging of the ligand with 
visible light allows it to bind to the repressor protein to open the expression gate and allow 
gene transcription. C). Simple summary of the proposed method. If there is neural activity 
in the presence of light and the caged ligand, expression of GFP will occur. However, in 
the absence of light, the neuron will remain unlabeled.  
 
4.3 DESIGN OF PHOTOCAGED LIGANDS 
As shown in the previous chapter, there exists a wide variety of photocages 
available for use in rendering the repressor ligands 4.1–4.4 biologically inert.193 It is 
important for our system however, that the photocage can be removed with low energy 
visible light because we plan implement the caged molecules in vivo, where even brief 
exposure to near-UV irradiation can cause DNA damage to neurons. Furthermore, it is 
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important that our caged compounds display good aqueous solubility, and that they are 
stable in the absence of light. Upon consideration of these requirements, the selection of 
photolabile protecting groups is more limited. We identified three photolabile protecting 
groups that would be suitable for our system. These photocages are DEAC450 (λmax = 456 
nm), CANBP (λmax = 397 nm), and NDBF (λmax = 330 nm) (Figure 4.4).214,216,221,237  
 
 
Figure 4.4. Possible photocages for preparation of caged ligands 
Each of these photocages offered distinct advantages that could be beneficial to our 
system. The strong absorbance in the visible region and the water solubilizing functional 
groups of the DEAC450 cage were attractive features, but, we were also aware that this 
cage is typically best suited for good leaving groups such as phosphates, meaning it may 
not be an appropriate cage for use with 4.1, 4.2, or 4.4. The o-nitro-based cages CANBP 
and NDBF, however, are capable of efficiently releasing a wider variety of leaving 
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groups,193 which made them appealing alternatives. Ultimately, the CANBP protecting 
group221 seemed to be the most suited for our goals. This photocage possesses a number of 
desirable traits including, strong absorbance at long wavelengths (λmax = 397 nm), fast 
deprotection rates (minutes), and the water solubilizing carboxyl groups should ensure 
good aqueous solubility of the caged ligand. Hence this cage was selected as the PPG of 
choice for our studies.  
Doxycycline had been previously rendered unable to bind to the rtTA protein of the 
TETON system through caging of the keto enol moiety of the molecule (NV-Dox, 4.8) 
(Figure 4.5).261 While the biological function of the rtTA protein is distinct from TetR, the 
ligand binding domain of the modified rtTA protein was left unchanged and is the same as 
with TetR.257 Therefore, compounds that were rendered inert with respect to rtTA should 
also be inert with respect to TetR. Furthermore, this keto-enol functionality has been shown 
to be important for the binding of tetracycline derivatives to the TetR protein.274,275 Based 
on this precedent, we set out to cage 4.1 or 4.2 in a similar fashion through the preparation 
of 4.9 and 4.10. We anticipated potential complications related to the benzylic stereocenter 
of the CANBP photocage. Caging a tetracycline derivative with 4.6 would result in a 
mixture of diastereomers (e.g. 4.9-Me or 4.10-Me) that could complicate the purification 
of the caged compounds. Furthermore, Cambridge found that one of the diastereomers of 
4.8 remained bioactive, despite being caged.261 With these potential pitfalls in mind, we 
planned to prepare the 4.6–H variant of the CANBP cage that does not possess the benzylic 
methyl group. We were aware that this compound may have diminished deprotection 
efficiency,193 but we anticipated that the deprotection would still be sufficient for our needs.  
For vanillic acid (4.4), there were no previous examples of rendering the ligand 
biologically inert with respect to the VanR protein via chemical modification. Furthermore, 
there exists no crystallographic data for vanillic acid bound to the VanR protein. Therefore, 
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it was unclear if vanillic acid would require caging at the phenol moiety or the carboxylic 
acid moiety to prevent it from binding to VanR. Hence, we planned to prepare two caged 
derivatives for this compound, 4.11 and 4.12 so that we could probe its binding to the VanR 
protein. 
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Figure 4.5. Planned photocaged derivatives of ligands 4.1, 4.2, and 4.4. 
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4.4 SYNTHESIS OF CANBP PHOTOCAGES 
Our efforts to prepare photocaged derivatives of 4.1, 4.2, 4.4, commenced with the 
synthesis of the known CANBP photocage.221 Commercially available 4-
nitrobromobenzene (4.13) was alkylated via vicarious nucleophilic substitution with tert-
butylchloroacetate (4.14) to afford 4.15 in 90% yield. Methylation of the benzylic carbon 
through treatment with sodium hydride and methyl iodide, followed by reduction of the t-
butyl ester with diisobutylaluminum hydride (DIBAL-H) delivered 4.17 in 72% yield over 
two steps. Construction of the biaryl ring was accomplished through a Suzuki coupling 
with 4.18 which delivered 4.19 in 85% yield. Final installation of the solubilizing carboxyl 
groups onto the aniline nitrogen of 4.19 was the only low yielding step in the preparation 
of the CANBP photocage. Alkylation of 4.19 with 4.20 delivered the desired compound 
4.21 in only 45% yield, and the remaining material consisted of the monoalkyated analogue 
4.22. While extensive effort has not been undertaken to optimize this reaction, some 
attempts of increasing the equivalence of 4.20, extending the reaction time, or inclusion of 
sodium iodide for an in-situ Finkelstein reaction, offered no improvement on the product 
distribution. Nevertheless, 4.21 was prepared in five steps and 25% overall yield. 
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Scheme 4.1. Synthesis of CANBP photocage 4.21. 
We prepared the novel nor-methyl CANBP photocage 4.25 in an analogous manner 
to 4.21, but omitting the alkylation with methyl iodide. In this fashion, the nor-methyl 
photocage 4.25 was prepared in four steps and 31% overall yield (Scheme 4.2).  
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Scheme 4.2. Synthesis of nor-methyl CANBP photocage 4.25. 
4.5 SYNTHESIS OF CAGED VANILIC ACID DERIVATIVES 
4.5.1 Caging Vanillic Acid – Ester Derivatization 
 We planned to cage the carboxylic acid of 4.4 by first installing an acid labile 
blocking group on the phenol and then activating the carboxylic acid towards ester bond 
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formation with photocage 4.21. The methoxymethyl acetal (MOM) protecting group was 
strategically chosen to enable a global removal of protecting groups upon unmasking of 
the carboxylic acid moieties of 4.21 through treatment with acid. Thus we prepared a MOM 
protected analogue of vanillic acid (4.4.) in two steps from vanillin (4.27). Alkylation of 
the phenol moiety of 4.27 followed oxidation of the aldehyde with KMnO4 delivered 4.29 
in 84% yield. We next sought suitable conditions to esterify 4.29 with the CANBP cage 
using intermediate 4.16 as a model system.  
 
 
Scheme 4.3. Preparation of MOM protected vanillic acid 4.29. 
We commenced our efforts to esterify 4.29 with 4.16 through carbodiimide 
mediated couplings. We first attempted a Steglich type esterification276 between 4.29 and 
4.16 using DCC and DMAP, but no product was observed and unreacted 4.16 was 
recovered (Equation 4.1). Previous reports in the literature showed that EDCI promoted 
esterifications worked well for the CANBP photocage during the preparation of caged 
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GABA derivatives,221 but unfortunately, application of these conditions to our system did 
not provide any of the desired product. 
 
 
 
 
We next attempted to form 4.30 through activation of 4.29 as a carbonate or an 
anhydride. Introduction of 4.16 and 4-dimethylaminopyridine (DMAP) to a solution of 
freshly prepared mixed anhydride of vanillic acid derived from pivaloyl chloride (4.31) or 
isobutyl chloroformate (4.32) gave no desired product, and again, only unreacted 4.16 was 
recovered (Equation 4.3). The initial conclusion was that the mixed anhydride 
intermediates were never formed during the first step of the reaction sequence; however, 
control experiments revealed there was clean conversion to the desired anhydride 
intermediates by 1H NMR and TLC analysis of the reaction mixtures. Attempts to drive 
the reaction to completion through increased reaction times and temperatures were 
unsuccessful, and only unreacted 4.16 was recovered. 
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We at last found success when we used the Yamaguchi reagent 4.29276 to form the 
more reactive mixed anhydride 4.34, which upon reaction with 4.16 and DMAP delivered 
4.30 in 33% yield along with the undesired ester 4.35 in 12% (Scheme 4.4). We recovered 
ca. 50% unreacted 4.16 from this reaction, but we had finally identified conditions to 
esterify 4.29. We speculated that the yield could be improved through increased 
equivalence of the photocage and longer reaction times. We applied this logic to the 
esterification of 4.29 with 4.21 using the Yamaguchi esterification conditions, and we 
obtained 4.30 in 57% yield (Equation 4.4). 
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Scheme 4.4. Yamaguchi esterification of 4.29 to prepare 4.30. 
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4.5.2 Caging Vanillic Acid – Phenol Derivatization 
With the successful preparation of 4.36, we next attempted to derivatize the phenol 
moiety of vanillic acid. Applying similar logic as before in choosing a protecting group for 
vanillic acid, we aimed to prepare the t-butyl ester of vanillic acid, which would enable a 
global removal of t-butyl groups from the caged derivative when necessary. Accordingly, 
vanillic acid (4.4) was prepared by silver oxide oxidation of vanillin (4.27), and it was 
subsequently converted into the t-butyl ester 4.38 through a Steglich esterification with 
tert-butanol as solvent (Scheme 4.5).  
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Scheme 4.5. Preparation of 4.38 from 4.27. 
Fortunately, alkylating the phenol of 4.38 proved less difficult than preparing 4.36. 
We discovered that a Mitsunobu reaction between 4.38 and model cage 4.16, delivered the 
desired alkylated product 4.39 in 60% yield (Equation 4.5). We next appended the full nor-
methyl CANBP cage 4.25 via the same Mitsunobu reaction conditions used on the model 
system that afforded 4.40 in 63% yield.  
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4.5.3 Synthesis of Caged Vanillic Acid Derivatives Summary and Conclusions 
We successfully designed methods to cage vanillic acid at the carboxylic acid 
moiety or the phenol moiety. While we did not investigate other photocages on this system, 
we expect these methods to prepare carboxylic acid or phenol caged vanillic acid would be 
readily translatable to other systems if desired. Unfortunately, Zemelman discovered that 
the vanO/VanR operon/repressor pair was ill suited for our neuronal labeling method. The 
VanR protein did not sufficiently repress transcription of the fluorescent protein in the 
absence of vanillic acid, and significant production of GFP was observed. Therefore, we 
abandoned our efforts towards caged vanillic acid analogs 4.36 and 4.40. We did not 
evaluate the aqueous solubility or the deprotection efficiencies of these compounds because 
they could not be used in our system. Instead we focused on using tetO/TetR in our 
expression gate system, and we moved on to preparing caged derivatives of doxycycline 
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(4.1) or anhydrotetracycline (4.2). Nevertheless, 4.36 and 4.40 represent novel photocaged 
compounds that would allow for a light-controlled cell labeling system. 
4.6 SYNTHESIS OF CAGED TETRACYCLINE DERIVATIVES  
Our new goal became the preparation of a photocaged derivative of 4.1 or 4.2. We 
began our investigations with 4.1, because NV-Dox had already been demonstrated to work 
well for the TETON
 system. Due to the chemical complexity of 4.1, we though it prudent to 
begin probing its reactivity through model systems instead of the more complex and light 
sensitive CANBP derivatives. Following the precedent from Cambridge,261 we first set out 
to find conditions that would enable caging at the phenolic diketone moiety of 4.1. 
Our initial efforts to alkylate doxycycline proved fruitless. Treatment of 4.1 with 
MOMCl at 0 ˚C, room temperature, or 70 ˚C, lead to intractable mixtures with no mass hits 
characteristic of useful products by LCMS analysis (Equation 4.7). Changing the alkylating 
agent to benzyl bromide provided similar results (Equation 4.8) and attempts to increase 
the nucleophilicity of doxycycline (4.1) through treatment with sodium hydride also proved 
ineffective (Equation 4.9).  
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Alkylating doxycycline with halogen-based electrophiles was proving to be 
unproductive, so we changed strategies and attempted to functionalize doxycycline in a 
similar fashion to the procedure reported by Cambridge.261 We used acetophenone (4.43) 
and 4.46 as starting points for alkylation model systems that would be similar to a 
photocage we could attach to doxycycline. The diazo compounds 4.45 and 4.47 were 
prepared through condensation of 4.43 or 4.46 with hydrazine (Equation 4.10) and then 
oxidation of the resulting hydrazone with MnO2 (Equation 4.11). Unfortunately, treatment 
of doxycycline with freshly prepared 4.45 or 4.47 resulted in only decomposition of the 
materials and the formation of intractable mixtures (Equation 4.12). 
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Doxycycline was proving difficult to alkylate with model systems, a problem we 
anticipated would be exacerbated by attempting to append the more structurally 
complicated light sensitive CANBP cage. Instead of attempting to alkylate 4.1, we instead 
focused on acylation reactions. We speculated that attachment of the CANBP cage through 
a carbonate linker may be a more reliable strategy than alkylation of the complex ligand. 
With no literature precedent available for selectively acylating doxycycline, we again 
turned to a model system to establish the reactivity profile.  
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Following literature precedent from Tan and coworkers in their studies of selective 
diol acylations,277 4.1 was treated with propionyl chloride in the presence of N-
methylimidazole (NMI) (20 mol%) (Equation 4.11). LCMS analysis of the reaction 
mixture revealed a mixture of mono- and bis-acylated doxycycline products that were 
inseparable by HPLC. While this model system did not lead to any structural information 
about the regiochemical outcome of the acylation, it did provide the first positive result 
towards caging doxycycline. 
 
 
Heartened by the limited success of acylating 4.1 with propionyl chloride, we 
continued our studies using benzyl chloroformate (CbzCl) as a model that would more 
closely resemble the carbonate linker the cages 4.21 and 4.25 would require. Subjecting 
doxycycline to the same reactions conditions in THF or CH3CN with CbzCl as the 
acylating reagent showed the major product to be a mono-acylated doxycycline derivate, 
along with other minor mono and bis-acylated products (Equation 4.14). After HPLC 
purification of the reaction mixture, we were able to isolate the major mono-acylated 
product, which was identified as 4.50 based on the downfield shift of the aromatic protons 
in the 1H NMR spectrum.  
 197 
 
Interestingly, when N-methylimidazole was excluded from the reaction, the 
selectivity for the phenol acylated product decreased, and a mixture (ca 1:1) of mono 
acylated products was observed (Scheme 4.6). The exact role that N-methylimidazole is 
playing in this reaction is unknown. It was originally included due to its ability to act as a 
1,2-diol activator through hydrogen bonding 277 with hopes that it would activate the enol 
moiety for acylation, instead, it increased the selectivity for the acylation of the phenol 
moiety. N-methylimidazole is also known to add to acyl chlorides to generate a more 
reactive acyl imidazolinium intermediate for acylation reactions, and it is possible that it is 
playing a similar function in this reaction. Regardless of its role, it is clear that the NMI 
increases the selectivity of the acylation.  
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Scheme 4.6. Acylation of 4.1 with CbzCl in the absence of NMI. 
While N-methylimidazole did improve the selectivity to provide one major product, 
the acylation still gave many other minor products with similar retention times that 
complicated the purification. Other efforts to increase the selectivity of the reaction were 
unsuccessful. A temperature screen revealed that no reaction occurred at –78 ˚C, while 
reactions at –30 ˚C and –15 ˚C provided comparable results to reactions performed at 0 ˚C. 
A small selection of solvents was screened including CH3CN, THF, and CH2Cl2. While 
THF and CH3CN provided comparable results, CH2Cl2 completely changed the selectivity 
of the reaction to a different mono-acylated isomer as the major product. Unfortunately, 
we were never able to isolate this product in sufficient purity to identify the structure. 
After establishing a set of acylation conditions that offered some selectivity in 
functionalizing doxycycline, we turned our attention to attaching the desired photocages. 
As before, we employed the less advanced intermediate 4.16 as a model system. 
Conversion of 4.16 to the corresponding chloroformate through treatment with triphosgene 
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worked well, delivering 4.52 in ca. 90% purity based upon the 1H NMR spectrum of the 
crude material (Equation 4.15). However, removal of residual triphosgene from the 
reaction mixture proved problematic, so we switched to preparing 4.52 through treatment 
with phosgene instead, which could be removed under reduced pressure (Equation 4.16). 
 
 
 
 
 
Gratifyingly, treating 4.1 with the freshly prepared chloroformate 4.52 in the 
presence of NMI demonstrated that the acylation conditions translated well from the CbzCl 
model system, delivering a mono-acylated Dox product as the major component, along 
with other minor acylation products and unreacted 4.1 (Equation 4.17). 1H NMR analysis 
of the crude reaction mixture showed the presence of a product with aromatic protons 
shifted downfield, and we speculated that the phenol acylated 4.53 was the major product. 
We next attempted the reaction with the full CANBP cage 4.21 and again saw a similar 
product distribution as before, where the major product was assumed to be 4.54 (Equation 
4.18). Unfortunately, all of our efforts to isolate material pure enough for biological 
purposes were not successful. The reaction mixture could not be purified by standard 
 200 
chromatography with silica gel or neutral alumina. Furthermore, we were unable to remove 
the impurities via HPLC purification as well. 
 
 
 
 
 
Due to the difficulty associated with purifying 4.54. we directed our efforts to 
preparing a caged derivative of ATc (4.2), reasoning that its decreased polarity relative to 
doxycycline would facilitate purification. We attempted to prepare anhydrotetracycline 
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according to previously reported procedures278 by heating tetracycline (4.55) and 
concentrated HCl in an alcoholic solvent under reflux; however we found the purity of the 
product to be highly variable. Following this procedure, we could isolate 
anhydrotetracycline in 80 – 93% purity based on the 1H NMR spectrum (Scheme 4.7). 
Various attempts to recrystallize or purify the material by column chromatography were 
unavailing. While it was never confirmed, we speculated that the product was epimerizing 
under the reaction conditions, and the minor impurity was the epimeric product 4.56. We 
circumvented this problem by running the reaction at room temperature rather than heating 
it under reflux (80 ˚C) (Equation 4.17). While the reaction time was significantly longer, 
requiring two days to go to completion, it proved to be a reliable, reproducible method to 
give anhydrotetracycline in excellent yield and purity on multigram scale.  
 
 
Scheme 4.7. Epimerization of ATc during the preparation from 4.55 
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Treatment of anhydrotetracycline with benzyl chloroformate under the established 
acylation conditions for doxycycline revealed a similar product distribution by LCMS as 
seen with our doxycycline studies, with the major product having a mass corresponding to 
the mono-acylated product that we tentatively assigned as the phenol acylated product 4.57 
(Equation 4.19). We next acylated anhydrotetracycline with chloroformate 4.52, and to our 
delight, we found the reaction could be purified using standard chromatography (Equation 
4.20). We isolated the desired product 4.58 in 12% yield, as well as some unidentified 
minor mono-acylated products. The majority of the material recovered from the reaction 
was unreacted anhydrotetracycline, as well ca. 50 mol % of 4.16, which was attributed to 
be the result of incomplete formation of 4.52. 
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With conditions identified for acylating 4.2, we had a clear path forward for 
installing the full CANBP photocages onto a tetracycline derivative. We began our studies 
with the nor-methyl CANBP cage 4.25, reasoning it would be easier to purify due to the 
absence of diastereomeric products. Gratifyingly, we found that the acylation conditions 
developed for the various model systems translated well when chloroformate 4.59 was 
used, and the desired product 4.60 was isolated in 52% yield (Scheme 4.8). Removal of the 
t-butyl groups of 4.60 was accomplished through treatment with trifluoroacetic acid (TFA), 
which delivered the final caged ATc derivative 4.61 in quantitative yield. 
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Scheme 4.8. Synthesis of caged ATc derivative 4.61. 
With 4.61 in hand, we began evaluating its possible use in our planned biological 
studies. To our dismay, we discovered that 4.61 is completely unstable in buffered aqueous 
solution, even in the absence of light. This was determined through control experiments of 
serial injections of an aqueous solution of 4.61 which had been protected from light onto 
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an analytical HPLC column. The caged compound 4.61 completely decomposed to 4.2 and 
4.6-H over the course of two hours. The instability of 4.61 was solvent dependent and we 
found that the compound was completely stable in organic solutions. Therefore, we 
assumed that carbonate linker was prone to hydrolysis. The poor stability of 4.61 has 
rendered this compound useless for our neuron labeling method and we were left with 
identifying a new strategy to cage anhydrotetracycline.  
4.7 SUMMARY AND FUTURE DIRECTIONS 
We have outlined a proposal for an exciting new method of identifying active 
neurons in the brain. If this method is successful, it could lead to a paradigm shift in the 
field of neurobiology and an unprecedented understanding of the brain. Unfortunately, so 
far, we have been unable to align the synthetic organic and neurobiology aspects of the 
project. That is to say, the synthetically accessible vanillic acid ligand is poorly behaved in 
the biological construct, and the biologically reliable tetracycline derivatives are 
challenging to selectively derivatize and purify. However, we think we have identified a 
clear path forward for preparing a water stable caged derivative of anhydrotetracycline. 
Ethylene diamine carbamate linkers have been shown to be effective substitutes for 
carbonate linkers in the event of aqueous instability.188 A recent example of this was 
demonstrated during a photocaging study of tamoxifen.279,280 Upon irradiation of 4.63 and 
subsequent loss of CO2, the by-products 4.64 and 4.65 were generated (Scheme 4.9). The 
carbamate 4.65 will then cyclize to form 4.66 and expel the leaving group, in this case 4.67. 
This strategy should be readily applicable to the preparation of a caged derivative of 4.2 
with a carbamate linker (Figure 4.6). We anticipate that the ATc derivative 4.68 would 
possess the necessary aqueous stability required for our studies, while maintaining a fast 
release rate of 4.2.  
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Scheme 4.9. Release of substrates from a photocage connected by an ethylene diamine 
carbamate linker.  
 
Figure 4.6 Carbamate linked caged ATc derivative. 
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Despite the instability of 4.61, we were able to identify practical reaction conditions 
to selectively functionalize 4.2 and easily isolate the caged derivatives via standard 
chromatography. While we have not yet probed the general substrate scope this method, 
we expect this protocol to be readily applicable to other activated acylation reagents. Given 
the popularity and utility of the TETON gene expression system,
249,250,281 a general method 
to easily functionalize a tetracycline derivative would be valuable to the synthetic and 
biological communities. The deficiencies of the previous method for preparing light 
sensitive derivatives of 4.1 reported by Cambridge261 further highlight the need for 
improvement. Thus, the preparation of 4.68 will also work towards establishing a general 
method for the preparation of caged derivatives of 4.2. Once 4.68 is prepared, we can 
undertake the necessary solubility, stability, and deprotection experiments to test its 
viability for use in our labeling method. 
 
  
 208 
 
PROGRESS TOWARDS THE TOTAL SYNTHESIS OF 
ALSTOSCHOLARISINE E 
Chapter 5: Alstoscholarisines A–E – Isolation and Previous Syntheses 
5.1 ISOLATION 
Natural products that modulate the growth of neurons are quickly becoming a focus 
for the synthetic community.282 Many neurogenic disorders, such as Alzheimer’s and 
Parkinson’s disease, are characterized by a progressive loss of neuronal activity. 
Consequently, novel therapies designed to restore neuronal viability or prevent neuronal 
decline are in high demand. The alstoscholarisines are five monoterpenoid indole alkaloids 
isolated from Alstonia scholaris collected in Yunnan Province, China by Luo in 2014 
(Figure 5.1).283  
 
Figure 5.1. Alstoscholarisines A–E (5.1–5.5) 
Alstoscholarisines A–E (5.1–5.5) share a pentacyclic core containing five 
contiguous stereocenters. They differ primarily in the presence or absence of a carboxyl 
moiety at C16, and the configuration of the methyl group at C19.283 Alstoscholarisines A–
E (5.1–5.5) were all found to promote neuronal stem cell (NSC) proliferation in a dosage 
dependent manner, with 5.1 being the most potent, functioning at a concentration of 0.1 
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μg/mL. Additionally, 5.1 was shown to promote NSC sphere formation and neuron 
differentiation. These compounds could play an important future role in discovering new 
treatments for neurodegenerative disorders such as Alzheimer’s, Parkinson’s, or 
Huntington’s diseases.  
The important biological activity and interesting structural features of the 
alstoscholarisines did not go unnoticed by the synthetic community, and there have been 
three reported syntheses of members of the alstoscholarisine family to date. Bihelovic and 
Ferjancic disclosed the first synthesis of (±)-alstoscholarisine A in 2016284 and soon after, 
Yang reported an enantioselective synthesis of (–)-alstoscholarisine A.285 Most recently, 
Weinreb pursued the more complex members of the alstoscholarisine family, and in 2017 
reported syntheses of (±)-alstoscholarisine B and (±)-alstoscholarisine C.286 
5.2 PREVIOUS SYNTHESES OF ALSTOSCHOLARISINE A 
5.2.1 Bihelovic and Ferjancic’s Synthesis of (±)-Alstoscholarisine A 
Bihelovic and Ferjancic’s synthesis commenced with the radical alkylation of 
skatole (5.6) using the xanthate ester 5.7, followed by protection of the indole nitrogen to 
afford the known intermediate 5.9 (Scheme 5.1).287 The ester enolate of 5.9 generated 
through treatment with lithium diisopropylamide (LDA) was allowed to react with 
aldehyde 5.10 to afford the aldol product 5.11. This intermediate was immediately treated 
with sodium hydride, which triggered the migration of the indole nitrogen t-butylcarbamate 
(Boc) protecting group to the free alcohol 5.12, and β-elimination of the newly formed 
carbonate delivered 5.13 in 75% yield from 5.9. Interestingly, 5.13 was isolated primarily 
as the E isomer, with only minor amounts of the Z isomer detected. Next, palladium 
mediated removal of the allyl carbamate protecting group delivered 5.14 in 72% yield, and 
the stage was set for the investigation of the key domino cyclization cascade. 
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Scheme 5.1. Synthesis of 5.14 
With 5.14 prepared, the domino cyclization sequence was investigated. Initially, 
the cascade was attempted using ethyl propiolate (5.15), but, only Michael addition into 
the alkyne was observed (5.16). The reaction did not progress to intermediate 5.17 (Scheme 
5.2). They hypothesized that the vinylogous carbamate 5.16 was not sufficiently 
nucleophilic to effect the second Michael addition and generate 5.17. To address this issue, 
they planned instead to use an aliphatic enamine, to provide enhanced reactivity and 
possibly complete the desired cyclization. 
 211 
 
Scheme 5.2. Attempted domino cyclization sequence using 5.15 
Accordingly, 4-(phenylselanyl)butanal (5.18) was used as a synthon for 3-butenal, 
and when 5.14 was heated with 5.18 in CH3CN in the presence of molecular sieves, it was 
smoothly converted to the tetracyclic products 5.21a,b in a 1:1 ratio (Scheme 5.3). 
Fortunately, the ratio of 5.21a and 5.21b could be improved to 5:1 when DBU was added, 
and the reaction mixture was heated after the cyclization. In this fashion, the desired 
diastereomer 5.21a was prepared in 71% yield (Equation 5.1). 
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Scheme 5.3 Successful domino cyclization sequence using 5.14 and 5.18 
 
 
Interestingly, the selenium containing aliphatic side chain adopted an axial 
orientation in both 5.21a and 5.21b. The stereochemical outcome of the cyclization was 
rationalized to occur as the result of an equilibration between the enamine 5.23 and the 
iminium salts 5.22 and 5.20 (Scheme 5.4). Intermediate 5.20 is proposed to be 
thermodynamically more stable than 5.22, due to the unfavorable gauche interactions 
present in 5.22 when the alkyl side chain is equatorial.  
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Scheme 5.4. Equilibration between 5.22 and 5.20.  
With an efficient route to 5.21a established, focus was shifted to the construction 
of the tetrahydropyran moiety of 5.1. Toward this end, the selenide moiety of 5.21a was 
oxidized with meta-chloroperoxybenzoic acid (m-CPBA), and the resulting selenoxide was 
eliminated to give olefin 5.24 in 83% yield. The ethyl ester was then reduced with 
diisobutylaluminum hydride (DIBAL) to afford the primary alcohol 5.25. The terminal 
olefin of 5.25 was converted to the aldehyde 5.26 in two steps through dihydroxylation 
followed by diol cleavage with Pb(OAc)4.  
In order to form the desired tetrahydropyran, the axial aldehyde moiety of 5.26 
required epimerization to the equatorial configuration. Unfortunately, 5.26 was unstable to 
a variety of basic conditions, possibly due to β-elimination of one of the indole moiety. 
Additionally, it seemed that the axial orientation of the aldehyde side chain of 5.26 was 
thermodynamically preferred because attempts to equilibrate it to the equatorial epimer 
were unsuccessful. Fortunately, when 5.26 was treated with DBU at room temperature, 
isomerization took place and the equatorial conformer was trapped as the mixture of 
hemiacetals 5.27, which was immediately oxidized with Dess–Martin periodinane (DMP) 
to deliver 5.28 in 34% yield from 5.25. The lactone 5.28 was converted to alstoscholarisine 
A (5.1) in two steps beginning with addition of MeLi to give hemiketal 5.29, followed by 
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a diastereoselective ionic reduction with Et3SiH and TMSOTf, where hydride delivery 
occurred from the convex face of the oxonium ion generated in-situ.  
 
 
Scheme 5.5. Elaboration of 5.14 to alstoscholarisine A (5.1) 
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Bihelovic and Ferjancic completed the synthesis of (±)-alstoscholarisine A (5.1) in 
13 steps and 1.7% overall yield from 5.5. Their synthesis relied on an efficient domino 
sequence that quickly constructed the core of the natural product (5.14 to 5.21a, Equation 
5.1). They were able to reach tetracyclic intermediate 5.21a, in only five steps and good 
yield. Unfortunately, the construction of the tetrahydropyran ring was cumbersome, 
requiring seven steps, four of which were redox manipulations. Nevertheless, this synthesis 
is notable in that it represents the first successful approach to 5.1. 
5.2.2 Yang’s Synthesis of (–)-Alstoscholarisine A 
Yang’s synthesis commenced with the preparation of the known butyrolactone 
5.32.285 This starting material 5.32 was available in two steps and 40% yield from 5.30, by 
a process involving ozonolysis of the terminal olefin to provide 5.31, followed by addition 
of a vinyl Grignard reagent to the newly formed aldehyde and intramolecular cyclization 
to provide 5.32.288 The lactone 5.32 was then used to acylate the skatole (5.5) nitrogen 
atom under Lewis acidic conditions to provide 5.33 in 75% yield. This intermediate was 
the precursor for the first key step in Yang’s enantioselective synthesis.  
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Scheme 5.6. Preparation of enantioselective Friedel–Crafts alkylation starting material. 
An intramolecular cyclization of the allylic alcohol to the 2-position of 5.33 through 
a catalytic asymmetric Friedel–Crafts alkylation generated 5.34 in 75% yield and 99% ee. 
The terminal olefin of 5.34 was then dihydroxylated using OsO4 to provide intermediate 
5.35 as an inconsequential mixture (5:1) of diastereomers. The crude diol moiety was 
protected as the acetonide and the major diastereomer, 5.36, was isolated in 75% yield and 
carried forward. Next, 5.36 was oxidized to the enone 5.37 through standard selenylation–
elimination conditions. The enone 5.37 was used as a synthetic handle to install the 
remaining carbon framework of the natural product through a tandem Michael–aldol 
addition sequence. Copper iodide promoted the 1,4–addition of vinyl Grignard to 5.37, and 
the resulting enolate was trapped with acetaldehyde to give 5.38 in 75% yield as a mixture 
(8:1) of diastereomers. The benzylic stereocenter of 5.37 was crucial to the success of the 
Michael–aldol sequence, as it directs the 1,4–addition, which in turn directs the 
stereochemistry of the aldol reaction. Yang did not report any additional details about the 
attempts to improve the diastereomeric mixture obtained during the conversion of 5.37 to 
5.38.  
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Scheme 5.7. Elaboration of 5.33 to 5.38. 
With the requisite stereocenters set and the carbon framework in place, focus was 
shifted to forming the final rings of 5.1. The diol of 5.38 was unmasked under acidic 
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conditions, cleaved with NaIO4, and the newly formed aldehyde was trapped as lactol 5.39 
after intramolecular cyclization. The tetrahydropyran moiety was installed through an ionic 
reduction of the lactol 5.39 to form 5.40. Hydroboration-oxidation of the terminal olefin of 
5.40, followed by oxidation of the primary alcohol with DMP afforded 5.41 in 81% yield. 
Finally, 5.41 was converted to (–)-5.1 through a reductive amination-cyclization sequence 
with methylamine to install the final ring.  
 
Scheme 5.8. Completion of (–)-5.1 from 5.38 
Yang’s synthesis of (–)-5.1 was accomplished in 12 steps and 3% overall yield from 
5.30.285 The highly selective intramolecular Friedel–Crafts alkylation proved to be a sound 
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strategy for the synthesis of (–)-5.1, as the stereocenter set during this initial cyclization 
directed the remaining carbon stereocenters later in the synthesis. Aside from having the 
only enantioselective approach to these natural products, Yang’s synthesis is unique in his 
strategy for the late stage construction of piperidine ring (i.e. conversion of 5.41 to 5.1). 
All other approaches to these natural products have instead constructed the tetrahydropyran 
moiety in the final step.  
5.2.3 Weinreb’s Synthesis of (±)-Alstoscholarisines B and C 
Weinreb’s synthesis of alstoscholarisines B (5.2) and C (5.3) commenced with the 
preparation of the Michael acceptor 5.45 (Scheme 5.9).286 2-Piperidone (5.42) was 
tosylated to give 5.43 (55%), which was then converted to 5.44 through treatment with 
excess lithium hexamethyldisilazide (LiHMDS) and sequential addition of allyl 
chloroformate followed by phenylselenium bromide. The selenide 5.44 was then oxidized 
and eliminated to afford Michael acceptor 5.45 in quantitative yield.   
 
 
 
Scheme 5.9. Preparation of the Michael acceptor 5.45 
For the nucleophilic component of the planned conjugate addition with Michael 
acceptor 5.45, Weinreb prepared 5.9 from 5.6 in the same manner as Bihelovic and 
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Ferjancic. The ester enolate of 5.9 was generated through treatment with lithium 
bis(trimethylsilyl)amide (LiHMDS) and then used in a Michael reaction with 5.45 to afford 
5.46 in 69% yield as a complex mixture of stereoisomers (Scheme 5.10). Subjection of 
5.46 to a one-pot C–allylation/decarboxylation process delivered 5.47 in 74% yield. This 
product was found to have a trans-configuration at C15 and C20, but it was a mixture of 
epimers at C16. The N-sulfonyllactam carbonyl moiety of 5.47 was reduced with DIBAL, 
and exposure of the aminal 5.48 to trifluoroacetic acid resulted in removal of the Boc 
protecting group and cyclization to afford 5.49 in 74% yield. The ester enolate of 5.49 was 
generated with LiHMDS and quenched with formaldehyde, and the resultant hydroxy 
methyl moiety was protected as the TBS ether delivering 5.50 in 80% yield. 
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Scheme 5.10 Synthesis of the tetracyclic core 5.50 of 5.2 and 5.3 
After having constructed the tetracyclic core 5.50 of the target natural products, 
attention was turned to the construction of the remaining tetrahydropyran ring. The allyl 
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group of 5.50 was required to be converted into a formyl group. The olefin of 5.50 was 
transposed through a thermal ene reaction with diethyl diazocarboxylate (DEAD) to afford 
the allylhydrazine 5.51 in 77% yield (Scheme 5.11). The desired aldehyde was then 
prepared through dihydroxylation of 5.51 followed by cleavage of the resultant diol with 
Pb(OAc)4 to afford 5.52 in 61% yield. The hydroxy methyl silyl ether protecting group was 
removed under acidic conditions to afford 5.53, which only required epimerization of the 
axial aldehyde to form the tetrahydropyran ring.  
Following a similar strategy to that used by Bihelovic and Ferjancic, 5.53 was 
treated with DBU to promote the formation of 5.54, which cyclized to form a lactol that 
could be trapped as the acetate 5.55 with acetic anhydride. For the synthesis of 
alstoscholarisine C, 5.55 was reacted with AlMe3 in the presence of TMSOTf to afford the 
methylated tetrahydropyran 5.56 as a single stereoisomer. This reaction presumably 
proceeds through the transfer of a methyl group from trimethylaluminum to the least 
hindered convex face of the intermediate oxocarbenium ion formed upon ionization of the 
acetate leaving group. Finally, alstoscholarisine C was completed through removal of the 
N-tosyl protecting group of 5.56, followed by a reductive methylation, which delivered 5.3 
in 60% yield. 
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Scheme 5.11. Elaboration of 5.50 to (±)-alstoscholarisine C (5.3) 
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To complete the synthesis of alstoscholarisine B, 5.53 was converted to the lactol 
5.57, which was oxidized to the lactone 5.58 with iodobenzene diacetate/TEMPO (Scheme 
5.12). Addition of methyllithium to 5.58 delivered 5.59 as a single stereoisomer, the 
absolute configuration of which was not determined. Subsequent ionic reduction of 5.59, 
removal of the tosyl protecting group, and finally N-methylation afforded alstoscholarisine 
B (5.2).  
 
 
Scheme 5.12. Elaboration of 5.53 to 5.2 
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Weinreb’s syntheses of (±)-alstoscholarisines B (5.2) and C (5.3) proceeded in 20 
and 17 steps respectively from 5.42. These syntheses represent the first successful 
approaches to these natural products. Although there was no novel method showcased 
during the preparation of these molecules, the strategy to transpose the olefin of 5.50 
through an ene reaction with DEAD (i.e. conversion of 5.50 to 5.51, Scheme 5.10) was an 
interesting approach to convert the allyl group of 5.50 to a formyl group. 
5.3 SUMMARY 
There have been three reported syntheses of an alstoscholarisine natural product 
since their isolation in 2014.283–286 Bihelovic and Ferjancic’s synthesis of (±)-
alstoscholarisine A (5.1) was the first reported synthesis of this natural product and they 
utilized an efficient domino cascade sequence to quickly construct the tetracyclic core of 
the molecule. Unfortunately, the construction of the remaining tetrahydropyran ring was 
less elegant, and detracted from the overall quality of their total synthesis. Nevertheless, 
they managed to complete a total synthesis of 5.1 relatively quickly, requiring only 13 steps 
in 1.7% overall yield. Yang also reported an efficient synthesis of alstoscholarisine A, with 
the added innovation of preparing 5.1 as a single enantiomer. While Yang’s synthesis did 
not showcase any new chemistry, his key steps generally proceeded in good yield and 
selectivity. Weinreb’s synthesis arguably also lacked innovation, but he did showcase a 
complicated conjugate addition (i.e. addition of 5.9 to 5.45 Scheme 5.8) and an interesting 
strategy to degrade an allyl group to a formyl group.  
We began devising an approach to alstoscholarisine E (5.5) soon after the natural 
products were isolated. During the course of our planning, the total syntheses of 
alstoscholarisine A were reported by Bihelovic and Ferjancic and Yang. Despite the 
efficiencies of these routes, we believed that our approach offered significant 
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improvements over the previous reports, primarily because our planned route required only 
six steps to prepare (±)-5.5. Accordingly, we continued forward with our plan for a rapid 
synthesis of alstoscholarisine E.  
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Chapter 6: Progress Towards the Total Synthesis of Alstoscholarisine E 
6.1 SYNTHETIC STRATEGY 
We envisioned a convergent synthesis of alstoscholarisine E (6.1) where 6.4 and 
6.5 would be joined through a metal catalyzed coupling to give 6.3, which could then be 
transformed to 6.1 in two steps through an olefin reduction followed by a reductive 
cyclization to form the final bridging aminal. Fragment 6.4 would be readily available 
through functionalization of 3-methylindole, and we planned to access 6.5 through a 
hetero-Diels–Alder (HDA) reaction of 6.6. Previous studies in the Martin group 
demonstrated that 6.6 would be a suitable substrate for a HDA reaction;289,290 however, our 
previous syntheses of compounds similar to 6.6 required seven steps to prepare. Given that 
a number of efficient syntheses of other members of this family of natural products have 
already been reported,284,285 accessing 6.6 efficiently was paramount to the effectiveness 
of our overall approach. Thus, we devised a novel method to prepare 6.6 in step from the 
readily available starting materials 6.7, 6.8, 6.9.  
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Scheme 6.1. Synthetic strategy for the preparation of alstoscholarisine E (6.1).  
6.1.2 Martin Group Previous Work: Intramolecular Hetero-Diels–Alder Reactions 
As part of our work in natural product synthesis, the Martin group became 
interested in the intramolecular Diels–Alder reactions of compounds such as 6.17.289–294  
The preparation of the HDA precursor commenced from the protected propargyl alcohol 
6.10, the alkyne of which was lithiated with n-BuLi and reacted with ethylene oxide to 
generate 6.11 in 81% yield. Partial hydrogenation of the alkyne moiety of 6.11 proceeded 
smoothly, and the free alcohol of 6.12 was tosylated to give 6.13. The activated tosyl 
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alcohol was then displaced with benzyl amine to afford 6.14, which was acylated using 
6.15 to afford the crotyl amide 6.16.  Finally, after removal of the methoxymethyl acetal 
(MOM) protecting group of 6.16, Swern oxidation of resulting free alcohol delivered 6.17 
in 7 steps and 39% overall yield from 6.10.  
At the time of these investigations, little was known about the intramolecular 
cyclization of trienes such as 6.17. While many examples of intermolecular Diels–Alder 
reactions between an electron rich dieneophile with an α,β-unsaturated aldehyde as the 
diene component existed,293 examples of intramolecular variants were sparse. Furthermore, 
6.17 was also a unique intramolecular HDA substrate in that the diene and dieneophile 
were both electron deficient. Thus, it was notable that thermolysis of 6.17 (190 °C) 
delivered a 5:1 separable mixture of 6.18:6.19, with the cis-cycloadduct 6.18 as the major 
component. With this proof of principle, we were then able to apply cycloadditions of this 
type towards several natural product syntheses.293,294 
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Scheme 6.2. Previous Martin group synthesis of intramolecular HDA precursors. 
The preference for cis-fused bicyclic products during intramolecular Diels–Alder 
cycloadditions of trienes linked by ester and amide tethers has been observed in other 
independent investigations.295–297 The interesting stereochemical outcome for these 
cyclizations prompted a number of theoretical mechanistic studies. The possible transition 
states that give rise to the cis and trans fused products 6.21 and 6.24 are depicted in scheme 
6.3. The substrate is capable of cyclizing from a chair- (6.22 and 6.25) or boat-like (6.20 
and 6.23) confirmation and there is an endo or exo arrangement possible for each. 
Theoretical mechanistic studies from our own lab293 and later ones from Tanitillo and 
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Houk298 on intramolecular cyclizations of this type were in agreement that endo geometries 
are favored over exo geometries, and that the boat-like conformations are preferred over 
the chair-like ones. However, these preferences can be influenced by the substituents 
present on the cycloaddition precursor of interest.298 The preference for the boat-like 
conformation has been attributed to the ability of the amide group to maintain near 
planarity in these transition states, translating to better orbital overlap during the 
cyclization.293 The orbital overlap between the diene and dienophile was determined to be 
maximized in the endo-boat-like transition state of type 6.23, resulting in the cis-
cycloadduct as the major product.298 The results of these theoretical investigations were in 
good agreement with experimentally observed product ratios.290,295,297  
 
 
Scheme 6.3. Possible transition states for intramolecular HDA cycloadditions for amide 
tethered trienes. 
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6.2 ONE-STEP PREPARATION OF HETERO-DIELS–ALDER PRECURSOR 
Hexahydrotriazines 6.26 have been shown to breakdown to N-substituted-N-
(chloromethyl)amides 6.29 upon reaction with acyl chlorides 6.27 (Scheme 2.4).299,300 
These reactive intermediates can be trapped with a nucleophile to quickly build chemical 
complexity. In this fashion, hexahydrotriazines can effectively act as synthons for N-
acyliminium ions 6.28 that can be generated in situ.  
 
 
 
 
Scheme 6.4 General reactivity of hexahydrotriazines with acyl chlorides and nucleophilic 
capture of intermediates 6.28 or 6.29. 
We planned to harness this reactivity of hexahydrotriazines to develop an efficient 
preparation of 6.6 in one step. Accordingly, we attempted this reaction using conditions 
similar to those previously reported from our group for vinylogous Mannich reactions of 
N-acylated immium ions with silylenol ethers.293 We first attempted this reaction at low 
temperature (–78 °C) with a dropwise addition of crotonyl chloride to a solution of 6.7 and 
6.8 (Equation 6.1). We hoped that as the N-chloromethyl amide intermediate 6.29 was 
formed, nucleophile 6.8 would be present to intercept the reactive intermediate. 
Gratifyingly, we found that the reaction was successful, although the yield of 6.6 was poor 
(33%) and it was accompanied with a by-product that was difficult to remove.  
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In order to optimize the yield of 6.6, it was necessary to identify which step of the 
reaction was problematic. It was not clear if the formation of the N-chloromethyl amide 
intermediate 6.31 was not proceeding well or if the nucleophilic addition of 6.8 was 
problematic. Thus, we sought to identify reaction conditions that would lead to quantitative 
generation of the 6.31. Interestingly, when 6.7 was treated with crotonyl chloride in THF 
at –78 °C, the major product was not the desired intermediate 6.31, but rather the by-
product 6.32. We thought one easy solution to this problem would be to warm the reaction 
mixture. However, executing the same reaction at 0 °C led to a complex mixture of 
products, and it became clear that this reaction would require a screen of different 
temperatures and solvents. 
 
 
We turned to literature examples for the acylation of hexahydrotriazines and next 
investigated dichloromethane as a solvent for this reaction.299,300 We discovered a positive 
correlation between temperature and product formation, and we found that heating the 
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reaction in a sealed tube at 50 °C afforded 6.31 (Equation 6.3). However, at lower 
temperatures (–78 or 0 °C) mixtures of 6.31 and 6.32 were observed. 
 
 
With conditions identified for the formation of 6.31, we returned to investigating 
the one-pot procedure to prepare 6.6. On our second approach to this transformation, we 
applied a stepwise one-pot procedure where 6.31 was first generated quantitatively prior to 
the addition of nucleophile 6.8. Fortunately, this proved to be an effective strategy, and we 
obtained 6.6 with an increased yield of 51%. However, significant formation of 6.32 was 
still observed (Equation 6.4). The presence of by-product 6.32 indicated that the formation 
of the N-chlormethyl amide intermediate was still problematic, and we sought to promote 
its formation through the addition of a Lewis acid. We discovered that inclusion of 
substoichiometric amounts of TMSOTf further enhanced the yield of 6.6, but significant 
formation of 6.32 was still observed (Equation 6.5). This problem led us to return to our 
investigation of solvents for the formation of 6.31. Since we previously observed a clear 
correlation between temperature and formation of 6.31, we reasoned that a higher boiling 
solvent might be required. After a screening the reaction of 6.7and 6.9 in THF, toluene, 
and acetonitrile at 70 °C, we discovered that acetonitrile gave complete conversion of 6.7 
to 6.31 with minimal by-product formation (Equation 6.6). Interestingly, the reactions in 
THF or toluene (PhMe) led to unidentified mixtures of products at 70 °C, showing solvent 
is an important reaction parameter for this transformation.  
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With a new set of conditions identified for the formation of 6.31, we applied them 
to the one-pot transformation, and gratifyingly, 6.6 was obtained in 85% yield with 
minimal formation of by-product 6.32 (Equation 6.7). Furthermore, we found that this one-
step preparation of the hetero-Diels-Alder precursor 6.6 was readily scalable to multigram 
quantities. 
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6.3 HETERO-DIELS-ALDER REACTION 
With a scalable and reliable method to prepare 6.6 in place, we turned our attention 
to the intramolecular hetero-Diels-Alder reaction. Fortunately, we found that heating 6.6 
in degassed xylenes at 190 °C delivered 6.33 and 6.34 as a mixture of cis:trans (7:1, 
6.33:6.34) cycloadducts as determined by the 1H NMR spectrum of the crude reaction 
material. However, the yield of 6.33 was poor (35%), and the remainder of the recovered 
material from the reaction appeared to be derived from unreacted starting material and was 
deemed to be a decomposition by-product of 6.6.  
 
 
We speculated that the low yield of 6.33 was due to inefficient heating of the 
reaction vessel. Fortunately, changing the reaction set up from a cylindrical sealed tube to 
a sealed round bottom flask allowed for more efficient stirring and coverage of the reaction 
volume in the oil bath, and we were able to increase the yield of 6.33 to 58%. We found 
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that this reaction was sensitive to solvent volume, and when the concentration was 
increased to 0.05 M we observed diminished yields of 6.33 (45%).  
 
 
6.4 HALOGENATION OF HETERO-DIELS–ALDER PRODUCT 
Our next task was to derivatize 6.33 so that it could be used in a cross-coupling 
reaction with skatole. We set out to install a halogen atom at the β-position of the vinyl 
ether moiety of 6.33 through a previously reported method for the preparation of 2-
haloglycals.301 Following this method, 6.33 was treated with NBS and a catalytic amount 
of AgNO3 in refluxing CH3CN to afford 6.35 in 46% yield. We attempted to improve the 
yield of 6.35 through increasing the reaction time and stoichiometry of AgNO3, but to no 
avail. When NIS was used in the reaction, the corresponding iodo-derivative 6.36 was 
obtained in 65% yield. This same trend of moderately increased yields for the preparation 
of iodoglycals over bromoglycals was observed in the original report as well.301 
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Mechanistically, this reaction is proposed to proceed as outlined in Scheme 6.5. 
AgNO3 activates the N-halosuccinimide reagent through coordination to one of the 
carbonyl oxygen atoms to form 6.38. Nucleophilic attack by the vinyl ether 6.37 then 
generates intermediate 6.39, which is trapped by the nitrate ion. Intermediate 6.41 then 
undergoes elimination to generate the β-halogenated vinyl ether 6.42. A proton transfer 
between 6.40 and 6.43 will then regenerate succinimide 6.44 and AgNO3, which can reenter 
the catalytic cycle.  
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Scheme 6.5 Proposed mechanism for the halogenation of vinyl ethers by N-
halosuccinimides and silver nitrate. 
6.5 SKATOLE CROSS COUPLING EFFORTS 
6.5.1 Direct C-2 Coupling to Skatole 
We next investigated strategies to couple 6.35 and 6.36 with skatole (6.45). We 
were attracted to previously reported methods for the direct C-2 couplings of free N-H 
indole derivatives302–305 because of the simplicity of the approach. While we were aware 
that these reactions had primarily been investigated for alkyl and aryl halide coupling 
partners, the possibility of directly coupling 6.35 or 6.36 with skatole (6.45) without the 
need for additional functionalization was a tempting prospect indeed. Following a 
previously reported method from Sames,304 6.35 and 6.45 were heated in 
dimethylacetamide in the presence of Pd(OAc)2 and diisopropylamine, but unfortunately 
 240 
no desired product 6.46 was obtained (Equation 6.12). Extending the reaction time to 36 
hours or increasing the temperature up to 150 °C did not improve the outcome, and only 
decomposition of 6.35 was observed. We also attempted an alternative strategy for a C-2 
coupling of N-H indole derivatives directed by norbornene.302,303 Unfortunately, these 
conditions also did not form the desired product 6.46 (Equation 6.13).  
 
 
 
6.5.2 C-2 Lithiation of Skatole 
Undeterred by the failures of these speculative strategies, we concluded that 
activation of the 2-position of 6.45 would be required to achieve our desired 
transformation. We pursued a strategy to derivatize 6.45 that would allow us to investigate 
multiple different approaches to join 6.35/6.36 and 6.45. The directed C-2 lithiation of N-
protected indole derivatives is well precedented,306–308 and the lithiated intermediates 6.48 
can be transmetallated with zinc 6.49, boron 6.50, or tin 6.51 reagents to give access to 
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Negishi, Suzuki, or Stille couplings, respectively (Scheme 6.6). Furthermore, there exists 
a variety of protecting groups available for the indole nitrogen atom that direct lithiation to 
the 2-position, including carboxyl (CO2H), tert-butyloxycarbonyl (Boc), methoxymethyl 
acetal (MOM), and tosyl (SO2PhMe), which provides us an additional element of flexibility 
when screening conditions to promote the desired coupling.  
 
 
Scheme 6.6. C-2 -lithiation of skatole derivatives and transmetallation of 6.48.  
We commenced our cross-coupling investigations with Negishi reactions because 
it provided the opportunity for an efficient one-pot coupling sequence. We envisioned a 
strategy where the indole nitrogen of skatole (6.45) could be deprotonated, and then 
protected in situ with CO2 to form 6.52, which would then be lithiated at the 2-positon to 
give 6.53. Subsequent transmetallation of 6.53 with zinc would form 6.54, and introduction 
of a palladium catalyst and 6.35 or 6.36 would deliver the desired product 6.55 (Scheme 
6.7). The relative instability of the carboxyl protecting group of 6.52 would also obviate 
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the need for a discrete deprotection step, making this approach a formal direct C-2 coupling 
of 6.35 or 6.36 to 6.45.  
 
 
Scheme 6.7. Proposed one-pot sequence for Negishi coupling of 6.45 and 6.35 or 6.36.  
In order to effect the Negishi coupling between 6.35 and 6.45, it was first necessary 
to identify suitable conditions for the formation of 6.52 and 6.53 (Scheme 6.8). After some 
experimentation, we found that deprotonation of 6.45 with n-BuLi followed by 
introduction of CO2 gas led to good conversion to 6.52. This intermediate was then treated 
with t-BuLi followed by quenching with D2O to afford ca 80% of 6.56 as determined by 
the 1H NMR spectrum of the crude reaction material.  
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Scheme 6.8. C-2 lithiation of 6.52 and subsequent deuterium quenching. 
With suitable conditions identified for the lithiation of 6.53, we investigated the 
key Negishi coupling (Equation 6.14). Unfortunately, introduction of Pd(PPh3)4 and 6.35 
to the reaction mixture after 6.53 was transmetallated with zinc did not result in formation 
of the desired product 6.55, and mostly unreacted 6.35 was recovered. Increasing the 
reaction temperature to 80 °C showed no improvement. Because this one-pot five step 
sequence was a complicated procedure with multiple points at which the reaction could 
fail, we decided to take a more stepwise approach in hopes of identifying the problem.   
 
 
In order to simplify our procedure, we decided to abandon the use of the CO2 
protecting group for the indole nitrogen of 6.45. Instead, we prepared the Boc protected 
derivative 6.57 in 90% yield through treatment of 6.45 with BoC-2O and 4-
dimethylaminopyridine (DMAP) (Equation 6.15). We next verified the lithiation 6.57 after 
treatment with t-BuLi by quenching the reaction with CD3OD, which afforded 85–90% 
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conversion to 6.58 based on the 1H NMR spectrum of the crude reaction material (Equation 
6.16). Furthermore, we observed similar conversions to 6.58 after the ltihiated intermediate 
was transmetalated with zinc, and the reaction was quenched with CD3OD, providing 
evidence that formation of the zincated intermediate was not problematic (Equation 6.17).  
 
 
 
 
 
 
With the critical reaction parameters for the formation of the metallated 
intermediates established, we returned to the Negishi coupling reactions with 6.35 or 6.36 
(Table 6.1). Attempting the coupling again in THF with Pd(PPh)3 as the catalyst led to no 
desired product formation, even at temperatures up to 125 °C (Table 6.1, Entry 1). We 
speculated that the palladium tetrakis catalyst was too sterically encumbered or was not 
active enough to effectively promote the reaction, so we next investigated alternative 
palladium precatalysts and phosphine ligand systems. Knochel previously reported the 
combination of Pd(dba)2 and P(o-fur)3 to be effective conditions for promoting Negishi 
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couplings,309 but, applying this combination to our system led to no product formation 
(Table 6.1, Entry 2). Similarly, Buchwald reported the combination of Pd(dba)2 and the 
RuPhos ligand to be a potent catalyst for promoting Negishi couplings,310 but again we 
observed no formation of 6.60 upon applying these conditions to our system (Table 6.1, 
Entry 3). Since we were observing no desired product formation in THF, we switched to 
dimethylacetamide as a solvent because it has been reported to be an effective solvent for 
Negishi couplings (Table 6.1, Entries 4–6).309 Unfortunately, these efforts were also 
unsuccessful, and no formation of 6.60 was observed. The only major by-product we could 
identify from these reactions was the dehalogenated material 6.33. While it is not exactly 
clear how this by-product would arise under the reaction conditions, phosphines have been 
shown to promote the dehydrohalogenation of 2-halogylcals, even in the absence of 
transition metal catalyst.311 Furthermore, the Boc protecting group of 6.59 was not stable 
to the reaction conditions, and was cleaved during the course of the reaction.  
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Table 6.1. Negishi coupling conditions screened to form 6.60 
 
Entry Catalyst Ligand Solvent T °C 
1 Pd(PPh3)4 – THF rt to 125 
2 Pd(dba)2 P(o-fur)3 THF rt to 125 
3 Pd(dba)2 RuPhos THF 80 
4 Pd(PPh3)2Cl2 – DMAc 80 
5 Pd(OAc)2 RuPhos DMAc 80 
6 Pd(OAc)2 – DMAc 80 
 
The failure of all of our attempts to couple 6.35 or 6.36 to skatole led us to pursue 
a simpler a Negishi coupling model reaction as a proof of principle. Using the Negishi 
coupling reactions reported by Buchwald,310 phenylzinc chloride (6.61) was heated with 
6.36 in THF in the presence of Pd(dba)2 and RuPhos to mixed results (Equation 6.18). 
While we did observe the formation of 6.62, it was isolated in only 20% yield as part of an 
inseparable mixture (ca. 2:1) of unreacted 6.36 and 6.62. The remainder of the material 
from the reaction contained numerous by-products that could not be identified. Despite the 
poor yield of 6.62, this model reaction provided key evidence that 6.36 could in fact be 
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employed in a metal catalyzed cross coupling, although, it also suggested that a  Negishi 
coupling may not be the best approach to join 6.36 and 6.45. 
 
 
 
We changed strategies and pursued a Suzuki coupling reaction to connect the two 
key fragments. We first explored a model Suzuki coupling between 6.36 and 6.63 to test 
the viability of 6.36 in these reactions. Fortunately, we found that 6.36 was converted to 
6.64 in ca 33% yield, albeit as an inseperable mixture (3:1) of 6.36 and 6.64. While the 
yield for this reaction was poor, we were heartened by the fact that there were few other 
by-products. This was sufficient proof of principle for us to move forward with our 
investigations.  
 
 
 
 Rather than attempt to optimize the yield of 6.64, we were eager to move forward 
and test the coupling on our actual system. After some trial and error, we were able to 
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prepare 6.65 through lithiation of 6.57 followed by quenching with B(OMe)3. Aqueous 
work up of the reaction then led to the formation of 6.65 in 85% yield. This boronic acid 
is unstable and was used immediately upon preparation in subsequent Suzuki couplings. 
Unfortunately, all of our efforts thus far have been unavailing. While we have not been 
able to probe this reaction extensively, our initial attempts have revealed the stability of 
6.65 is problematic. Under the conditions outlined in Equations 6.21 and 6.22, the boronic 
acid 6.65 appears to decompose before the desired coupling can progress. Furthermore, the 
Boc protecting group of 6.65 is also unstable under these conditions, and skatole (6.45) is 
recovered from the reaction along with unreacted 6.35 or 6.36. While these initial results 
are troubling, there are still a number of options available to couple skatole (6.45) and 6.36, 
which will be discussed in the following section.  
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6.6 SUMMARY 
In summary, we have proposed an efficient synthesis of alstoscholarisine E (6.1), 
which could require as few as six steps. We have demonstrated that the first three steps of 
this synthesis are feasible and proceed in good yield. An important feature of this work was 
the development of a high yielding, and scalable method to prepare hetero-Diels-Alder 
precursors such as 6.6 in one step. This represents a dramatic improvement over the 
previous syntheses of these substrates, which required seven total steps, and several of 
required purification via HPLC.290 Acylation of 6.7 with 6.9 was shown to give 6.31, which 
was alkylated with 6.8 to give the hetero-Diels–Alder precursor 6.6 in 86% yield in one 
chemical operation (Scheme 6.9). Thermolysis of 6.6 resulted in the intramolecular Diels–
Alder cycloaddition to afford 6.33 in 58% yield. This product was then halogenated to give 
6.36 in 65% yield. Although our efforts to couple 6.36 and skatole have to this point been 
unsuccessful, there remains a number of different strategies available to complete the 
desired transformation.  
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Scheme 6.9. Summary of progress towards the total synthesis of alstoscholarisine E. 
 
 251 
6.7 FUTURE DIRECTIONS  
The convergent synthetic strategy for joining the hetero-Diels–Alder product and 
skatole was attractive in its versatility. There exists a wide variety of strategies available to 
troubleshoot this transformation. Despite the failure of our initial attempts to couple 6.36 
and 6.65, the Suzuki reaction remains a promising strategy to join these two fragments. 
First, Suzuki reactions are well precedented for 2-haloglycals,311 and while 6.36 is more 
hindered than previously reported substrates, the coupling of 6.36 and 6.63 (Equation 6.19) 
provides promising supporting evidence that 6.36 is a valid coupling partner. Our 
investigations have indicated that the instability of the boronic acid 6.65 is the primary 
reason for our inability to couple it with 6.36. The instability of 2-heteroaryl boronic acids 
is well known, and there has been recent innovations in catalyst design to overcome this 
problem.312 Buchwald reported the use of catalyst 6.68 for promoting Suzuki reactions of 
a variety of unstable boronic acids, including 6.66 (Equation 6.23). The reaction took place 
under mild conditions, and 6.66 was coupled with 6.67 to give 6.69 in 88% yield with no 
reported loss of the Boc protecting group.312 Therefore, the instability of 6.65 does not 
seem an insurmountable problem, and application of these reaction conditions to our 
system could lead to desired formation of 6.60 (Equation 6.24).  
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Another potential problem arises in that both of these coupling partners are 
sterically demanding substrates. The large Boc protecting group of 6.65 only exacerbates 
this issue. Hence, changing the indole nitrogen protecting group could be beneficial. 
Exploring the use of the MOM protected derivative 6.70 in a Suzuki reaction with 6.36 
would be a worthwhile investigation (Equation 6.25).  
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Although not ideal, one final strategy to investigate within Suzuki reactions would 
be to convert 6.36 to 6.71 and use it as a coupling partner with a 2-halogenated indole 6.72 
(Scheme 6.10). While this strategy would add an additional step to the synthesis, it could 
solve the problem of the instability of the skatole boronic acid derivatives.  
 
Scheme 6.10. Alternative Suzuki coupling strategy for connecting 6.36 and 6.72. 
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Branching away from Suzuki reactions, there also exists the entire realm of Stille 
couplings to explore. The coupling partner 6.51 should be readily available from  6.48 and 
could be used in a coupling reaction with 6.36, opening a different coupling strategy with 
reaction conditions to screen and optimize (Scheme 6.11). With the number of promising 
strategies available, we are confident that skatole (6.4) and the heteo-Diels–Alder product 
can be coupled, and the remaining steps of the synthesis could then be investigated.  
 
 
Scheme 6.11. Stille coupling strategy to prepare 6.3. 
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Chapter 7 Experimental Procedures 
7.1 GENERAL EXPERIMENTAL 
Tetrahydrofuran and diethyl ether were dried by filtration through two columns of 
activated, neutral alumina according to the procedure described by Grubbs.313 Methanol, 
acetonitrile and dimethylformamide were dried by filtration through two columns of 
activated molecular sieves, and toluene was dried by filtration through one column of 
activated, neutral alumina followed by one column of Q5 reactant. Benzene was distilled 
from sodium and benzophenone. Methylene chloride, diisopropylamine, triethylamine, and 
diisopropylethylamine were distilled from calcium hydride immediately prior to use. 
Pyridine was distilled from potassium hydroxide (KOH) and calcium hydride and stored 
over KOH pellets. All other reagents and solvents were reagent grade and were purchased 
and used as received unless otherwise noted. Reactions were performed under a nitrogen 
or argon atmosphere in round-bottom flasks sealed under rubber septa with magnetic 
stirring, unless otherwise noted. Water sensitive reactions were performed with flame- or 
oven-dried glassware, stir-bars, and steel needles. Reaction temperatures are reported as 
the temperatures of the bath surrounding the vessel. Sensitive reagents and solvents were 
transferred using plastic syringes and steel needles using standard techniques. Proton 
nuclear magnetic resonance (1H NMR) and carbon nuclear magnetic resonance (13C NMR) 
spectra were acquired in CDCl3 unless otherwise noted. Chemical shifts are reported in 
parts per million (ppm, δ), downfield from tetramethylsilane (TMS, δ = 0.00 ppm) and are 
referenced to residual solvent (CDCl3, δ = 7.26 ppm (1H) and 77.16 ppm (13C). Coupling 
constants (J) are reported in hertz (Hz) and the resonance multiplicity abbreviations used 
are: s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; sex, sextet; sep, septet; dt, doublet 
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of triplets; dd, doublet of doublets; ddd, doublet of doublet of doublets; dddd, doublet of 
doublet of doublet of doublets; m, multiplet; comp, overlapping multiplets of magnetically 
non-equivalent protons. The abbreviations br and app stand for broad and apparent, 
respectively. Infrared (IR) spectra were obtained with a Thermo Scientific Nicolet IR-100 
FT-IR series spectrometer as thin films on sodium chloride plates. Melting points were 
determined using a Thomas-Hoover Uni-melt capillary melting point apparatus. Thin-layer 
chromatography (TLC) was performed on EMD 60 F254 glass- backed pre-coated silica 
gel plates and were visualized using one or more of the following methods: UV light (254 
nm) and staining with basic potassium permanganate (KMnO4) or acidic p-anisaldehyde 
(PAA). Flash chromatography was performed using glass columns and with Silicycle® 
SiliaFlash F60® (40-63 µm) silica gel eluting with the solvents indicated. 
7.2 EXPERIMENTAL PROCEDURES 
 
(1S,5S,6S)-5-Bromo-7-oxabicyclo[4.2.0]oct-2-en-8-one (2.59) (DK-3-118). N-
Bromosuccinimide (3.871 g, 21.75 mmol) was added to a solution of 1,4-dihydrobenzoic 
acid (2.7 g, 21.8 mmol) and catalyst 2.94 (0.964 g, 2.18 mmol) in PhMe/CH2Cl2 (1:1) (220 
mL) at –50 °C, and the solution was stirred for 14 h. The reaction was quenched with 
saturated aqueous Na2SO3 (150 mL), and the mixture was warmed to room temperature 
with vigorous stirring.  The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (3 x 75 mL). The combined organic layers were washed with 5% aqueous Na2CO3 
(2 x 150 mL), dried (MgSO4), filtered, and concentrated under reduced pressure. The crude 
residue was purified by column chromatography, eluting with hexanes/EtOAc (9:1) to give 
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3.1 g (70%) of 2.59 as a white solid: mp 96–98 °C: spectra matched the previously reported 
data;19
 1H NMR (CDCl3, 400 MHz) δ ppm 6.10 – 6.00 (m, 1H), 5.90 (dddd, J = 9.9, 6.1, 
1.8, 1.3 Hz, 1H), 4.94 (dd, J = 5.7, 3.1 Hz, 1H), 4.55 (q, J = 3.1 Hz, 1H), 4.28 (t, J = 6.1 
Hz, 1H), 2.72 (comp, 2H); ]25D –49.0 (c = 1.0, CHCl3); HPLC (210 nm): OD-H (1% i-
PrOH/hexanes, 1.0 mL/min) 16.6 min (major) 18.0 min (minor). 2.59 was recrystallized 
from hexanes (10 mg/100 mL) to give (1.9 g, 45%) of 2.59 as a single enantiomer. HPLC 
(210 nm): OD-H (1% i-PrOH/hexanes, 1.0 mL/min) 16.6 min  
 
 
NMR Assigntment. 1H NMR (CDCl3, 400 MHz) δ ppm 6.10 – 6.00 (m, 1H, C2-
H), 5.90 (dddd, J = 9.9, 6.1, 1.8, 1.3 Hz, 1H, C3-H), 4.94 (dd, J = 5.7, 3.1 Hz, 1H, C6-H), 
4.55 (q, J = 3.1 Hz, 1H, C5-H), 4.28 (t, J = 6.1 Hz, 1H, C1-H), 2.72 (comp, 2H, C4-H) 
 
 
(1R,2R,3S,5R,6R)-5-Bromo-2,3-dihydroxy-7-oxabicyclo[4.2.0]octan-8-one 
(2.60) (DK-3-122). The olefin 2.59 (0.8 g, 3.9 mmol) was added to a solution of citric acid 
(0.824 g, 4.29 mmol), potassium osmate (0.143 g, 0.39 mmol, 0.1 mol %), and 4-
methylmorpholine N-oxide (0.502 g, 4.29 mmol) in H2O/t-BuOH (1:1) (16 mL) at 0 ˚C. 
The reaction mixture was stirred for 18 h, then solid sodium sulfite (500 mg) was added, 
and stirring was continued for 15 min at room temperature. The organic layer was removed 
under reduced pressure, and the aqueous layer was extracted with ethyl acetate (5 x 25 
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mL). The combined organic extracts were washed with brine (75 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure. The crude material was recrystallized 
from ethanol to give 0.55 g (60%) of 2.60 as white crystals: mp 211–212˚C.1H NMR 
(CD3OD, 400 MHz,) δ ppm 4.51 (dd, J = 4.3, 1.2 Hz, 1 H), 4.13 (s, 1 H), 4.03 (dd, J = 
9.59, 2.93 Hz, 1 H), 3.80 (ddd, J = 11.54, 9.59, 7.04 Hz, 1 H), 2.75 (m, 1 H), 2.67 (ddd, J 
= 14.18, 6.95, 5.09 Hz, 1 H), 2.11 (tdd, J = 11.80, 11.80, 2.70 Hz, 1 H). 13C NMR (CD3OD, 
100 MHz) δ ppm 175.0, 83.1, 74.4, 72.6, 54.8, 49.8, 36.3; IR (film) 3380, 2955, 1711, 
1439, 1261, 1202 cm
-1
; mass spectrum (ESI) m/z 258.9576 [M+Na]+, 260.9553[M+Na]+ 
[C7H9BrO4 [M+Na]
+  requires 258.9576, 260.9553]. 
 
 
NMR Assignment. 1H NMR (CD3OD, 400 MHz)  ppm 4.51 (dd, J = 4.30, 1.17 
Hz, 1 H, C3-H) 4.13 (s, 1 H C7-H) 4.03 (dd, J = 9.59, 2.93 Hz, 1 H, C2-H) 3.80 (ddd, J = 
11.54, 9.59, 7.04 Hz, 1 H, C4-H) 2.75 (ddd, J = 1.00 Hz, 1 H, C6-H) 2.67 (ddd, J = 14.18, 
6.95, 5.09 Hz, 1 H, C5-H) 2.11 (tdd, J = 11.80, 11.80, 2.70, 0.80 Hz, 1 H, C5-H) 13C NMR 
(400 MHz) 175.0 C1, 83.1 C3, 74.4 C7, 72.6 C6, 54.8 C4, 49.8 C2 36.3 C5-H 
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Methyl (3aR,6S,7aS)-6-hydroxy-2,2-dimethyl-3a,6,7,7a-tetrahydrobenzo-
[d][1,3]dioxole-4-carbo-xylate (2.98) (DK-3-134). Diol 2.60 (0.258 g, 1.09 mmol) was 
added to a suspension of K2CO3 (0.225 g, 1.63 mmol) of MeOH (11 mL, 0.1 M), and the 
reaction was stirred for 2 h, whereupon, the solvent was removed under reduced pressure. 
The residue was redissolved in MeOH (5 mL) and excess K2CO3 was removed by vacuum 
filtration. The filtrate was evaporated under reduced pressure, and the crude triol 2.97 was 
carried in the next step without further purification. The crude 2.97 (0.205 g, 1.09 mmol) 
was suspended in CH2Cl2 (17 mL, 0.065M) containing 4 Å mol sieves (1 g). 
Camphorsulfonic acid (0.886 g, 3.82 mmol) and 2,2-dimethoxy propane (0.284 g, 0.35 mL, 
2.73 mmol) were added, and the reaction was heated under reflux for 3 h, whereupon, it 
was cooled to room temperature and filtered. The filtrate was concentrated under reduced 
pressure, and the crude product was directly purified by column chromatography eluting 
with hexanes/EtOAc (1:1) to give 0.186 g (75%) of 2.98 as a white solid: mp 75–76 ˚C. 1H 
NMR (400 MHz, CDCl3) δ ppm 7.05 (dd, J = 5.2, 1.1 Hz, 1 H), 4.91 (d, J = 5.5 Hz, 1 H), 
4.59 (tdt, J = 4.4,  2.4, 1.2,Hz, 1 H), 4.30-4.23 (m, 1 H), 3.81 (s, 3 H), 3.13 (d, J = 10.6 Hz, 
1 H), 2.39 (dddd, J = 15.1, 4.4, 3.1, 1 Hz, 1 H), 1.98 (ddd, J = 15.1, 4.7, 2.5 Hz, 1 H), 1.43 
(s, 3 H), 1.39 (s, 3 H). 13C NMR (CDCl3, 100 MHz) δ ppm 166.6, 139.7, 129.9, 109.9, 
73.1, 71.0, 62.9, 52.2, 31.6, 28.2, 26.3.; IR (film) 3454, 2987, 2938, 1723, 1651, 1438, 
1372, 1314, 1259, 1219 cm-1; mass spectrum (ESI) m/z 251.0892 [M+Na]+ [C11H16O5 
[M+Na]+ requires 251.0890].  
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NMR Assignment. . 1H NMR (400 MHz, CDCl3)  ppm 7.05 (dd, J = 5.18, 1.08 
Hz, 1 H, C4-H) 4.91 (d, J = 5.5 Hz, 1 H, C11-H) 4.59 (tdt, J = 4.4,  2.4, 1.2,Hz, 1 H C5-H) 
4.30-4.23 (m, 1 H C7-H) 3.81 (s, 3 H, C1-H) 3.13 (d, J = 10.6 Hz, 1 H, C5-OH) 2.39 (dddd, 
J = 15.1, 4.4, 3.1, 1 Hz, 1 H, C6-H) 1.98 (ddd, J = 15.1, 4.7, 2.5 Hz, 1 H, C6-H) 1.43 (s, 3 
H, C10-H) 1.39 (s, 3 H, C9-3H) 13C NMR (400 MHz) 166.6 C2, 139.7 C4, 129.9 C3, 109.9 
C8, 73.1 C11, 71.0 C7, 62.9 C5, 52.2 C1, 31.6 C6, 28.2 C10, 26.3 C9 
 
 
 
Methyl(3aR,6S,7aS)-6-(methoxymethoxy)-2,2-dimethyl-3a,6,7,7a,tetra-
hydrobenzo[d][1,3]-dioxole-4-carboxylate (2.105) (DK-3-135). Chloromethyl methyl 
ether (0.105 g, 1.3 mmol) was added to a solution of 2.98 (0.150 g, 0.66 mmol) and 
diisopropylethylamine (0.25 g, 2.0 mmol) in CH2Cl2 (2.5 mL, 0.25 M), and the reaction 
was heated under reflux for 4 h. The solvent was removed under reduced pressure, and the 
reaction mixture was purified directly by column chromatography eluting with 
hexanes:EtOAc (7:3) to give 0.27 g (95%) of 2.98 as a white solid; mp 70–71 °C. 1H NMR 
(CDCl3, 400 MHz) δ ppm 7.12 (s, 1 H) 4.80 (d, J = 5.8 Hz, 1 H) 4.74 (s, 2 H) 4.32 - 4.20 
(comp, 2 H) 3.81 (s, 3 H) 3.41 (s, 3 H) 2.21 (dt, J = 12.2, 5.1 Hz, 1 H) 1.76 (dt, J = 12.2, 
10.3 Hz, 1 H) 1.49 (s, 3 H) 1.43 (s, 3 H) 13C NMR (CDCl3, 100 MHz) δ ppm 166.6, 139.73, 
129.9, 109.9, 95.8, 73.1, 71.0, 62.9, 56.7, 52.2, 31.6, 28.2, 26.3; IR (film) 2987, 2938, 1723, 
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1651, 1438, 1372, 1314, 1259, 1219 cm-1; mass spectrum (ESI) m/z 295.1158 [M+Na]+, 
[C13H20O6 [M+Na]
+ requires 295.1158]. 
 
 
NMR Assignment 1H NMR (CDCl3, 400 MHz) δ ppm 7.12 (s, 1 H, C4-H) 4.80 (d, 
J = 5.8 Hz, 1 H, C11-H) 4.74 (s, 2 H, C12-H) 4.32– 4.20 (comp, 2 H, C5-H, C7-H) 3.81 
(s, 3 H, C1-H) 3.41 (s, 3 H, C13-H) 2.21 (dt, J = 12.2, 5.1 Hz, 1 H, C6-H) 1.76 (dt, J = 
12.2, 10.3 Hz, 1 H, C6-H) 1.49 (s, 3 H, C9-H) 1.43 (s, 3 H, C10-H) 13C NMR (CDCl3, 100 
MHz) δ ppm 166.6 C2, 139.73 C4, 129.9 C3, 109.9 C8, 95.8 C12, 73.1 C11, 71.0 C7, 62.9 
C5, 56.7 C13, 52.2 C1, 31.6 C6, 28.2 C10, 26.3 C9. 
 
 
(3aR,6S,7aS)-6-(Methoxymethoxy)-2,2-dimethyl-3a,6,7,7a,tetrahydrobenzo-
[d][1,3]dioxole-4-carboxylic acid (2.105) (DK-3-137). 1 M aq LiOH (0.72 mL, 0.72 
mmol) was added to a solution of 2.98 (0.1 g, 0.36 mmol) in CH3CN (3.6 mL, 0.1 M), and 
the reaction was stirred for 14 h. The solvent was removed under reduced pressure, and the 
residue was dissolved in EtOAc (5 mL). Amberlite® IR120 acidic resin was added until 
the pH was ca. 5. The solution was filtered, and the filtrate was concentrated under reduced 
pressure. The crude product was purified by column chromatography eluting with 
hexanes/EtOAc/AcOH (85:15:0.1) to give 0.081 g (87%) of 2.105 as a white solid; mp 74–
75 ˚C. 1H NMR (CDCl3, 400 MHz) δ ppm 7.25 (d, J = 2.1 Hz, 1 H) 4.79 (d, J = 5.8 Hz, 1 
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H) 4.76 (d, J =1.7 Hz, 2 H) 4.33 (dt, J = 10.1, 5.1 Hz, 1 H) 4.30–4.24 (m, 1 H) 3.42 (s, 3 
H) 2.23 (dt, J = 12.3, 5.1 Hz, 1 H) 1.81 (dt, J = 12.3, 10.1 Hz, 1 H) 1.51 (s, 3 H) 1.44 (s, 3 
H) 13C NMR (CDCl3, 100 MHz) δ ppm 171.3, 135.5, 130.73, 121.1, 95.5, 86.1, 74.6, 72.4, 
58.2, 32.3, 28.2, 26.3. IR (film) 3454, 2980, 2924, 1722, 1651, 1434, 1372, 1314, 1259, 
1219 cm-1; mass spectrum (ESI) m/z 257.10330 [M–H]–, [C12H18O6 [M–H]–  requires 
257.1031]. 
 
 
NMR Assignment. 1H NMR (CDCl3, 400 MHz) δ ppm 7.25 (d, J = 2.1 Hz, 1 H, 
C3-H) 4.79 (d, J = 5.8 Hz, 1 H, C10-H) 4.76 (d, J =1.7 Hz, 2 H, C11-H) 4.33 (dt, J = 10.1, 
5.1 Hz, 1 H, C6-H) 4.30–4.24 (m, 1 H, C4-H) 3.42 (s, 3 H, C12-H) 2.23 (dt, J = 12.3, 5.1 
Hz, 1 H, C5-H) 1.81 (dt, J = 12.3, 10.1 Hz, 1 H, C5-H) 1.51 (s, 3 H, C8-H) 1.44 (s, 3 H, 
C9-H) 13C NMR (CDCl3, 100 MHz) δ ppm 171.3 C1, 135.5 C3, 130.73 C2, 121.1 C7, 95.5 
C11, 86.1 C10, 74.6 C4, 72.4 C6, 58.2 C12, 32.3 C5, 28.2 C8, 26.3 C9. 
 
 
(3aS,5S,7aS)-7-iodo-5-(methoxymethoxy)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxole (2.109) (DK-2-286) Oxalyl chloride (113 mg, 0.89 
mmol) was added to a solution of carboxylic acid 2.105 (46 mg, 0.178 mmol) and DMF (2 
µL ,0.017 mmol) in CH2Cl2 (0.6 mL) at 0 ˚C. The reaction was warmed to room 
temperature and stirred for 0.5 h, whereupon the solvent was removed under reduced 
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pressure. The crude residue was dissolved in CH2Cl2 (0.36 mL), and 2-mercaptopyridine 
N-oxide sodium salt (32 mg, 0.21 mmol), and 2,2,2-trifluoroethyl iodide (187 mg, 0.89 
mmol) were added. The reaction vessel was sealed and irradiated with a 150 W electric 
flood lamp for 1 h. The solvent was removed under reduced pressure, and the crude reaction 
mixture was purified directly by column chromatography eluting with hexanes/EtOAc 
(95:5) to give 21 mg (34%) of 2.109 as a clear oil. 1H NMR (400 MHz, CDCl3)  ppm 6.69 
(d, J = 3.4 Hz, 1 H) 4.70 (s, 2 H) 4.51 (d, J = 5.8 Hz, 1 H) 4.34 (ddd, J = 8.0, 5.7, 4.1 Hz, 
1 H) 4.08–4.03 (m, 1 H) 3.39 (s, 3 H) 2.21 (dt, J = 13.7, 4.8 Hz, 1 H) 1.99 (dt, J = 14.3, 6.7 
Hz, 1 H) 1.53 (s, 3 H), 1.41 (s, 3H) 13C NMR (100 MHz, CDCl3)  ppm 131.3, 120.1, 98.2, 
96.1, 73.1, 71.0, 64.9, 52.2, 31.6, 28.2, 26.3 
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3)  ppm 6.69 (d, J = 3.4 Hz, 1 H, 
C11-H) 4.70 (s, 2 H, C2-H) 4.51 (d, J = 5.8 Hz, 1 H, C9-H) 4.34 (ddd, J = 8.0, 5.7, 4.1 Hz, 
1 H, C3-H) ) 4.08 – 4.03 (m, 1 H, C5-H) 3.39 (s, 3 H, C1-H) 2.21 (dt, J = 13.7, 4.8 Hz, 1 
H, C4-H) 1.99 (dt, J = 14.3, 6.7 Hz, 1 H, C4-H) 1.53 (s, 3 H, C7-H), 1.41 (s, 3H, C8-H); 
13C NMR (100 MHz, CDCl3)  ppm 131.3 C11, 120.1 C6, 98.2 C2, 96.1 C10, 73.1 C9, 
71.0 C3, 64.9 C5, 52.2 C1, 31.6 C4, 28.2 C7, 26.3 C8 
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(3aS,5S,7aS)-7-Iodo-5-(methoxymethoxy)-2,2-dimethyl-3a,4,5,7a-tetrahydro-
benzo-[d][1,3]dioxole (2.110) (DK-3-139). Carboxylic acid 2.99 (0.025 g, 0.1 mmol) 
dissolved in CH2Cl2 (0.5 mL) was added to a solution of EDCI•HCl (0.037 g, 0.19 mmol) 
and 2.78 (0.029 g, 0.19 mmol) in CH2Cl2 (1.5 mL) cooled to 0 C. The reaction was warmed 
to room temperature and stirred for 1.5 h, whereupon it was diluted with CH2Cl2 (5 mL) 
and the organic layer was washed with saturated NH4Claq (3 x 5 mL). The layers were 
separated, and the organic layer was dried (MgSO4), filtered, and concentrated under 
reduced pressure to give crude 2.108, which was used directly in the next step. The crude 
2.108 was dissolved in Cl3Br (2 mL) and irradiated with a 150 W electric flood lamp for 
10 min. The solvent was removed under reduced pressure, and the crude material was 
purified by column chromatography eluting with hexanes/EtOAc (9:1) to give 0.016 g 
(55%) of 2.110 as a clear oil. 1H NMR (CDCl3, 400 MHz) δ ppm 6.39 (d, J = 3.4 Hz, 1 H) 
4.70 (s, 2 H) 4.51 (d, J = 5.8 Hz, 1 H) 4.34 (ddd, J = 8.0, 5.7, 4.1 Hz, 1 H) 4.08–4.03 (m, 
1 H) 3.39 (s, 3 H) 2.21 (dt, J = 13.7, 4.8 Hz, 1 H) 1.99 (dt, J = 14.3, 6.7 Hz, 1 H) 1.53 (s, 3 
H), 1.41 (s, 3H) 13C NMR (100 MHz, CDCl3) δ ppm 134.3, 123.0, 110.0, 95.7, 76.0, 72.8, 
70.9, 55.4, 31.7, 28.1, 26.2. IR (film): 2928, 2854, 1618, 1465, 1256, 1090, 837 cm–1; mass 
spectrum (ESI) m/z 315.02080 [M+Na]+, 317.01880 [M+Na]+ [C11H17BrO4 [M+Na]
+  
requires 315.02082, 317.01878].  ]25D –64.0 (c = 0.5, CHCl3) 
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NMR Assignment. 1H NMR (CDCl3, 400 MHz) δ ppm 6.39 (d, J = 3.4 Hz, 1 H, 
C11-H) 4.70 (s, 2 H, C2-H) 4.51 (d, J = 5.8 Hz, 1 H, C9-H) 4.34 (ddd, J = 8.0, 5.7, 4.1 Hz, 
1 H, C3-H) 4.08–4.03 (m, 1 H, C5-H) 3.39 (s, 3 H, C1-H) 2.21 (dt, J = 13.7, 4.8 Hz, 1 H, 
C-H) 1.99 (dt, J = 14.3, 6.7 Hz, 1 H, C4-H) 1.53 (s, 3 H, C7-H), 1.41 (s, 3H, C8-H) 13C 
NMR (100 MHz, CDCl3) δ ppm 134.3 C11, 123.0 C10, 110.0 C6, 95.7 C2, 76.0 C9, 72.8 
C3, 70.9 C5, 55.4 C1, 31.7 C4, 28.1 C7, 26.2 C8. 
 
 
4-Pentadecynoic acid (2.164) (DK-4-293). n-Butyllithium (2.5 M in hexanes, 10.2 
mL, 25 mmol) was added dropwise to a solution of pent-4-ynoic acid (2.207) (1.0 g, 10 
mmol) in THF/HMPA (4:1) (100 mL) at –78 °C. The reaction was warmed to 0 °C and 
stirred for 2 h, whereupon it was cooled back to –78 °C, and iododecane (6.0 g, 22.4 mmol) 
was added dropwise. The reaction was slowly warmed to room temperature and stirred for 
12 h, whereupon 2 M aq LiOH (100 mL) was added. The reaction was stirred for an 
additional 18 h, whereupon 6 M HCl was added until the reaction mixture was ca. pH 2. 
The layers were separated, and the aqueous portion was extracted with EtOAc (3 x 150 
mL). The combined organic layers were washed with brine (5 x 100 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure. The crude material was purified by 
column chromatography eluting with hexanes/EtOAc (9:1 → 3:1) to give 2.0 g (82%) of 
2.208 as a white solid; mp 61–62 °C. 1H NMR (CDCl3, 400 MHz) δ 2.55 (dd, J = 14.5, 7.9 
Hz, 2 H) 2.52 – 2.42 (comp, 2 H) 2.12 (tt, J = 7.0, 2.2 Hz, 2 H) 1.45 (dddd, J = 13.8, 6.5 
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Hz, 2 H)1.19 – 1.39 (comp, 14 H) 0.88 (t, J = 6.7 Hz, 3 H). 13C NMR (100 MHz, CDCl3) 
δ ppm 178.8, 81.7, 77.9, 34.2, 32.1, 29.8, 29.8, 29.6, 29.4, 29.1, 29.1, 22.9, 18.9, 14.7, 14.3; 
IR (film) 3450, 2980, 2924, 2354, 1745, 1421, 1384, 1314, 1259, 1215 cm-1; mass spectrum 
(ESI) m/z 237.1860 [M–H]–, [C15H26O2 [M–H]– requires 237.1860] 
 
 
NMR Assignment. 1H NMR (CDCl3, 400 MHz) δ 2.55 (dd, J = 14.5, 7.9 Hz, 2 H, 
C2-H) 2.52 – 2.42 (comp, 2 H, C3-H) 2.12 (tt, J = 7.0, 2.2 Hz, 2 H, C6-H) 1.45 (dddd, J = 
13.8, 6.5 Hz, 2 H, C7-H)1.19 – 1.39 (comp, 14 H, C8–C14-H) 0.88 (t, J = 6.7 Hz, 3 H, 
C15-H). 13C NMR (100 MHz, CDCl3) δ ppm 178.8 C1, 81.7 C4, 77.9 C5, 34.2 C2, 32.1, 
29.8 C6, 29.8, 29.6, 29.4, 29.1, 29.1, 22.9, 18.9, 14.7, 14.3, C3,C6–C15 
 
 
(Z)-Pentadec-4-enoic acid (2.158) (DK-3-263). NaBH4 (0.480 g, 12.6 mmol) 
dissolved in EtOH (20 mL) was added to a suspension of Ni(OAc)2•4H2O (3.14 g, 12.6 
mmol) in EtOH (80 mL), and the reaction was stirred for 30 min at room temperature. 
Ethylenediamine (0.30 g, 5.04 mmol) was added, followed by a solution of 2.208 (1.0 g, 
4.2 mmol) in EtOH (8 mL), and the reaction was placed under an atmosphere of H2. The 
reaction was stirred for 1 h, and H2O (60 mL) was then added. The reaction mixture was 
acidified with 1 M HCl until ca. pH 2, and the organic layer was removed under reduced 
pressure. The aqueous layer was extracted with Et2O (5 x 100 mL), and the combined 
organic layers were washed with brine (2 x 250 mL), dried (MgSO4), filtered, and 
 267 
concentrated under reduced pressure. The crude product was purified by column 
chromatography, eluting with hexanes/EtOAc (9:1) to give 0.86 g (85%) of 9 as a pale 
yellow oil. 1H NMR (CDCl3, 400 MHz) δ 5.48 – 5.39 (m, 1 H), 5.38 – 5.28 (m, 1 H), 2.44 
– 2.29 (comp, 4 H), 2.04 (dd, J = 7.2, 1.4 Hz, 2 H), 1.39 – 1.17 (comp, 17 H), 0.88 (t, J = 
6.7 Hz, 3 H). 13C NMR (CDCl3, 100 MHz) δ 179.6, 131.9, 126.8, 34.1, 31.9, 29.7, 29.6, 
29.6, 29.5, 29.3, 29.3, 27.2, 22.7, 22.5, 14.1. IR (film) 3454, 2987, 2913, 1719, 1634, 1435, 
1370, 1310, 1225, 1216 cm-1; mass spectrum (ESI) m/z 239.2017 [M–H]–, [C15H28O2 [M–
H]– requires 239.2017] 
 
 
NMR Assignment. 1H NMR (CDCl3, 400 MHz) δ 5.48 – 5.39 (m, 1 H C4-H), 5.38 
– 5.28 (m, 1 H, C5-H), 2.44 – 2.29 (comp, 4 H, C2-H, C3-H), 2.04 (dd, J = 7.2, 1.4 Hz, 2 
H, C6-H), 1.39 – 1.17 (comp, 17 H C7–C14-H), 0.88 (t, J = 6.7 Hz, 3 H, C15-H). 13C NMR 
(CDCl3, 100 MHz) δ 179.6 C1, 131.9 C4, 126.8 C5, 34.1 C2, 31.9 C3, 29.7, 29.6, 29.6, 
29.5, 29.3, 29.3, 27.2, 22.7, 22.5, 14.1.C6–C15 
 
 
(R)-5-((R)-1-Iodoundecyl)dihydrofuran-2(3H)-one (2.156) (DK-3-217). N-
iodosuccinimide (461 mg, 2.05 mmol) and iodine (43 mg, 0.171 mmol) were added to a 
solution of 2.158 (410 mg, 1.71 mmol) and 2.94 (76 mg, 0.171 mmol) in PhMe/CH2Cl2 
(2:1) (60 mL) at –20 °C. The solution was stirred for 14 h, whereupon saturated aqueous 
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Na2S2O3 (20 mL) was added, and the mixture was warmed to room temperature with 
vigorous stirring. The layers were separated, and the aqueous layer was extracted with 
CH2Cl2 (2 × 20 mL). The combined organic layers were dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The crude residue was purified by column 
chromatography, eluting with hexanes/EtOAc (95:5) to give  530 mg (85%) of 2.156 as a 
colorless oil: 1H NMR (CDCl3, 400 MHz) δ ppm 4.36 (td, J = 7.4, 3.4 Hz, 1 H) 4.15 (dt, J 
= 10.0, 3.9 Hz, 1 H) 2.70 (ddd, J = 18.1, 10.6, 4.7 Hz, 1 H) 2.56 (ddd, J = 18.5, 10.1, 8.5 
Hz, 1 H) 2.48–2.32 (m, 1 H) 2.11 (dddd, J = 13.1, 10.6, 8.3, 7.0 Hz, 1 H) 1.97–1.85 (m, 1 
H) 1.81–1.71 (m, 1 H) 1.65–1.51 (m, 1 H) 1.44–1.16 (comp, 15 H) 0.88 (t, J = 6.7, 3 H). 
13C NMR (CDCl3, 100 MHz) δ ppm 176.7, 82.1, 39.4, 35.8, 32.1, 29.8, 29.8, 29.8, 29.6, 
29.5, 29.0, 28.9, 27.0, 22.9, 14.4. IR (film) 2969, 1762, 1469, 1166, 986 cm–1; mass 
spectrum (ESI) m/z 389.0954 [M+Na]+, [C15H27IO2 [M+Na]
+ requires 389.0954]. ]26D 
+11 (c = 0.5, CHCl3). HPLC (254 nm): Whelk-O1 (8% i-PrOH / hexanes, 1.0 mL/min) 
28.2 min (major), 39.9 min (minor); 95:5 er. 
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NMR Assignment. 1H NMR (CDCl3, 400 MHz) δ ppm 4.36 (td, J = 7.4, 3.4 Hz, 1 
H, C5-H) 4.15 (dt, J = 10.0, 3.9 Hz, 1 H, C4-H) 2.70 (ddd, J = 18.1, 10.6, 4.7 Hz, 1 H, C2-
H) 2.56 (ddd, J = 18.5, 10.1, 8.5 Hz, 1 H, C2-H) 2.48–2.32 (m, 1 H C3-H) 2.11 (dddd, J = 
13.1, 10.6, 8.3, 7.0 Hz, 1 H, C3-H) 1.97–1.85 (m, 1 H C6-H) 1.81–1.71 (m, 1 H, C6-H) 
1.65–1.51 (m, 1 H, C7-H) 1.44–1.16 (comp, 15 H, C7–C14-H) 0.88 (t, J = 6.7, 3 H, C15-
H). 13C NMR (CDCl3, 100 MHz) δ ppm 176.7 C1, 82.1 C4, 39.4, 35.8, 32.1, 29.8, 29.8, 
29.8, 29.6, 29.5, 29.0, 28.9, 27.0, 22.9, 14.4. C2,C3,C5–C15 
 
 
(2S,3R)-2-Decyl-3-(5-methylhex-3-en-1-yl)oxirane (2.166) (DK-3-256). DIBAL 
(1 M in hexanes, 0.6 mL, 0.6 mmol) was added dropwise to a solution of 2.158 (200 mg, 
0.55 mmol) in Et2O (6 mL) at –78 °C and the reaction was stirred for 2 h. The reaction 
mixture was added via cannula to a solution of isobutyltriphenylphosphonium bromide 
(500 mg. 1.28 mmol) and n-butyllithium (2.1 M in hexanes, 0.6 mL, 1.2 mmol) in THF (6 
mL) that had been stirred for 45 min at 0 °C. The reaction was warmed to room temperature 
and stirred for 2 h. The solvent was removed under reduced pressure, and the solid was 
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suspended in hexanes (20 mL) and filtered. The filter cake was washed with additional 
hexanes (3 x 10 mL), and the filtrate was concentrated under reduced pressure. The crude 
residue was purified by column chromatography, eluting with hexanes/EtOAc (98:2) to 
give 95 mg (62%) of 2.166 as an inseparable mixture of cis:trans isomers (5:1) as a 
colorless oil. 1H NMR (CDCl3, 400 MHz) δ ppm 5.47–5.20 (comp, 2 H,) 2.95–2.89 (comp, 
2H), 2.61 (dd, J = 13.5, 6.9 Hz, 1H), 2.27–2.14 (comp, 2H), 1.63–1.19 (comp, 20H), 0.96 
(t J = 6.5 Hz, 6H), 0.88 (t, J = 6.7 Hz, 3H). 13C NMR (CDCl3, 100 MHz) δ 138.5, 138.4, 
125.9, 125.8, 57.3, 56.8, 31.9, 29.6, 29.5, 29.3, 28.1, 27.9, 27.8, 26.6, 26.4, 24.4, 23.1, 22.7, 
14.1. IR (film) 2987, 1643, 1465, 1256, 1090 cm–1; mass spectrum (ESI) m/z 303.2663 
[M+Na]+, [C19H36O [M+Na]
+ requires 303.2664] 
 
 
NMR Assignments. 1H NMR (CDCl3, 400 MHz) δ ppm 5.47–5.20 (comp, 2 H, 
C4-H, C3-H) 2.95–2.89 (comp, 2H, C8-H, C7-H), 2.61 (dd, J = 13.5, 6.9 Hz, 1H, C2-H), 
2.27–2.14 (comp, 2H, C5-H), 1.63–1.19 (comp, 20H C6,C9–117-H), 0.96 (t J = 6.5 Hz, 
6H, C1-H), 0.88 (t, J = 6.7 Hz, 3H, C18-H). 13C NMR (CDCl3,100 MHz) δ 138.5 C4, 138.4 
C3, 125.9 C4, 125.8 C3, 57.3 C7, 56.8 C8, 31.9, 29.6, 29.5, 29.3, 28.1, 27.9, 27.8, 26.6, 
26.4, 24.4, 23.1, 22.7, 14.1.C1,C2,C5,C6,C9–18 
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(2S,3R)-2-Decyl-3-(5-methylhexyl)oxirane, (+)-disparlure (2.111) (DK-4-281). 
PtO2 (5 mg, 0.02 mmol) was added to a solution of 2.166 (50 mg, 0.18 mmol) in hexanes 
(1.5 mL) under an H2 atmosphere. The reaction was stirred for 1 h, whereupon it was 
filtered, and the solvent was removed under reduced pressure. The crude residue was 
purified by column chromatography, eluting with hexanes/EtOAc (99:1) to give 45 mg 
(90%) of 2.11 as a colorless oil. The compound was consistent with the previously reported 
data.166,172 ]26D +0.8 (c = 0.3, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 2.90 (p, J = 4.2 Hz, 
2 H), 1.62 – 1.13 (comp, 28 H), 0.87 (d, J = 6.6 Hz, 6 H) 13C NMR (126 MHz, CDCl3) δ 
57.4, 39.1, 32.1, 29.8, 29.7, 29.5, 28.1, 28.0, 28.0, 27.5, 27.0, 26.7, 22.8, 22.8, 22.8, 14.3. 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 2.90 (p, J = 4.2 Hz, 2 H C8,C7-
H), 1.62 – 1.13 (comp, 28 H C2–C18-H), 0.87 (d, J = 6.6 Hz, 6 H, C1-H)  
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Table 7.1 Comparison of 13C NMR peaks of disparlure with reported literature values. 
Grubbs172 Prasad166 Wang147 Pandey314 Martin Martin 
100 MHz 75 MHz 20 MHz 100 MHz 126 MHz 126 MHz 
57.4 57.2 57.12 57.2 57.3 57.28 
57.4 38.9 39.05 38.8 38.9 38.91 
39.1 31.9 32.03 31.8 31.9 31.91 
32.2 29.5 26.69 29.5 29.6 29.61 
32.1 29.3 29.47 29.3 29.6 29.57 
29.8 27.9 28 27.8 29.3 29.34 
29.7 27.3 27.44 27.8 27.9 27.91 
29.6 26.8 27.02 27.8 27.9 27.87 
29.5 26.6 26.73 27.3 27.8 27.83 
28.0 (3C) 22.6 22.68 26.8 27.3 27.34 
27.5 22.5 14.15 26.5 26.9 26.87 
27.4 14.1  26 26.6 26.61 
26.8   22.6 22.7 22.69 
26.2   22.6 22.6 22.63 
22.8 (2C)    14.1 22.6 22.62 
14.3    14.1 14.12 
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tert-Butyl 2-(5-bromo-2-nitrophenyl)acetate (4.15) (DK-3-211) A solution of 4-
bromonitrobenzene (5.00g, 24.8 mmol) and tert-butylchloroacetate (5.60 g, 37.2 mmol) in 
DMF (60 mL) was added via cannula to a stirred solution of t-BuOK (16.7 g, 148.8 mmol) 
in DMF (16.7 g, 148.8 mmol). The reaction was stirred at room temperature for 2 h, 
whereupon it was cooled to 0 °C and 1 M HCl (120 mL) was added. The mixture was 
extracted with EtOAc (3 x 150 mL) and the combined organic layers were washed with 
brine (3 x 150 mL). The organic layers were dried (Mg2SO4), filtered, and concentrated 
under reduced pressure. The crude mixture was purified by column chromatography, 
eluting with hexanes/EtOAc (95:5 to 90:10) to give 7.05 g (90%) of 4.15 as a yellow solid. 
The compound was consistent with the previously reported data.221 1H NMR (400 MHz, 
CDCl3) δ 7.96 (d, J = 8.5 Hz, 1H), 7.57 (dd, J = 8.5, 2.0 Hz, 1H), 7.48 (d, J = 2.0 Hz, 1H), 
3.89 (s, 2H), 1.41 (s, 9H),  
 
 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 8.5 Hz, 1H, C2-
H), 7.57 (dd, J = 8.5, 2.0 Hz, 1H, C3-H), 7.48 (d, J = 2.0 Hz, 1H, C5-H), 3.89 (s, 2H, C7-
H), 1.41 (s, 9H, C10-H) 
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tert-Butyl-2-(5-bromo-2-nitrophenyl)propanoate (4.16) (DK-3-213) Sodium 
hydride (60% dispersion in mineral oil, 0.75 g, 18.3 mmol) was added to a solution of 4.15 
(6.21 g, 18.3 mmol) in THF (65 mL). Methyl iodide (5.3 g, 37.6 mmol) was added 
dropwise, and the reaction was stirred at room temperature for 14 h, whereupon, H2O (60 
mL) was added, and the layers were separated. The aqueous layer was extracted with 
EtOAc (3 x 100 mL) and the combined organic layers were washed with brine (2 x 100 
mL), dried (Mg2SO4), filtered, and concentrated under reduced pressure. The crude 
material was purified by column chromatography, eluting with hexanes/EtOAc (95:5) to 
give 4.83 g (80%) of 4.16 as a yellow solid. The compound was consistent with the 
previously reported data.221 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.5 Hz, 1H), 7.62 
(d, J = 2.0 Hz, 1H), 7.54 (dd, J = 8.5, 2.0 Hz, 1H), 4.21 (q, J = 7.1 Hz, 1H), 1.57 (d, J = 
7.1 Hz, 3H), 1.40 (s, 9H).  
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.5 Hz, 1H, C2-H), 
7.62 (d, J = 2.0 Hz, 1H, C3-H), 7.54 (dd, J = 8.5, 2.0 Hz, 1H, C3-H), 4.21 (q, J = 7.1 Hz, 
1H, C7-H), 1.57 (d, J = 7.1 Hz, 3H, C11-H), 1.40 (s, 9H C10-H).  
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2-(5-Bromo-2-nitrophenyl)propan-1-ol (4.17) (DK-3-234) DIBAL (1 M in 
hexanes, 18.2 mL, 18.2 mmol) was added dropwise to a solution 4.16 (2.0 g, 6.06 mmol) 
in THF (76 mL) at 0 °C. The reaction was stirred for 3 h, whereupon, 6 M HCl (50 mL) 
was added slowly. The reaction mixture was extracted with EtOAc (3 x 150mL) and the 
combined organic layers were washed with a 10% aqueous solution of Rochelle’s salt (3 x 
50 mL), then dried (Mg2SO4), filtered, and concentrated under reduced pressure. The crude 
material was purified by column chromatography eluting with hexanes/EtOAc (9:1) to give 
1.42 g (90%) of 4.17 as a red oil. The compound was consistent with the previously 
reported data.221 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 8.7 Hz, 1H), 7.63 (d, J = 2.1 
Hz, 1H), 7.49 (dd, J = 8.6, 2.1 Hz, 1H), 3.79 (ddd, J = 17.9, 10.8, 6.5 Hz, 2H), 3.55 (ddd, 
J = 13.8, 6.9 Hz, 1H), 1.33 (d, J = 6.9 Hz, 3H). 
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 8.7 Hz, 1H C2-H), 
7.63 (d, J = 2.1 Hz, 1H, C5-H), 7.49 (dd, J = 8.6, 2.1 Hz, 1H, C3-H), 3.79 (ddd, J = 17.9, 
10.8, 6.5 Hz, 2H, C8-H), 3.55 (ddd, J = 13.8, 6.9 Hz, 1H, C7-H), 1.33 (d, J = 6.9 Hz, 3H, 
C9-H). 
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2-(4'-Amino-4-nitro-[1,1'-biphenyl]-3-yl)propan-1-ol (4.19) (DK-2-244). 
Pd(OAc)2 (50.5 mg, 0.194 mmol) was added to a solution of 4.17 (505 mg, 1.95 mmol), 4-
amino-phenyl boronic acid hydrochloride (404 mg, 2.3 mmol), K2CO3 (725 mg, 5.24 
mmol), B4NBr (626 mg, 1.94 mmol) in degassed EtOH/H2O (2:1, 15 mL), and the reaction 
was heated under reflux for 3 h. Upon cooling to room temperature, H2O (50 mL) was 
added and the mixture was extracted with EtOAc (3 x 50mL). The combined organic 
extracts were washed with brine (50 mL), dried (Mg2SO4), and concentrated under reduced 
pressure. The crude product was purified by column chromatography eluting with 
hexanes/EtOAc (7:3) to give 425 mg (81%) of 4.19 as an orange solid. The compound was 
consistent with the previously reported data.221 1H NMR (400 MHz, CD3OD) δ 7.81 (d, J 
= 8.5 Hz, 1H), 7.66 (d, J = 2.0 Hz, 1H), 7.54 (dd, J = 8.5, 2.0 Hz, 1H), 7.46 (d, J = 8.6 Hz, 
2H), 6.79 (d, J = 8.6 Hz, 2H), 3.80 (dd, J = 10.8, 6.9 Hz, 1H), 3.70 (dd, J = 10.8, 6.4 Hz, 
1H), 3.53 (dd, J = 13.6, 6.8 Hz, 1H), 1.36 (d, J = 6.9 Hz, 3H). 
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NMR Assignment. 1H NMR (400 MHz, CD3OD) δ 7.81 (d, J = 8.5 Hz, 1H, C2-
H), 7.66 (d, J = 2.0 Hz, 1H, C11-H), 7.54 (dd, J = 8.5, 2.0 Hz, 1H, C3-H), 7.46 (d, J = 8.6 
Hz, 2H, C6,C10-H), 6.79 (d, J = 8.6 Hz, 2H, C7,C9-H), 3.80 (dd, J = 10.8, 6.9 Hz, 1H, 
C14-H), 3.70 (dd, J = 10.8, 6.9 Hz, 1H, C14-H), 3.53 (dd, J = 13.6, 6.9 Hz, 1H, C13-H), 
1.36 (d, J = 6.9 Hz, 3H, C15-H). 
 
 
Di-tert-butyl 2,2'-((3'-(1-hydroxypropan-2-yl)-4'-nitro-[1,1'-biphenyl]-4-yl)-
azanediyl)diacetate (4.21) (DK-4-156). tert-Butyl 2-bromoacetate (0.382 g, 0.289 mL, 
1.96 mmol) was added to a solution of 4.19 (0.195 g, 0.717 mmol) and i-PrNEt2 (0.279 g, 
0.375 mL, 2.15 mmol) in DMF (10 mL). The reaction mixture was heated to 80 °C and 
stirred for 12 h, whereupon it was cooled to room temperature and quenched with saturated 
aqueous NaHCO3 (10 mL). The mixture was extracted with EtOAc (3 x 20 mL), and the 
combined organic extracts were washed with brine (5 x 20 mL), dried (Mg2SO4), filtered, 
and concentrated under reduced pressure. The crude material was purified by column 
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chromatography eluting with hexanes/EtOAc (7:3) to afford 190 mg (45%) of 4.21 as an 
orange solid. The compound was consistent with the previously reported data.221 1H NMR 
(400 MHz, CDCl3) δ 7.85 (d, J = 8.5 Hz, 1H), 7.59 (d, J = 1.8 Hz, 1H), 7.51 – 7.46 (comp, 
3H), 6.67 (d, J = 8.8 Hz, 2H), 4.06 (s, 4H), 3.86 – 3.82 (comp, 2H), 3.67 (dd, J = 13.3, 6.6 
Hz, 1H), 1.48 (s, 18H), 1.37 (d, J = 6.9 Hz, 3H). 
 
 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.5 Hz, 1H, C2-
H), 7.59 (d, J = 1.8 Hz, 1H, C11-H), 7.51 – 7.46 (comp, 3H, C6,C10,C3-H ), 6.67 (d, J = 
8.8 Hz, 2H, C7,C9-H), 4.06 (s, 4H, C16-H), 3.86–3.82 (comp, 2H, C14-H), 3.67 (dd, J = 
13.3, 6.6 Hz, 1H, C13-H), 1.48 (s, 19H, C18-H), 1.37 (d, J = 6.9 Hz, 3H, C15-H). 
 
 
2-(5-Bromo-2-nitrophenyl)ethan-1-ol (4.23) (DK-5-219). DBAL (1 M in 
hexanes, 30.0 mL, 30.0 mmol) was added to a solution of 4.15 (3.15 g, 10 mmol) in THF 
(100 mL) at 0 °C. The was stirred for 3 h, whereupon, 6 M HCl (50 mL) was added slowly, 
and the layers were separated. The aqueous layer was washed with EtOAc (3 x 50 mL) and 
the combined organic layers were washed with a 10% aqueous solution of Rochelle’s salt 
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(3 x 50 mL), then dried (Mg2SO4), filtered, and concentrated under reduced pressure. The 
crude material was purified by column chromatography eluting with hexanes/EtOAc (9:1) 
to give 2.2 g (90%) of 4.23 as a red-orange oil. 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 
8.7 Hz, 1H), 7.60 (d, J = 2.1 Hz, 1H), 7.53 (dd, J = 8.7, 2.2 Hz, 1H), 3.96 (t, J = 6.3 Hz, 
2H), 3.16 (t, J = 6.3 Hz, 2H). 13C NMR (CDCl3,100 MHz)  148.2, 141.0, 131.6, 130.4, 
127.5, 125.7, 67.6, 36.4. mass spectrum (ESI) m/z 268.0 [M+Na]+, 270.0 [M+Na]+ 
[C8H8BrNO3 [M+Na]
+  requires 268.96 , 269.96].   
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.7 Hz, 1H, C2-H), 
7.60 (d, J = 2.1 Hz, 1H, C5-H), 7.53 (dd, J = 8.7, 2.2 Hz, 1H, C3-H), 3.96 (t, J = 6.3 Hz, 
2H, C8-H), 3.16 (t, J = 6.3 Hz, 2H, C7-H). 13C NMR (CDCl3,100 MHz)  148.2 C1, 141.0 
C6, 131.6 C5, 130.4 C3, 127.5 C4, 125.7 C2, 67.6 C8, 36.4 C7. 
 
 
2-(4'-Amino-4-nitro-[1,1'-biphenyl]-3-yl)ethan-1-ol (4.24) (DK-5-209). 
Pd(OAc)2 (50.5 mg, 0.194 mmol) was added to a solution of 4.23 (500 mg, 2.0 mmol), 4-
amino-phenyl boronic acid hydrochloride (404 mg, 2.3 mmol), K2CO3 (725 mg, 5.24 
mmol), B4NBr (626 mg, 2.0 mmol) in degassed EtOH/H2O (2:1, 15 mL), and the reaction 
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was heated under reflux for 3 h. Upon cooling to rt, H2O (50 mL) was added and the 
mixture was extracted with EtOAc (3 x 50mL). The combined organic extracts were 
washed with brine (50 mL), dried (Mg2SO4), and concentrated under reduced pressure. The 
crude was purified by column chromatography eluting with hexanes/EtOAc (7:3) to give 
425 mg (81%) of 4.24 as an orange solid. m.p. 162–163 °C. 1H NMR (400 MHz, CDCl3) 
δ 8.01 (d, J = 8.4 Hz, 1H), 7.52 (dd, J = 4.4, 2.0 Hz, 1H), 7.49 (d, J = 2.1 Hz, 1H), 7.43 (d, 
J = 8.7 Hz, 2H), 6.75 (d, J = 8.7 Hz, 2H), 3.98 (dd, J = 11.8, 6.2 Hz, 2H), 3.85 (s, 2H), 3.24 
(t, J = 6.4 Hz, 2H). 13C NMR (100MHz, CDCl3) 147.2, 145.9, 139.0, 129.0, 127.3, 125.7, 
125.2, 124.7, 115.4, 111.8, 68.1, 36.5. mass spectrum (ESI) m/z 258.1 [M+H]+, 
[C14H14N2O3 [M+H]
+ requires 258.10].  
 
 
NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.4 Hz, 1H, C2-H), 
7.52 (dd, J = 4.4, 2.0 Hz, 1H, C3-H), 7.49 (d, J = 2.1 Hz, 1H, C12-H), 7.43 (d, J = 8.7 Hz, 
2H, C6-H), 6.75 (d, J = 8.7 Hz, 2H, C7-H), 3.98 (dd, J = 11.8, 6.2 Hz, 2H, C15-H), 3.85 
(s, 2H, NH2), 3.24 (t, J = 6.4 Hz, 2H, C14-H). 13C NMR (100MHz, CDCl3) 147.2 C1, 145.9 
C4, 139.0 C8, 129.0 C6, 127.3 C3, 125.7 C2, 125.2 C7, 124.7 C5, 115.4 C12, 111.8 C13, 
68.1 C15, 36.5 C14 
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Di-tert-butyl 2,2'-((3'-(2-hydroxyethyl)-4'-nitro-[1,1'-biphenyl]-4-yl)azanedi-
yl)diacetate (4.25) (DK-5-213). tert-Butyl 2-bromoacetate (0.280 g, 0.21 mL, 1.45 mmol) 
was added to a solution of 4.24 (0.150 g, 0.58 mmol) and i-PrNEt2 (0.225 g, 0.3 mL, 1.74 
mmol) in DMF (6 mL). The reaction mixture was heated to 80 °C and stirred for 12 h. 
Upon cooling to room temperature, the reaction was quenched with saturated aqueous 
NaHCO3 (10 mL). The mixture was extracted with EtOAc (3 x 20 mL), and the combined 
organic extracts were washed with brine (5 x 20 mL), dried (Mg2SO4), filtered, and 
concentrated under reduced pressure. The crude material was purified by column 
chromatography eluting with hexanes/EtOAc (7:3) to afford 0.145 g (52%) of 4.25 as an 
orange solid. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.4 Hz, 1H), 7.58 – 7.46 (comp, 
4H), 6.67 (d, J = 8.9 Hz, 2H), 4.06 (s, 4H), 3.99 (t, J = 6.4 Hz, 2H), 3.25 (t, J = 6.4 Hz, 
2H), 1.48 (s, 18H). 13C NMR (100MHz, CDCl3) δ 169.7, 148.6, 148.4, 139.1, 145.8, 139.0, 
128.2, 125.7, 125.2, 124.7, 112.6, 82.0, 68.1, 54.5, 30.9, 24.4; mass spectrum (ESI) m/z 
486.2 [M+H]+, [C26H34N2O7 [M+H]
+ requires 486.24].  
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NMR Assignment. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.4 Hz, 1H, C2-H), 
7.58 – 7.46 (comp, 4H, C3,C12,C6-H), 6.67 (d, J = 8.9 Hz, 2H, C7-H), 4.06 (s, 4H, C-H), 
3.99 (t, J = 6.4 Hz, 2H, C15-H), 3.25 (t, J = 6.4 Hz, 2H, C14-H), 1.48 (s, 18H, C11-H). 13C 
NMR (100MHz, CDCl3) δ 169.7 C16, 148.6 C1, 148.4 C5, 139.1 C8, 139.0 C8, 128.2 C6, 
125.7 C3, 125.2 C7, 124.7 C5, 112.6 C12, 82.0 C10, 68.1 C15, 54.5 C15, 30.9 C9, 24.4 
C14.  
 
 
 
Di-tert-butyl 2,2'-((3'-(1-((3-methoxy-4-(methoxymethoxy)-benzoyl)oxy)-
propan-2-yl)-4'-nitro-[1,1'-biphenyl]-4-yl)azanediyl)diacetate. (4.36) (DK-4-157). 
Triethylamine (0.04 g, 0.4 mmol) and DMAP (0.004 g, 0.03 mmol) were added to a 
solution of 4.21 (0.1 g, 0.2 mmol), 4.36 (0.042 g, 0.2 mmol), and 2,4,6-trichlorobenzoyl 
chloride (0.05 g, 0.2 mmol) in THF (2 mL) at 0 °C. The reaction was warmed to room 
temperature over 2 h and was stirred for an additional 2 h, whereupon it was diluted with 
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H2O (5 mL) followed by EtOAc (5 mL). The layers were separated and the organic layer 
was dried (Na2SO4), filtered, and concentrated. The crude material was purified by column 
chromatography eluting with hexanes/EtOAc (9:1) to give 0.080 g of 4.36 as a yellow film. 
1H NMR (400 MHz, CDCl3) δ 7.85 (dd, J = 8.5, 3.1 Hz, 1H), 7.66 – 7.41 (comp, 5H), 7.12 
(d, J = 8.5 Hz, 1H), 6.66 (dd, J = 8.7, 4.5 Hz, 2H), 6.40 (s, 2H), 5.28 (d, J = 8.2 Hz, 2H), 
4.50 (d, J = 6.9 Hz, 2H), 4.08–4.01 (comp, 3H), 3.90–3.79 (comp, 3H), 3.50 (d, J = 7.0 Hz, 
2H), 1.53–1.42 (comp, 12H); mass spectrum (ESI) m/z 694.3 [M+H]+, [C37H46N2O11 
[M+H]+ requires 694.31]. 
 
 
Di-tert-butyl 2,2'-((3'-(1-(4-(tert-butoxycarbonyl)-2-methoxyphenoxy)pro-
pan-2-yl)-4'-nitro-[1,1'-biphenyl]-4-yl)azanediyl)diacetate (4.40) (DK-4-153). Diethyl 
azodicarboxylate (DEAD) (0.016 g, 0.092 mmol) was added to a solution of 4.21 (0.046 g, 
0.092 mmol), tert-butyl 4-hydroxy-3-methoxybenzoate (0.014 g, 0.062 mmol), and 
triphenylphosphine (0.024 g, 0.0923 mmol) in THF (0.6 mL), and the reaction stirred for 
14 h. The solvent was removed under reduced pressure and the crude material was purified 
by column chromatography eluting with hexanes/EtOAc (90:10) to give 0.027 g (63%)of 
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4.40 as a yellow film. 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 8.5 Hz, 1H), 7.82 (d, J = 
1.8 Hz, 1H), 7.59 – 7.46 (comp, 5H), 6.85 (d, J = 8.4 Hz, 1H), 6.67 (d, J = 8.9 Hz, 2H), 
4.33 (dd, J = 9.4, 5.0 Hz, 1H), 4.19 (dd, J = 9.4, 6.1 Hz, 1H), 4.08 (d, J = 12.4 Hz, 4H), 
4.00 (dd, J = 12.1, 6.0 Hz, 1H), 3.81 (s, 3H), 1.63 – 1.42 (comp, 30H). 13C NMR (100 MHz 
CDCl3) δ 168.4, 164.7, 153.8, 150.8, 150.0, 149.6, 144.4, 142.3, 132.6, 131.3, 128.1, 127.6, 
123.9, 123.3, 122.7, 117.9, 116.0, 114.1, 82.0, 75.1, 56.8, 52.0, 36.4, 28.4, 17.9; mass 
spectrum (ESI) m/z 706.3 [M+H]+, [C39H50N2O10 [M+H]
+ requires 706.35].  
 
 
(1S,4aS,12aS)-3-Carbamoyl-2,4a,6,7-tetrahydroxy-N,N,11-trimethyl-4,5-
dioxo-1,4,4a,5,12,12a-hexahydrotetracen-1-aminium (ATc-HCl, 4.2-HCl) (DK-4-
241). Tetracycline (0.5 g, 1.04 mmol) was suspended in a solution of i-PrOH/HCl/MeOH 
(20:5:1) (6 mL) and stirred at room temperature for 48 h. The suspension was filtered, and 
the filter cake was washed with i-PrOH (3 x 5 mL) followed by Et2O (2 x 5 mL). The 
filtered solid was collected and dried to give 0.440 (85%) of 4.2-HCl as an orange solid. 
This sample was identical to commercially available 4.2-HCl. 1H NMR (400 MHz, 
CD3OD) δ 7.59 (d, J = 7.9 Hz, 1H), 7.48 (dd, J = 8.5, 0.9 Hz, 1H), 6.89 (dd, J = 7.8, 0.8 
Hz, 1H), 4.26 (d, J = 4.0 Hz, 1H), 3.63 (dd, J = 17.4, 4.9 Hz, 1H), 3.42 (dt, J = 9.2, 4.9 Hz, 
1H), 3.09 (d, J = 25.4 Hz, 6H), 2.45 (s, 3H), mass spectrum (ESI) m/z 426.1 [M+H]+, 
[C22H22N2O7 [M+H]
+ requires 426.14].  
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NMR Assignment. 1H NMR (400 MHz, CD3OD) δ 7.59 (d, J = 7.9 Hz, 1H, C3-
H), 7.48 (dd, J = 8.5, 0.9 Hz, 1H, C2-H), 6.89 (dd, J = 7.8, 0.8 Hz, 1H, C1-H), 4.26 (d, J = 
4.0 Hz, 1H, C7-H), 3.63 (dd, J = 17.4, 4.9 Hz, 1H, C6-H), 3.42 (dt, J = 9.2, 4.9 Hz, 1H, 
C5-H), 3.09 (comp, 7H, C8-H, C5-H), 2.45 (s, 3H, C4-H),  
 
 
 
Di-tert-butyl 2,2'-((3'-(2-(((((6aS,7S,10aS)-9-carbamoyl-7-(dimethylamino)-
8,10a,12-trihydroxy-5-methyl-10,11-dioxo-6,6a,7,10,10a,11-hexahydrotetracen-1-
yl)oxy)carbonyl)oxy)ethyl)-4'-nitro-[1,1'-biphenyl]-4-yl)azanediyl)diacetate (4.61) 
(DK-4-289). A solution of i-PrNEt2 (0.031 g, 0.24 mmol) and 4.25 (0.080 g, 0.16 mmol) 
in THF (0.8 mL) was added drop wise to a solution of phosgene (15% wt in PhMe, 0.527 
g, 0.573 mL, 0.8 mmol) in THF (0.8 mL) at 0 °C and the reaction stirred for 0.5 h. The 
solvent was removed under reduced pressure and the crude material was dissolved in 
CH3CN (0.75 mL), and added dropwise to a solution of 4.2-HCl (0.061 g, 0.133 mmol), 
N-methylimidazole (0.002 g, 0.0267 mmol), and i-PrNEt2 (0.038 g, 0.293 mmol) in CH3CN 
(0.75 mL) at 0 °C. The reaction was stirred for 1 h, whereupon, the solvent was removed 
under reduced pressure, and the crude material was purified by chromatography eluting 
 286 
with CH2Cl2/MeOH (98.5:1.5) to give 0.07 g (52%) of 4.61 as an orange solid. 
1H NMR 
(400 MHz, CDCl3) δ 8.07 (d, J = 8.5 Hz, 1H), 7.87 (d, J = 8.8 Hz, 1H), 7.64–7.49 (comp, 
5H), 7.10 (d, J = 7.2 Hz, 1H), 6.66 (d, J = 8.9 Hz, 2H), 6.02 (s, 1H), 4.63 (td, J = 6.5, 2.2 
Hz, 2H), 4.06 (s, 4H), 3.62–3.18 (comp, 6H), 2.68 (m, 1H), 2.54 – 2.36 (comp, 9 H), 1.66 
– 1.37 (comp, 18 H); mass spectrum (ESI) m/z 939.4 [M+H]+, [C22H22N2O7 [M+H]+ 
requires 939.36] 
 
 
 
 
(E)-N-methyl-N-((E)-5-oxopent-3-en-1-yl)but-2-enamide (6.6) (DK-5-86). 
Crotonyl chloride (1.28 g, 12.2 mmol) was added drop wise to a solution of 6.7 (0.53 g, 
4.1 mmol) in CH3CN (15 mL) at 0 °C. The reaction was stirred for 0.5 h, and then heated 
under reflux for 1 h. After cooling to room temperature, TMSOTf (0.09 g, 0.5 mmol) and 
6.8 (2.0 g, 14.3 mmol) were added, and the reaction was stirred for 14 h. The reaction was 
quenched with saturated aqueous NH4Cl (20 mL) and the organic layer was removed under 
reduced pressure. The remaining aqueous layer was extracted with CH2Cl2 (3 x 40 mL) 
and the combined organic layers were washed with brine (2 x 50 mL), dried (Na2SO4), 
filtered, and concentrated under reduced pressure. The crude material was purified by 
chromatography eluting with hexanes/EtOAc (25:75) to afford 2.2 g of 6.6 as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 9.50 (d, J = 7.9 Hz, 1H), 7.04–6.70 (comp, 2H), 6.31–6.06 
(comp, 2H), 3.59 (dt, J = 13.9, 6.7 Hz, 2H), 3.15–2.93 (comp, 3H), 2.62 (dd, J = 13.9, 6.7 
Hz, 2H), 1.89 (dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 192.7, 170.0, 154.0, 
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139.5, 131.7, 121.2, 47.4, 34.7, 29.4, 17.3; mass spectrum (ESI) m/z 182.1 [M+H]+, 
[C10H15NO2 [M+H]
+ requires 182.12] 
 
 
 
 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 9.50 (d, J = 7.9 Hz, 1H, C1-
H), 7.04–6.70 (comp, 2H, C3,C8-H), 6.31 – 6.06 (comp, 2H, C2,C7-H), 3.59 (dt, J = 14.3, 
7.0 Hz, 2H, C5-H), 3.15–2.93 (comp, 3H C6-H), 2.62 (dd, J = 13.5, 6.4 Hz, 2H, C4-H), 
1.89 (dd, J = 6.9, 1.7 Hz, 3H, C9). 13C NMR (100 MHz, CDCl3) δ 192.7 C1, 170.0 C10, 
154.0 C3, 139.5 C8, 131.7 C2, 121.2 C7, 47.4 C6, 34.7 C5, 29.4 C4, 17.3 C9. 
 
 
(1S,4aR,8aR)-1,7-dimethyl-1,4a,5,6,7,8a-hexahydro-8H-pyrano[3,4-c]pyridin-
8-one (6.33) (DK-5-63) The triene 6.6 (0.5 g, 2.76 mmol) was dissolved in degassed 
xylenes (180 mL) and the reaction vessel was sealed and heated to 190 °C for 18 h. After 
cooling to room temperature, the solvent was removed under reduced pressure and the 
crude material was purified by chromatography eluting with hexanes/EtOAc (1:1 to 1:3) 
to give 0.29 g (58%) of 6.33. as a gold oil. 1H NMR (500 MHz, CDCl3) δ 6.41 (dd, J = 6.2, 
1.9 Hz, 1H), 4.84 (qd, J = 6.6, 3.8 Hz, 1H), 4.55 (dd, J = 5.8, 2.9 Hz, 1H), 3.39 (ddd, J = 
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11.9, 10.5, 4.5 Hz, 1H), 3.16 (dt, J = 12.0, 4.7 Hz, 1H), 2.95 (s, 3H), 2.78 – 2.67 (comp, J 
= 8.5, 2.7 Hz, 1H), 2.41 (dd, J = 5.6, 4.2 Hz, 1H), 1.99 (dddd, J = 13.8, 10.1, 5.1, 3.7 Hz, 
1H), 1.88 – 1.75 (m, 1H), 1.36 (d, J = 6.7 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 171.0, 
144.4 100.5, 70.2, 46.7, 44.4, 35.2, 27.1, 25.9, 18.2. mass spectrum (ESI) m/z 182.1 
[M+H]+, [C10H15NO2 [M+H]
+ requires 182.12] 
 
 
NMR Assignment. 1H NMR (500 MHz, CDCl3) δ 6.41 (dd, J = 6.4, 1.9 Hz, 1H, 
C10-H), 4.84 (qd, J = 6.4, 3.8 Hz, 1H, C9-H), 4.55 (dd, J = 5.7, 2.9 Hz, 1H, C2-H), 3.39 
(ddd, J = 12.0, 10.5, 4.4 Hz, 1H, C6-H), 3.16 (dt, J = 12.0, 4.6 Hz, 1H, C6-H), 2.95 (s, 3H, 
C5-H), 2.78 – 2.67 (m, 1H, C8-H), 2.41 (dd, J = 5.7, 4.4 Hz, 1H, C3-H), 1.99 (dddd, J = 
13.8, 10.1, 5.1, 3.7 Hz, 1H C7-H), 1.88 – 1.75 (m, 1H, C7-H), 1.36 (d, J = 6.7 Hz, 3H, C1-
H).  
 
 
(1S,4aS,8aR)-4-Iodo-1,7-dimethyl-1,4a,5,6,7,8a-hexahydro-8H-pyrano[3,4-
c]pyridin-8-one (6.36) (DK-5-175). N-Iodosuccinimide (0.5 g, 2.2 mmol) and AgNO3 
(0.01 g 0.55 mmol) were added to solution of 6.33 (0.39 g, 1.7 mmol) in CH3CN (18 mL) 
at 80 °C and the reaction was stirred for 2 h. After cooling to room temperature, the solvent 
was removed under reduced pressure and the crude material was dissolved in CH2Cl2 (15 
mL), and washed with H2O (2 x 10 mL). The layers were separated and the organic layer 
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was dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude material 
was purified by column chromatography eluting with hexanes/EtOAc (1:1 to 1:3) to give 
0.35 g (67%) of 6.36 as a yellow oil.1H NMR (400 MHz, CDCl3) δ 6.71 (d, J = 1.8 Hz, 
1H), 4.82 (qd, J = 6.6, 4.3 Hz, 1H), 3.73 (ddd, J = 6.7, 3.4, 1.7 Hz, 1H), 3.31 (ddd, J = 19.9, 
11.3, 6.9 Hz, 2H), 3.12 (dt, J = 12.3, 5.0 Hz, 1H), 2.98–2.87 (comp, 3H), 2.76 – 2.69 (m, 
1H), 2.55 (dt, J = 16.6, 8.3 Hz, 1H), 2.08 – 2.00 (comp, 2H), 1.88 – 1.80 (m, 1H), 1.35 (d, 
J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 169.7, 142.3, 76.0, 45.6, 44.7, 36.8, 34.5, 
26.8, 19.1. mass spectrum (ESI) m/z 308.0 [M+H]+, [C10H14INO2 [M+H]
+ requires 308.01] 
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